[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 185
1. Pagot-Mathis V, Benouaich X, Mathis A, Rico-Lattes I, Dumoulin A: [Management of complicated retinal detachment using a heavy silicon oil as temporary tamponade]. J Fr Ophtalmol; 2006 Feb;29(2):137-45
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Tamponnement interne par huile de silicone lourde (Oxane Hd) dans les décollements de rétine complexes.
  • Recurrent retinal detachment with proliferative vitreoretinopathy occurred in eight cases during heavy silicon oil tamponade.
  • CONCLUSION: Heavy silicon oil (Oxane Hd) is as safe and effective as standard silicon oil in the treatment of selected retinal detachment, but intraocular manipulations are quite difficult.
  • A prospective study is necessary to compare the efficacy of Oxane Hd and standard silicon oil in selected cases of retinal detachment with inferior breaks and in cases of large inferior retinectomy.
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Female. Follow-Up Studies. Humans. Male. Middle Aged. Postoperative Complications / epidemiology. Retreatment. Time Factors

  • MedlinePlus Health Information. consumer health - Retinal Detachment.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16523154.001).
  • [ISSN] 1773-0597
  • [Journal-full-title] Journal français d'ophtalmologie
  • [ISO-abbreviation] J Fr Ophtalmol
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Silicone Oils
  •  go-up   go-down


2. de Kovel CG, Trucks H, Helbig I, Mefford HC, Baker C, Leu C, Kluck C, Muhle H, von Spiczak S, Ostertag P, Obermeier T, Kleefuss-Lie AA, Hallmann K, Steffens M, Gaus V, Klein KM, Hamer HM, Rosenow F, Brilstra EH, Trenité DK, Swinkels ME, Weber YG, Unterberger I, Zimprich F, Urak L, Feucht M, Fuchs K, Møller RS, Hjalgrim H, De Jonghe P, Suls A, Rückert IM, Wichmann HE, Franke A, Schreiber S, Nürnberg P, Elger CE, Lerche H, Stephani U, Koeleman BP, Lindhout D, Eichler EE, Sander T: Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain; 2010 Jan;133(Pt 1):23-32
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies.
  • Studies of structural genomic variations have revealed a significant excess of recurrent microdeletions at 1q21.1, 15q11.2, 15q13.3, 16p11.2, 16p13.11 and 22q11.2 in various neuropsychiatric disorders including autism, intellectual disability and schizophrenia.
  • Microdeletions at 15q13.3 have recently been shown to constitute a strong genetic risk factor for common idiopathic generalized epilepsy syndromes, implicating that other recurrent microdeletions may also be involved in epileptogenesis.
  • The present results indicate an involvement of microdeletions at 15q11.2 and 16p13.11 in epileptogenesis and strengthen the evidence that recurrent microdeletions at 15q11.2, 15q13.3 and 16p13.11 confer a pleiotropic susceptibility effect to a broad range of neuropsychiatric disorders.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Epilepsia. 1989 Jul-Aug;30(4):389-99 [2502382.001]
  • [Cites] Gesundheitswesen. 2005 Aug;67 Suppl 1:S26-30 [16032514.001]
  • [Cites] Epilepsia. 2005;46 Suppl 9:10-4 [16302871.001]
  • [Cites] Epilepsia. 2005;46 Suppl 9:21-33 [16302873.001]
  • [Cites] Community Genet. 2006;9(1):55-61 [16490960.001]
  • [Cites] Nat Genet. 2006 Aug;38(8):904-9 [16862161.001]
  • [Cites] Science. 2007 Apr 20;316(5823):445-9 [17363630.001]
  • [Cites] Hum Mutat. 2007 Jul;28(7):674-82 [17480035.001]
  • [Cites] Hum Mol Genet. 2008 Feb 15;17(4):628-38 [18156158.001]
  • [Cites] Am J Hum Genet. 2008 Feb;82(2):477-88 [18252227.001]
  • [Cites] N Engl J Med. 2008 Feb 14;358(7):667-75 [18184952.001]
  • [Cites] Lancet Neurol. 2008 Mar;7(3):231-45 [18275925.001]
  • [Cites] Nat Genet. 2008 Mar;40(3):322-8 [18278044.001]
  • [Cites] Hum Genet. 2008 Aug;124(1):1-17 [18512078.001]
  • [Cites] Hum Mol Genet. 2008 Aug 15;17(16):2441-55 [18469343.001]
  • [Cites] Nature. 2008 Sep 11;455(7210):237-41 [18668038.001]
  • [Cites] Nature. 2008 Sep 11;455(7210):232-6 [18668039.001]
  • [Cites] N Engl J Med. 2008 Oct 16;359(16):1685-99 [18784092.001]
  • [Cites] Nature. 2008 Oct 16;455(7215):919-23 [18923514.001]
  • [Cites] Hum Mol Genet. 2008 Dec 15;17(24):4045-53 [18806272.001]
  • [Cites] Nat Genet. 2008 Dec;40(12):1466-71 [19029900.001]
  • [Cites] Prog Neurobiol. 2009 Jan 12;87(1):41-57 [18952142.001]
  • [Cites] Nat Genet. 2009 Feb;41(2):160-2 [19136953.001]
  • [Cites] Hum Mutat. 2009 Feb;30(2):135-44 [18837009.001]
  • [Cites] PLoS Genet. 2009 Feb;5(2):e1000373 [19197363.001]
  • [Cites] Am J Hum Genet. 2009 Feb;84(2):148-61 [19166990.001]
  • [Cites] PLoS One. 2009;4(3):e4906 [19300510.001]
  • [Cites] Hum Mol Genet. 2009 Apr 15;18(8):1497-503 [19181681.001]
  • [Cites] J Med Genet. 2009 Apr;46(4):223-32 [18550696.001]
  • [Cites] J Med Genet. 2009 Apr;46(4):242-8 [18805830.001]
  • [Cites] Eur J Hum Genet. 2009 May;17(5):687-92 [19050728.001]
  • [Cites] Curr Opin Genet Dev. 2009 Jun;19(3):196-204 [19477115.001]
  • [Cites] Nat Rev Genet. 2009 Aug;10(8):551-64 [19597530.001]
  • [Cites] J Med Genet. 2009 Aug;46(8):511-23 [19372089.001]
  • [Cites] Hum Mol Genet. 2009 Oct 1;18(19):3626-31 [19592580.001]
  • [CommentIn] Brain. 2010 Jan;133(Pt 1):7-8 [20047903.001]
  • (PMID = 19843651.001).
  • [ISSN] 1460-2156
  • [Journal-full-title] Brain : a journal of neurology
  • [ISO-abbreviation] Brain
  • [Language] ENG
  • [Grant] United States / NICHD NIH HHS / HD / HD043376; United States / NICHD NIH HHS / HD / HD043569; United States / Howard Hughes Medical Institute / /
  • [Publication-type] Comparative Study; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2801323
  •  go-up   go-down


3. Catov JM, Wu CS, Olsen J, Sutton-Tyrrell K, Li J, Nohr EA: Early or recurrent preterm birth and maternal cardiovascular disease risk. Ann Epidemiol; 2010 Aug;20(8):604-9
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Early or recurrent preterm birth and maternal cardiovascular disease risk.
  • PURPOSE: Preterm birth (PTB) has been associated with a later increased risk of maternal cardiovascular disease (CVD).
  • We hypothesized a more pronounced relation between early or recurrent PTB and maternal CVD risk.
  • Recurrent PTB was associated with higher CVD morbidity compared to women with one PTB, particularly for ischemic events (HR = 1.78 [1.40, 2.27] vs. 1.22 [1.09, 1.36]).
  • CONCLUSIONS: Women with PTB, especially recurrent PTB, were at increased risk for CVD, suggesting common causes of these conditions.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2010 Elsevier Inc. All rights reserved.
  • [Cites] Am J Obstet Gynecol. 2000 Feb;182(2):465-72 [10694353.001]
  • [Cites] Int J Epidemiol. 2008 Oct;37(5):1109-20 [18577529.001]
  • [Cites] JAMA. 2000 Mar 22-29;283(12):1591-6 [10735396.001]
  • [Cites] Lancet. 2000 Dec 16;356(9247):2066-7 [11145495.001]
  • [Cites] Lancet. 2001 Jun 23;357(9273):2002-6 [11438131.001]
  • [Cites] BMJ. 2001 Nov 24;323(7323):1213-7 [11719411.001]
  • [Cites] J Epidemiol Community Health. 2003 Jun;57(6):462-3 [12775796.001]
  • [Cites] Am J Obstet Gynecol. 1993 Feb;168(2):585-91 [8438933.001]
  • [Cites] N Engl J Med. 1994 Apr 14;330(15):1041-6 [8127331.001]
  • [Cites] J Clin Epidemiol. 1996 Aug;49(8):893-7 [8699210.001]
  • [Cites] Obstet Gynecol. 1997 Jul;90(1):63-7 [9207815.001]
  • [Cites] BMJ. 1997 Nov 8;315(7117):1189-93 [9393220.001]
  • [Cites] Int J Epidemiol. 1998 Apr;27(2):248-54 [9602406.001]
  • [Cites] Dan Med Bull. 1998 Jun;45(3):320-3 [9675544.001]
  • [Cites] Dan Med Bull. 1999 Jun;46(3):263-8 [10421985.001]
  • [Cites] Obstet Gynecol. 1999 Aug;94(2):284-9 [10432144.001]
  • [Cites] Epidemiology. 2005 Jul;16(4):563-9 [15951676.001]
  • [Cites] Am J Epidemiol. 2005 Jul 1;162(1):57-65 [15961587.001]
  • [Cites] Stat Methods Med Res. 2006 Apr;15(2):103-26 [16615652.001]
  • [Cites] Pediatrics. 2007 Oct;120(4):723-33 [17908758.001]
  • [Cites] J Perinatol. 2007 Nov;27(11):672-80 [17855807.001]
  • [Cites] Am J Epidemiol. 2007 Dec 1;166(11):1312-9 [17906337.001]
  • [Cites] BMJ. 2000 Mar 25;320(7238):839-40 [10731177.001]
  • (PMID = 20609340.001).
  • [ISSN] 1873-2585
  • [Journal-full-title] Annals of epidemiology
  • [ISO-abbreviation] Ann Epidemiol
  • [Language] ENG
  • [Grant] United States / NICHD NIH HHS / HD / HD043441-09; United States / NICHD NIH HHS / HD / K12 HD043441; United States / NICHD NIH HHS / HD / K12 HD043441-09; United States / NICHD NIH HHS / HD / K12HD043441-06
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS209658; NLM/ PMC2901249
  •  go-up   go-down


Advertisement
4. Lange NE, Rifas-Shiman SL, Camargo CA Jr, Gold DR, Gillman MW, Litonjua AA: Maternal dietary pattern during pregnancy is not associated with recurrent wheeze in children. J Allergy Clin Immunol; 2010 Aug;126(2):250-5, 255.e1-4
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Maternal dietary pattern during pregnancy is not associated with recurrent wheeze in children.
  • OBJECTIVE: To determine whether overall maternal dietary pattern during pregnancy is associated with recurrent wheeze in children.
  • Multivariable logistic regression was used to look at associations between dietary pattern and the primary outcome of recurrent wheeze at 3 years.
  • RESULTS: None of these dietary patterns was associated with the primary outcome of recurrent wheeze in children in either the crude or the multivariable model (multivariable model, odds ratio per 1-point increase in Mediterranean diet, 0.98 [95% CI, 0.89-1.08]; AHEI-P, 1.07 [0.87-1.30]; Prudent, 1.02 [0.83-1.26]; Western, 0.98 [0.81-1.19]).
  • CONCLUSION: Overall dietary pattern during pregnancy is not associated with recurrent wheeze in this cohort.

  • Genetic Alliance. consumer health - Pregnancy.
  • MedlinePlus Health Information. consumer health - Asthma.
  • MedlinePlus Health Information. consumer health - Asthma in Children.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
  • [Cites] J Asthma. 2005 Jul-Aug;42(6):513-8 [16293548.001]
  • [Cites] Allergy. 2010 Jun 1;65(6):758-65 [20102358.001]
  • [Cites] Pediatrics. 2006 Jun;117(6):e1132-8 [16740815.001]
  • [Cites] Prev Chronic Dis. 2006 Jul;3(3):A76 [16776877.001]
  • [Cites] Am J Respir Crit Care Med. 2006 Sep 1;174(5):499-507 [16763215.001]
  • [Cites] Am J Clin Nutr. 2006 Oct;84(4):903-11 [17023719.001]
  • [Cites] Pediatr Pulmonol. 1999 Dec;28(6):394-401 [10587412.001]
  • [Cites] Am J Respir Crit Care Med. 2000 Oct;162(4 Pt 1):1403-6 [11029352.001]
  • [Cites] Am J Clin Nutr. 2000 Nov;72(5):1214-22 [11063452.001]
  • [Cites] Am J Clin Nutr. 2000 Nov;72(5):1223-31 [11063453.001]
  • [Cites] MMWR Surveill Summ. 2002 Mar 29;51(1):1-13 [12420904.001]
  • [Cites] Am J Clin Nutr. 2002 Dec;76(6):1261-71 [12450892.001]
  • [Cites] N Engl J Med. 2003 Jun 26;348(26):2599-608 [12826634.001]
  • [Cites] Am J Clin Nutr. 2003 Sep;78(3 Suppl):508S-513S [12936941.001]
  • [Cites] J Pediatr. 2004 Feb;144(2):240-5 [14760269.001]
  • [Cites] Allergy. 2004 May;59(5):469-78 [15080825.001]
  • [Cites] Ann Epidemiol. 2004 Nov;14(10):754-62 [15519898.001]
  • [Cites] Am J Respir Crit Care Med. 2005 Jan 15;171(2):121-8 [15531754.001]
  • [Cites] N Engl J Med. 2005 Oct 27;353(17):1848-50 [16251542.001]
  • [Cites] Br Med Bull. 1988 Oct;44(4):1037-51 [3076825.001]
  • [Cites] J Am Diet Assoc. 1996 Mar;96(3):234-7 [8613655.001]
  • [Cites] N Engl J Med. 1997 Nov 20;337(21):1491-9 [9366580.001]
  • [Cites] Am J Clin Nutr. 2007 Feb;85(2):530-7 [17284754.001]
  • [Cites] Am J Clin Nutr. 2007 Mar;85(3):788-95 [17344501.001]
  • [Cites] Am J Clin Nutr. 2007 Mar;85(3):853-9 [17344509.001]
  • [Cites] J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):642-4 [17267210.001]
  • [Cites] Clin Exp Allergy. 2007 Apr;37(4):518-25 [17430348.001]
  • [Cites] Thorax. 2007 Jun;62(6):503-8 [17251311.001]
  • [Cites] Diabetes Care. 2007 Jul;30(7):1753-7 [17429059.001]
  • [Cites] Am J Clin Nutr. 2007 Aug;86(2):488-95 [17684223.001]
  • [Cites] Thorax. 2007 Aug;62(8):677-83 [17412780.001]
  • [Cites] Thorax. 2007 Sep;62(9):773-9 [17389754.001]
  • [Cites] Thorax. 2007 Sep;62(9):786-91 [17504819.001]
  • [Cites] Early Hum Dev. 2007 Dec;83(12):789-94 [17905543.001]
  • [Cites] Paediatr Perinat Epidemiol. 2008 Jan;22(1):47-59 [18173784.001]
  • [Cites] Eur J Clin Nutr. 2008 Apr;62(4):471-9 [17375108.001]
  • [Cites] J Allergy Clin Immunol. 2008 May;121(5):1161-1166.e3 [18466784.001]
  • [Cites] J Pediatr. 2008 Jun;152(6):823-8, 828.e1-2 [18492525.001]
  • [Cites] Thorax. 2008 Jun;63(6):507-13 [18198206.001]
  • [Cites] Am J Respir Crit Care Med. 2008 Jul 15;178(2):124-31 [18403722.001]
  • [Cites] Allergy. 2008 Oct;63(10):1310-6 [18782109.001]
  • [Cites] Sci Total Environ. 2008 Aug 1;400(1-3):115-41 [18657851.001]
  • [Cites] Eur Respir J. 2009 Jan;33(1):33-41 [18829673.001]
  • [Cites] Thorax. 2009 May;64(5):411-7 [19213776.001]
  • [Cites] J Am Diet Assoc. 2009 Jun;109(6):1004-11 [19465182.001]
  • [Cites] Thorax. 2009 Sep;64(9):815-21 [19497922.001]
  • [Cites] Respir Res. 2009;10:122 [20003306.001]
  • [Cites] Curr Opin Allergy Clin Immunol. 2010 Apr;10(2):139-44 [20164763.001]
  • [Cites] Allergy. 2010 May;65(5):606-15 [19845575.001]
  • [Cites] Br J Nutr. 2010 May;103(9):1354-65 [19995472.001]
  • [Cites] Paediatr Perinat Epidemiol. 2006 Jan;20(1):35-42 [16420339.001]
  • (PMID = 20584543.001).
  • [ISSN] 1097-6825
  • [Journal-full-title] The Journal of allergy and clinical immunology
  • [ISO-abbreviation] J. Allergy Clin. Immunol.
  • [Language] ENG
  • [Grant] United States / NHLBI NIH HHS / HL / HL064925-09; United States / NICHD NIH HHS / HD / HD034568-09; United States / NIAID NIH HHS / AI / R01 AI035786-17; United States / NICHD NIH HHS / HD / HD34568; United States / NHLBI NIH HHS / HL / K24 HL068041-09; United States / NIAID NIH HHS / AI / R01 AI035786; United States / NICHD NIH HHS / HD / R37 HD034568; United States / NHLBI NIH HHS / HL / R01 HL064925; United States / NHLBI NIH HHS / HL / HL68041; United States / NHLBI NIH HHS / HL / HL61907; None / None / / K24 HL068041-09; United States / NIAID NIH HHS / AI / AI035786-17; United States / NHLBI NIH HHS / HL / HL007427; United States / NHLBI NIH HHS / HL / HL007427-30; United States / NHLBI NIH HHS / HL / HL64925; United States / NHLBI NIH HHS / HL / K24 HL068041; United States / NIAID NIH HHS / AI / AI35786; United States / NICHD NIH HHS / HD / R01 HD034568-09; United States / NIAID NIH HHS / AI / R56 AI035786; United States / NICHD NIH HHS / HD / R01 HD034568; United States / NHLBI NIH HHS / HL / R01 HL064925-09; United States / NHLBI NIH HHS / HL / T32 HL007427; United States / NHLBI NIH HHS / HL / T32 HL007427-30
  • [Publication-type] Clinical Trial; Comparative Study; Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS218235; NLM/ PMC2917539
  •  go-up   go-down


5. Wickham L, Tranos P, Hiscott P, Charteris D: The use of silicone oil-RMN3 (Oxane HD) as heavier-than-water internal tamponade in complicated inferior retinal detachment surgery. Graefes Arch Clin Exp Ophthalmol; 2010 Sep;248(9):1225-31
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The use of silicone oil-RMN3 (Oxane HD) as heavier-than-water internal tamponade in complicated inferior retinal detachment surgery.
  • In this study we evaluated the efficacy of Oxane HD in the management of complex retinal detachments involving lower quadrants of the retina.
  • Patients with grade C3 PVR or greater and inferior retinal breaks, recurrent inferior retinal detachments (with or without PVR) and giant retinal tears were included.
  • In those patients who re-detached under heavy silicone oil (n = 4), retro-oil epiretinal membranes (ERMs) were obtained at the time of subsequent surgery to analyse the immunopathological response to oxane HD.
  • CONCLUSION: We failed to observe an advantage following the use of Oxane HD in the treatment of inferior retinal detachments.
  • Moreover, Oxane HD was difficult to remove and was associated with a higher incidence of complications.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Combined Modality Therapy. Epiretinal Membrane / metabolism. Epiretinal Membrane / pathology. Humans. Immunohistochemistry. Intraocular Pressure. Laser Coagulation. Lasers, Excimer. Macrophages / pathology. Middle Aged. Neuroglia / pathology. Prospective Studies. Retinal Perforations / surgery. Retinal Pigment Epithelium / pathology. Tonometry, Ocular. Treatment Outcome. Visual Acuity. Vitrectomy. Vitreoretinopathy, Proliferative / surgery

  • MedlinePlus Health Information. consumer health - Retinal Detachment.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Graefes Arch Clin Exp Ophthalmol. 2011 Jun;249(6):949; author reply 951-2 [20737159.001]
  • [Cites] Br J Ophthalmol. 1987 Apr;71(4):262-7 [2437955.001]
  • [Cites] Ophthalmology. 1988 May;95(5):583-91 [3174019.001]
  • [Cites] Arch Ophthalmol. 1997 Mar;115(3):335-44 [9076205.001]
  • [Cites] Graefes Arch Clin Exp Ophthalmol. 1986;224(1):34-7 [3943733.001]
  • [Cites] Graefes Arch Clin Exp Ophthalmol. 2006 May;244(5):609-19 [16205937.001]
  • [Cites] Retina. 2004 Aug;24(4):567-73 [15300078.001]
  • [Cites] Retina. 1986 Spring-Summer;6(2):77-80 [3749624.001]
  • [Cites] Graefes Arch Clin Exp Ophthalmol. 2002 Dec;240(12):965-71 [12483317.001]
  • [Cites] Ophthalmology. 1998 Sep;105(9):1587-97 [9754162.001]
  • [Cites] Eye (Lond). 2008 Oct;22(10):1342-59 [18344952.001]
  • [Cites] Br J Ophthalmol. 1994 Mar;78(3):219-22 [7511932.001]
  • [Cites] Graefes Arch Clin Exp Ophthalmol. 2004 Jul;242(7):617-20 [15029505.001]
  • [Cites] Graefes Arch Clin Exp Ophthalmol. 2002 Dec;240(12):989-95 [12483321.001]
  • [Cites] Aust N Z J Ophthalmol. 1998 Nov;26(4):299-304 [9843257.001]
  • [Cites] Br J Ophthalmol. 2007 Feb;91(2):258-62 [17005544.001]
  • [Cites] Br J Ophthalmol. 2004 Nov;88(11):1439-42 [15489490.001]
  • [Cites] Br J Ophthalmol. 2001 Feb;85(2):179-83 [11159482.001]
  • [Cites] Retina. 2003 Jun;23(3):335-42 [12824833.001]
  • [Cites] Graefes Arch Clin Exp Ophthalmol. 1994 Jul;232(7):438-44 [7926877.001]
  • [Cites] Br J Ophthalmol. 2004 May;88(5):692-6 [15090425.001]
  • [Cites] Ophthalmologe. 1996 Apr;93(2):121-5 [8652975.001]
  • [Cites] Am J Ophthalmol. 1991 Aug 15;112(2):159-65 [1867299.001]
  • [Cites] Retina. 1986 Summer-Fall;6(3):176-8 [3797834.001]
  • [Cites] Ophthalmology. 1992 Sep;99(9):1364-7 [1407970.001]
  • (PMID = 20349080.001).
  • [ISSN] 1435-702X
  • [Journal-full-title] Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
  • [ISO-abbreviation] Graefes Arch. Clin. Exp. Ophthalmol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Silicone Oils; 0 / oxane HD
  •  go-up   go-down


6. Gammill HS, Powers RW, Clifton RG, Van Dorsten JP, Klebanoff MA, Lindheimer MD, Sibai B, Landon MB, Miodovnik M, Dombrowski M, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network, Bethesda, MD: Does C-reactive protein predict recurrent preeclampsia? Hypertens Pregnancy; 2010;29(4):399-409
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Does C-reactive protein predict recurrent preeclampsia?
  • OBJECTIVE: Evaluate association of the inflammatory marker C-reactive protein with recurrent preeclampsia.
  • CONCLUSION: In this group of women with previous preeclampsia, neither baseline C-reactive protein concentration nor change in concentration over gestation was associated with recurrent preeclampsia.

  • Genetic Alliance. consumer health - Preeclampsia.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Gynaecol Obstet. 2005 Jun;89(3):299-300 [15919407.001]
  • [Cites] Clin Chem Lab Med. 2005;43(3):308-13 [15843237.001]
  • [Cites] J Am Coll Cardiol. 2005 Aug 2;46(3):464-9 [16053959.001]
  • [Cites] J Soc Gynecol Investig. 2005 Oct;12(7):518-28 [16202929.001]
  • [Cites] Clin Immunol. 2005 Nov;117(2):104-11 [16214080.001]
  • [Cites] Eur J Obstet Gynecol Reprod Biol. 2005 Nov 1;123(1):46-51 [16260340.001]
  • [Cites] Hypertension. 2005 Dec;46(6):1243-9 [16230510.001]
  • [Cites] Am J Epidemiol. 2005 Dec 15;162(12):1198-206 [16269584.001]
  • [Cites] Eur J Obstet Gynecol Reprod Biol. 2006 Feb 1;124(2):164-7 [16054746.001]
  • [Cites] Semin Fetal Neonatal Med. 2006 Oct;11(5):309-16 [16828580.001]
  • [Cites] Clin Appl Thromb Hemost. 2006 Jul;12(3):330-7 [16959687.001]
  • [Cites] Am J Hypertens. 2007 Jan;20(1):98-103 [17198919.001]
  • [Cites] Hypertension. 2008 Jun;51(6):1499-505 [18413489.001]
  • [Cites] Acta Obstet Gynecol Scand. 2008;87(9):969-71 [18720045.001]
  • [Cites] Am J Obstet Gynecol. 2008 Nov;199(5):523.e1-6 [18539258.001]
  • [Cites] Am J Obstet Gynecol. 2009 Jan;200(1):58.e1-8 [18691690.001]
  • [Cites] J Obstet Gynaecol Res. 2009 Feb;35(1):94-8 [19215554.001]
  • [Cites] J Clin Endocrinol Metab. 2001 Jun;86(6):2505-12 [11397847.001]
  • [Cites] Obstet Gynecol. 2001 Nov;98(5 Pt 1):757-62 [11704165.001]
  • [Cites] BMJ. 2001 Nov 24;323(7323):1213-7 [11719411.001]
  • [Cites] Int J Gynaecol Obstet. 2001 Dec;75(3):243-9 [11728484.001]
  • [Cites] BJOG. 2002 Mar;109(3):297-301 [11950185.001]
  • [Cites] BJOG. 2002 Jul;109(7):759-64 [12135211.001]
  • [Cites] Hypertension. 2003 Jul;42(1):39-42 [12743016.001]
  • [Cites] Clin Chem. 2003 Aug;49(8):1258-71 [12881440.001]
  • [Cites] J Reprod Immunol. 2003 Jun;59(1):29-37 [12892901.001]
  • [Cites] Hypertens Pregnancy. 2003;22(2):129-41 [12908997.001]
  • [Cites] Am J Hypertens. 2004 Feb;17(2):154-60 [14751658.001]
  • [Cites] Hypertension. 2004 Nov;44(5):708-14 [15452036.001]
  • [Cites] Am J Obstet Gynecol. 1989 Nov;161(5):1200-4 [2589440.001]
  • [Cites] J Clin Endocrinol Metab. 1997 Dec;82(12):4196-200 [9398739.001]
  • [Cites] N Engl J Med. 1998 Mar 12;338(11):701-5 [9494145.001]
  • [Cites] Am J Reprod Immunol. 1998 Aug;40(2):102-11 [9764352.001]
  • [Cites] Am J Obstet Gynecol. 1999 Feb;180(2 Pt 1):499-506 [9988826.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 1999 Apr;19(4):972-8 [10195925.001]
  • [Cites] J Biol Chem. 2004 Nov 19;279(47):48487-90 [15337754.001]
  • [Cites] N Engl J Med. 2004 Dec 16;351(25):2599-610 [15602020.001]
  • [Cites] Epidemiology. 2005 Mar;16(2):206-15 [15703535.001]
  • [Cites] N Engl J Med. 2005 Apr 14;352(15):1611-3 [15829550.001]
  • [Cites] Eur J Obstet Gynecol Reprod Biol. 2005 Aug 1;121(2):154-8 [16054955.001]
  • (PMID = 20701468.001).
  • [ISSN] 1525-6065
  • [Journal-full-title] Hypertension in pregnancy
  • [ISO-abbreviation] Hypertens Pregnancy
  • [Language] ENG
  • [Grant] United States / NICHD NIH HHS / HD / U10 HD021414-15; United States / NICHD NIH HHS / HD / HD36801; United States / NICHD NIH HHS / HD / HD27861; United States / NICHD NIH HHS / HD / UG1 HD027869; United States / NICHD NIH HHS / HD / HD27905; United States / NICHD NIH HHS / HD / U10 HD036801-15; United States / NICHD NIH HHS / HD / P01 HD030367; United States / NICHD NIH HHS / HD / U10 HD027861-10; United States / NICHD NIH HHS / HD / HD27883; United States / NICHD NIH HHS / HD / HD27869; United States / NICHD NIH HHS / HD / HD27860; United States / NICHD NIH HHS / HD / UG1 HD027915; United States / NICHD NIH HHS / HD / HD21414; United States / NICHD NIH HHS / HD / U10 HD027905; United States / NICHD NIH HHS / HD / U10 HD021410-29; United States / NICHD NIH HHS / HD / U10 HD027883-06; United States / NICHD NIH HHS / HD / U10 HD027905-10; United States / NICHD NIH HHS / HD / U10 HD027915-23; United States / NICHD NIH HHS / HD / U10 HD027883; United States / NICHD NIH HHS / HD / HD030367-18; United States / NICHD NIH HHS / HD / U10 HD027917-24; United States / NICHD NIH HHS / HD / HD21410; United States / NICHD NIH HHS / HD / U10 HD027869; United States / NICHD NIH HHS / HD / U10 HD027869-24; United States / NICHD NIH HHS / HD / U10 HD027917; United States / NICHD NIH HHS / HD / P01 HD030367-18; United States / NICHD NIH HHS / HD / U10 HD027915; United States / NICHD NIH HHS / HD / HD19897; United States / NICHD NIH HHS / HD / U10 HD027860; United States / NICHD NIH HHS / HD / HD27889; United States / NICHD NIH HHS / HD / U01 HD019897; United States / NICHD NIH HHS / HD / 2P01-HD30367; United States / NICHD NIH HHS / HD / HD27915; United States / NICHD NIH HHS / HD / U10 HD027860-15; United States / NICHD NIH HHS / HD / HD27917; United States / NICHD NIH HHS / HD / U10 HD021410; United States / NICHD NIH HHS / HD / U10 HD036801; United States / NICHD NIH HHS / HD / HD21434; United States / NICHD NIH HHS / HD / U01 HD036801; United States / NICHD NIH HHS / HD / HD027883-06
  • [Publication-type] Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers; 9007-41-4 / C-Reactive Protein
  • [Other-IDs] NLM/ NIHMS366726; NLM/ PMC3339658
  •  go-up   go-down


7. Mefford HC, Clauin S, Sharp AJ, Moller RS, Ullmann R, Kapur R, Pinkel D, Cooper GM, Ventura M, Ropers HH, Tommerup N, Eichler EE, Bellanne-Chantelot C: Recurrent reciprocal genomic rearrangements of 17q12 are associated with renal disease, diabetes, and epilepsy. Am J Hum Genet; 2007 Nov;81(5):1057-69
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recurrent reciprocal genomic rearrangements of 17q12 are associated with renal disease, diabetes, and epilepsy.
  • In an effort to broaden the phenotypic spectrum of this disease model, we assessed 155 autopsy samples from fetuses with well-defined developmental pathologies in regions predisposed to recurrent rearrangement, by array-based comparative genomic hybridization.
  • Fine-scale mapping of the breakpoints in different patient cohorts revealed a recurrent 1.5-Mb de novo deletion in individuals with phenotypes that ranged from congenital renal abnormalities to maturity-onset diabetes of the young type 5.
  • We describe the first example of a recurrent genomic disorder associated with diabetes.


8. Zhang F, Potocki L, Sampson JB, Liu P, Sanchez-Valle A, Robbins-Furman P, Navarro AD, Wheeler PG, Spence JE, Brasington CK, Withers MA, Lupski JR: Identification of uncommon recurrent Potocki-Lupski syndrome-associated duplications and the distribution of rearrangement types and mechanisms in PTLS. Am J Hum Genet; 2010 Mar 12;86(3):462-70
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Identification of uncommon recurrent Potocki-Lupski syndrome-associated duplications and the distribution of rearrangement types and mechanisms in PTLS.
  • Nonallelic homologous recombination (NAHR) can mediate recurrent rearrangements in the human genome and cause genomic disorders.
  • In addition to these common recurrent rearrangements, an uncommon recurrent 5 Mb SMS-associated deletion has been identified.
  • By both oligonucleotide-based comparative genomic hybridization and recombination hot spot analyses, we identified two cases of the predicted 5 Mb uncommon recurrent PTLS-associated duplication.
  • Our findings of the uncommon recurrent PTLS-associated duplication at a relative prevalence reflecting the de novo mutation rate and the distribution of 17p11.2 duplication types in PTLS reveal insights into both the contributions of new mutations and the different underlying mechanisms that generate genomic rearrangements causing genomic disorders.

  • Genetic Alliance. consumer health - Potocki-Lupski syndrome.
  • COS Scholar Universe. author profiles.
  • Coriell Cell Repositories. culture/stock collections - Coriell Cell Repositories .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
  • [Cites] Science. 2010 Feb 12;327(5967):835 [20044538.001]
  • [Cites] J Dev Behav Pediatr. 2010 Feb-Mar;31(2):137-43 [20110824.001]
  • [Cites] Science. 2010 Feb 12;327(5967):876-9 [20044541.001]
  • [Cites] Am J Hum Genet. 1999 Feb;64(2):471-8 [9973284.001]
  • [Cites] Nat Genet. 2000 Jan;24(1):84-7 [10615134.001]
  • [Cites] Am J Med Genet. 2000 Oct 2;94(4):296-9 [11038442.001]
  • [Cites] Trends Genet. 2002 Feb;18(2):74-82 [11818139.001]
  • [Cites] Genome Res. 2002 May;12(5):713-28 [11997338.001]
  • [Cites] Genome Res. 2002 May;12(5):729-38 [11997339.001]
  • [Cites] Science. 2002 Aug 9;297(5583):1003-7 [12169732.001]
  • [Cites] Nat Genet. 2003 Apr;33(4):466-8 [12652298.001]
  • [Cites] Am J Hum Genet. 2003 May;72(5):1101-16 [12649807.001]
  • [Cites] Am J Hum Genet. 2003 Oct;73(4):823-34 [14505274.001]
  • [Cites] Am J Hum Genet. 2003 Dec;73(6):1302-15 [14639526.001]
  • [Cites] Am J Med Genet A. 2004 Jan 15;124A(2):173-8 [14699617.001]
  • [Cites] Am J Hum Genet. 2004 Jul;75(1):75-81 [15148657.001]
  • [Cites] Genome Biol. 2004;5(10):242 [15461806.001]
  • [Cites] Am J Med Genet. 1986 Jul;24(3):415-20 [2425620.001]
  • [Cites] Am J Med Genet. 1991 Dec 15;41(4):446-50 [1776635.001]
  • [Cites] Nat Genet. 1992 Apr;1(1):29-33 [1301995.001]
  • [Cites] Nat Genet. 1996 Mar;12(3):288-97 [8589720.001]
  • [Cites] Hum Genet. 1996 May;97(5):642-9 [8655146.001]
  • [Cites] Nat Genet. 1997 Oct;17(2):154-63 [9326934.001]
  • [Cites] Trends Genet. 1998 Oct;14(10):417-22 [9820031.001]
  • [Cites] Am J Med Genet. 1999 Jan 15;82(2):183-6 [9934986.001]
  • [Cites] Genome Res. 2004 Nov;14(11):2209-20 [15520286.001]
  • [Cites] Hum Mutat. 2005 Feb;25(2):207-21 [15643617.001]
  • [Cites] Hum Mutat. 2005 Aug;26(2):125-34 [15977178.001]
  • [Cites] Hum Mutat. 2005 Oct;26(4):362-73 [16110485.001]
  • [Cites] Am J Hum Genet. 2006 Jul;79(1):41-53 [16773564.001]
  • [Cites] Am J Hum Genet. 2006 Nov;79(5):890-902 [17033965.001]
  • [Cites] J Clin Invest. 2006 Nov;116(11):3035-41 [17024248.001]
  • [Cites] Nat Genet. 2006 Dec;38(12):1419-23 [17115058.001]
  • [Cites] Nat Genet. 2006 Dec;38(12):1363-4 [17133221.001]
  • [Cites] Am J Hum Genet. 2007 Apr;80(4):633-49 [17357070.001]
  • [Cites] Hum Genet. 2007 Jul;121(6):697-709 [17457615.001]
  • [Cites] PLoS Genet. 2007 Oct;3(10):1939-49 [17953488.001]
  • [Cites] Cell. 2007 Dec 28;131(7):1235-47 [18160035.001]
  • [Cites] Nat Genet. 2008 Jan;40(1):90-5 [18059269.001]
  • [Cites] J Biol Chem. 2008 Jan 4;283(1):1-5 [17999957.001]
  • [Cites] Am J Med Genet A. 2008 Apr 1;146A(7):917-24 [18327785.001]
  • [Cites] PLoS Genet. 2008;4(9):e1000175 [18773114.001]
  • [Cites] Nat Genet. 2008 Sep;40(9):1124-9 [19165926.001]
  • [Cites] PLoS Genet. 2009 Jan;5(1):e1000327 [19180184.001]
  • [Cites] Hum Mol Genet. 2009 Jun 15;18(12):2188-203 [19324899.001]
  • [Cites] PLoS One. 2009;4(5):e5324 [19492091.001]
  • [Cites] Nat Genet. 2009 Jul;41(7):849-53 [19543269.001]
  • [Cites] Trends Genet. 2009 Jul;25(7):298-307 [19560228.001]
  • [Cites] Nat Rev Genet. 2009 Aug;10(8):551-64 [19597530.001]
  • [Cites] Science. 2010 Feb 12;327(5967):836-40 [20044539.001]
  • (PMID = 20188345.001).
  • [ISSN] 1537-6605
  • [Journal-full-title] American journal of human genetics
  • [ISO-abbreviation] Am. J. Hum. Genet.
  • [Language] ENG
  • [Grant] United States / NINDS NIH HHS / NS / R01NS058529; United States / NCRR NIH HHS / RR / M01 RR000188; United States / NICHD NIH HHS / HD / P30 HD024064; United States / NICHD NIH HHS / HD / P30HD024064; United States / NINDS NIH HHS / NS / R01 NS058529; United States / NCRR NIH HHS / RR / M01RR00188
  • [Publication-type] Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2833368
  •  go-up   go-down


9. Yost NP, Owen J, Berghella V, Thom E, Swain M, Dildy GA 3rd, Miodovnik M, Langer O, Sibai B, National Institute of Child Health and Human Development, Maternal-Fetal Medicine Units Network: Effect of coitus on recurrent preterm birth. Obstet Gynecol; 2006 Apr;107(4):793-7
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Effect of coitus on recurrent preterm birth.
  • OBJECTIVE: To estimate the impact of sexual behavior on the risk of recurrent spontaneous preterm birth at less than 37 weeks of gestation.
  • METHODS: This is a secondary analysis of a multicenter, blinded observational study of endovaginal sonographic examinations performed at 16-18 weeks of gestation on 187 women with singleton gestations who were at high risk for recurrent spontaneous preterm birth (prior spontaneous preterm birth at < 32 weeks of gestation).
  • Women who reported infrequent sexual intercourse during early pregnancy had an incidence of recurrent spontaneous preterm birth of 28% compared with 38% in those women who reported some intercourse (P = .35).
  • CONCLUSION: Self-reported coitus during early pregnancy was not associated with an increased risk of recurrent preterm delivery.
  • There was an association between increasing number of sexual partners in a woman's lifetime and recurrent preterm delivery.
  • [MeSH-minor] Adolescent. Adult. Age Factors. Double-Blind Method. Female. Gestational Age. Humans. Incidence. Logistic Models. Maternal Age. Parity. Pregnancy. Probability. Risk Assessment. Statistics, Nonparametric

  • MedlinePlus Health Information. consumer health - Health Problems in Pregnancy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16582114.001).
  • [ISSN] 0029-7844
  • [Journal-full-title] Obstetrics and gynecology
  • [ISO-abbreviation] Obstet Gynecol
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / HD21414; United States / NICHD NIH HHS / HD / HD27860; United States / NICHD NIH HHS / HD / HD27869; United States / NICHD NIH HHS / HD / HD27905; United States / NICHD NIH HHS / HD / HD34116; United States / NICHD NIH HHS / HD / HD34136; United States / NICHD NIH HHS / HD / HD34208; United States / NICHD NIH HHS / HD / HD34210; United States / NICHD NIH HHS / HD / HD36801
  • [Publication-type] Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  •  go-up   go-down


10. Rhee H, Miles MS, Halpern CT, Holditch-Davis D: Prevalence of recurrent physical symptoms in U.S. adolescents. Pediatr Nurs; 2005 Jul-Aug;31(4):314-9, 350
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prevalence of recurrent physical symptoms in U.S. adolescents.
  • PURPOSE: To estimate the prevalence of 10 recurrent physical symptoms and to examine how prevalence differs by gender and age in healthy American adolescents.
  • [MeSH-minor] Adult. Age Distribution. Cough / epidemiology. Cross-Sectional Studies. Dizziness / epidemiology. Health Surveys. Humans. Logistic Models. Nonlinear Dynamics. Nurse's Role. Pharyngitis / epidemiology. Population Surveillance. Prevalence. Recurrence. Sex Distribution. Surveys and Questionnaires. United States / epidemiology

  • MedlinePlus Health Information. consumer health - Fatigue.
  • MedlinePlus Health Information. consumer health - Headache.
  • MedlinePlus Health Information. consumer health - Pain.
  • MedlinePlus Health Information. consumer health - Stomach Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16229130.001).
  • [ISSN] 0097-9805
  • [Journal-full-title] Pediatric nursing
  • [ISO-abbreviation] Pediatr Nurs
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / P01-HD31921
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  •  go-up   go-down


11. Mercer BM, Macpherson CA, Goldenberg RL, Goepfert AR, Hauguel-de Mouzon S, Varner MW, Iams JD, Meis PJ, Moawad AH, Miodovnik M, Caritis SN, Van Dorsten JP, Sorokin Y, Thurnau GR, Spong CY, NICHD Maternal-Fetal Medicine Units Network: Are women with recurrent spontaneous preterm births different from those without such history? Am J Obstet Gynecol; 2006 Apr;194(4):1176-84; discussion 1184-5
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Are women with recurrent spontaneous preterm births different from those without such history?
  • OBJECTIVE: This study was undertaken to determine whether women with recurrent spontaneous preterm births (rSPBs) have different clinical characteristics or systemic markers than those with isolated preterm (iSPBs) or recurrent term births (rTBs), when assessed remote from delivery.
  • [MeSH-minor] Adult. Female. Humans. Pregnancy. Recurrence

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Am J Obstet Gynecol. 2010 Nov;203(5):496. Haugel-De Mouzon, Sylvie [corrected to Hauguel-de Mouzon, Sylvie]
  • (PMID = 16580328.001).
  • [ISSN] 1097-6868
  • [Journal-full-title] American journal of obstetrics and gynecology
  • [ISO-abbreviation] Am. J. Obstet. Gynecol.
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / HD19897; United States / NICHD NIH HHS / HD / HD21410; United States / NICHD NIH HHS / HD / HD21414; United States / NICHD NIH HHS / HD / HD27860; United States / NICHD NIH HHS / HD / HD27861; United States / NICHD NIH HHS / HD / HD27869; United States / NICHD NIH HHS / HD / HD27883; United States / NICHD NIH HHS / HD / HD27905; United States / NICHD NIH HHS / HD / HD27915; United States / NICHD NIH HHS / HD / HD27917; United States / NICHD NIH HHS / HD / HD34208; United States / NICHD NIH HHS / HD / HD36801; United States / NICHD NIH HHS / HD / HD40544
  • [Publication-type] Comparative Study; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


12. Heinzlmann M, Mueller-Lisse UG, Mühling T, Hölscher M, Nothdurft HD, von Sonnenburg F, Löscher T: [33 year old Libanese woman with recurrent haemoptysis and cystic lesion of the lung]. Internist (Berl); 2006 May;47(5):523-7
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [33 year old Libanese woman with recurrent haemoptysis and cystic lesion of the lung].
  • A 33 year old woman from Lebanon presented with recurrent hemoptysis, subfebrile temperature, dyspnoe in stress, fatigue, weight loss, and pruritus.
  • [MeSH-minor] Adult. Albendazole / therapeutic use. Diagnosis, Differential. Echinococcosis, Hepatic / diagnostic imaging. Echinococcosis, Hepatic / drug therapy. Female. Humans. Tomography, X-Ray Computed

  • Hazardous Substances Data Bank. ALBENDAZOLE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Rev Allergy Immunol. 2004 Apr;26(2):93-104 [15146106.001]
  • [Cites] Swiss Med Wkly. 2002 Oct 12;132(37-38):548-52 [12508139.001]
  • [Cites] Am J Trop Med Hyg. 2005 Mar;72(3):291-4 [15772324.001]
  • [Cites] Clin Infect Dis. 1999 Aug;29(2):310-1 [10476733.001]
  • [Cites] Ann Trop Med Parasitol. 2002 Oct;96(7):745-8 [12537637.001]
  • [Cites] Clin Diagn Lab Immunol. 1999 Jul;6(4):504-8 [10391851.001]
  • [Cites] Acta Trop. 2003 Feb;85(2):165-71 [12606093.001]
  • [Cites] Lancet. 2003 Oct 18;362(9392):1295-304 [14575976.001]
  • [Cites] Ann Trop Med Parasitol. 2005 Oct;99(7):649-59 [16212799.001]
  • [Cites] Fundam Clin Pharmacol. 2003 Apr;17(2):205-12 [12667231.001]
  • [Cites] J Med Liban. 1996;44(3):121-8 [9296962.001]
  • [Cites] Br J Dermatol. 2003 Jun;148(6):1245-9 [12828756.001]
  • [Cites] J R Coll Surg Edinb. 2002 Oct;47(5):689-92 [12463709.001]
  • [Cites] Mayo Clin Proc. 2003 Jun;78(6):744-52 [12934786.001]
  • [Cites] Ann Thorac Surg. 1988 Sep;46(3):342-6 [3046523.001]
  • [Cites] Eur Respir J. 1999 Sep;14 (3):503-7 [10543267.001]
  • [Cites] Clin Infect Dis. 1992 Sep;15(3):473-80 [1520796.001]
  • (PMID = 16575613.001).
  • [ISSN] 0020-9554
  • [Journal-full-title] Der Internist
  • [ISO-abbreviation] Internist (Berl)
  • [Language] ger
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] F4216019LN / Albendazole
  •  go-up   go-down


13. van Tilburg MA, Venepalli N, Ulshen M, Freeman KL, Levy R, Whitehead WE: Parents' worries about recurrent abdominal pain in children. Gastroenterol Nurs; 2006 Jan-Feb;29(1):50-5; quiz 56-7
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Parents' worries about recurrent abdominal pain in children.
  • Recurrent abdominal pain is a common childhood disorder characterized by multiple episodes of stomachaches severe enough to interrupt daily activities.
  • Recurrent abdominal pain is a difficult diagnosis for parents, children, and clinicians since there is no definitive cause of the symptoms.
  • Research has shown recurrent abdominal pain is at least partly learned through social modeling.
  • The purpose of this study was to understand parental worries and fears of recurrent abdominal pain that explain parental reinforcement of illness behavior.
  • In-depth interviews were held with 15 parents of children diagnosed with recurrent abdominal pain.
  • Parental cognitions about recurrent abdominal pain revolved around the fear of a disease and a desire for diagnosis and effective treatment.
  • This study adds to our understanding of parents' view on recurrent abdominal pain and gives us tools to address cognitions that can perpetuate symptoms in children.
  • [MeSH-minor] Adaptation, Psychological. Adult. Child. Child, Preschool. Female. Health Surveys. Humans. Male. Middle Aged. Pain Threshold. Parent-Child Relations. Physician-Patient Relations. Recurrence. Sensitivity and Specificity. Severity of Illness Index. Sick Role. Stress, Psychological. Surveys and Questionnaires

  • MedlinePlus Health Information. consumer health - Abdominal Pain.
  • MedlinePlus Health Information. consumer health - Anxiety.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16552300.001).
  • [ISSN] 1042-895X
  • [Journal-full-title] Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates
  • [ISO-abbreviation] Gastroenterol Nurs
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / R01 HD036069; United States / NICHD NIH HHS / HD / HD36069; United States / NIDDK NIH HHS / DK / R01 DK31369; United States / PHS HHS / / R24 67674
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  •  go-up   go-down


14. Jeon GH, Kim SR, Kim SH, Chae HD, Kim CH, Kang BM: Etiologic characterization of recurrent miscarriages in Koreans. J Reprod Med; 2009 Sep;54(9):569-75

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Etiologic characterization of recurrent miscarriages in Koreans.
  • OBJECTIVE: To investigate recurrent miscarriages in Koreans in terms of causative factors and the prognosis for subsequent successful pregnancies in primary and secondary recurrent miscarriages cases.
  • STUDY DESIGN: The study retrospectively examined the clinical records of 222 recurrent miscarriage cases that were presented at the Department of Obstetrics and Gynecology, Asan Medical Center, Seoul, Korea, from July 1989 to June 2008.
  • RESULTS: The etiologic analysis indicated that anatomic abnormality (29.4%) was the most common cause of recurrent miscarriage in Koreans, followed by immunologic (26.7%), inexplicable (24.1%), endocrinologic (15.0%) and genetic (11.2%) causes.
  • The subsequent successful pregnancy rate was higher in the secondary recurrent miscarriage group than the primary recurrent miscarriage group (47.9% vs. 31.7%, p < 0.05).
  • CONCLUSION: The causative factors of recurrent miscarriages in Koreans differed from those reported in Western studies on the frequency of causes.
  • The prognosis for subsequent successful pregnancies was better in the secondary recurrent miscarriage group, as we expected.
  • [MeSH-minor] Adult. Female. Humans. Korea. Pregnancy. Pregnancy Rate. Prognosis. Recurrence. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19947035.001).
  • [ISSN] 0024-7758
  • [Journal-full-title] The Journal of reproductive medicine
  • [ISO-abbreviation] J Reprod Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


15. Sharp AJ, Selzer RR, Veltman JA, Gimelli S, Gimelli G, Striano P, Coppola A, Regan R, Price SM, Knoers NV, Eis PS, Brunner HG, Hennekam RC, Knight SJ, de Vries BB, Zuffardi O, Eichler EE: Characterization of a recurrent 15q24 microdeletion syndrome. Hum Mol Genet; 2007 Mar 1;16(5):567-72
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Characterization of a recurrent 15q24 microdeletion syndrome.
  • Our results define microdeletion of 15q24 as a novel recurrent genomic disorder.
  • [MeSH-minor] Adolescent. Adult. Base Sequence. Chromosome Breakage. DNA Mutational Analysis. Humans. Male. Molecular Sequence Data. Oligonucleotide Array Sequence Analysis. Syndrome


16. Hauswald H, Stoiber E, Rochet N, Lindel K, Grehn C, Becker HD, Debus J, Harms W: Treatment of recurrent bronchial carcinoma: the role of high-dose-rate endoluminal brachytherapy. Int J Radiat Oncol Biol Phys; 2010 Jun 1;77(2):373-7
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Treatment of recurrent bronchial carcinoma: the role of high-dose-rate endoluminal brachytherapy.
  • PURPOSE: This study's aim was to assess outcome and toxicity of high-dose-rate endoluminal brachytherapy (HDREB) for recurrent bronchial carcinoma.
  • METHODS AND MATERIALS: From 1987 to 2005, 41 patients were treated with HDREB for symptomatic recurrent bronchial carcinoma.
  • A total of 24% of patients (n = 10) showed no response or progressive disease within 8 weeks after treatment.
  • None of the patients with locally controlled disease showed grade 3 or 4 late effects.
  • CONCLUSIONS: Palliative treatment of symptomatic, locally recurrent bronchial carcinoma with HDREB can effectively relieve symptoms in the majority of patients while causing only few complications.
  • [MeSH-minor] Adult. Aged. Cause of Death. Disease-Free Survival. Female. Follow-Up Studies. Humans. Male. Middle Aged. Palliative Care. Radiation Injuries / complications. Radiation Injuries / pathology. Radiotherapy Dosage. Retreatment. Retrospective Studies. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Inc. All rights reserved.
  • (PMID = 19836162.001).
  • [ISSN] 1879-355X
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


17. Park L, Delaney TF, Liebsch NJ, Hornicek FJ, Goldberg S, Mankin H, Rosenberg AE, Rosenthal DI, Suit HD: Sacral chordomas: Impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor. Int J Radiat Oncol Biol Phys; 2006 Aug 1;65(5):1514-21
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sacral chordomas: Impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor.
  • METHODS AND MATERIALS: The records of 16 primary and 11 recurrent sacral chordoma patients treated from November 1982 to November 2002 by proton/photon radiation therapy alone (6 patients) or combined with surgery (21 patients) have been analyzed for local control, survival, and treatment-related morbidity.
  • RESULTS: Outcome results show a large difference in local failure rate between patients treated for primary and recurrent chordomas.
  • Local control results by surgery and radiation were 12/14 vs. 1/7 for primary and recurrent lesions.
  • For margin-positive patients, local control results were 10 of 11 and 0 of 5 in the primary and recurrent groups, respectively; the mean follow-up on these locally controlled patients was 8.8 years (4 at 10.3, 12.8, 17, and 21 years).
  • CONCLUSION: These data indicate a high local control rate for surgical and radiation treatment of primary (12 of 14) as distinct from recurrent (1 of 7) sacral chordomas.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Combined Modality Therapy. Female. Humans. Male. Middle Aged. Photons / therapeutic use. Protons / therapeutic use. Survival Analysis. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16757128.001).
  • [ISSN] 0360-3016
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P01 CA21239
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Protons
  •  go-up   go-down


18. Meis PJ, Klebanoff M, Dombrowski MP, Sibai BM, Leindecker S, Moawad AH, Northen A, Iams JD, Varner MW, Caritis SN, O'Sullivan MJ, Miodovnik M, Leveno KJ, Conway D, Wapner RJ, Carpenter M, Mercer B, Ramin SM, Thorp JM, Peaceman AM, Gabbe S: Does progesterone treatment influence risk factors for recurrent preterm delivery? Obstet Gynecol; 2005 Sep;106(3):557-61
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Does progesterone treatment influence risk factors for recurrent preterm delivery?
  • OBJECTIVE: To examine how demographic and pregnancy characteristics can affect the risk of recurrent preterm delivery and the how the effectiveness of progesterone treatment for prevention alters these relationships.
  • METHODS: This was a secondary analysis of a randomized trial of 17alpha-hydroxyprogesterone caproate to prevent recurrent preterm delivery in women at risk.
  • CONCLUSION: The use of 17alpha-hydroxyprogesterone caproate in women with a previous preterm delivery reduces the overall risk of preterm delivery and changes the epidemiology of risk factors for recurrent preterm delivery.
  • [MeSH-minor] Adult. Female. Humans. Multivariate Analysis. Pregnancy. Recurrence. Risk Factors

  • MedlinePlus Health Information. consumer health - Preterm Labor.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16135587.001).
  • [ISSN] 0029-7844
  • [Journal-full-title] Obstetrics and gynecology
  • [ISO-abbreviation] Obstet Gynecol
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / HD21410; United States / NICHD NIH HHS / HD / HD21414; United States / NICHD NIH HHS / HD / HD27860; United States / NICHD NIH HHS / HD / HD27861; United States / NICHD NIH HHS / HD / HD27869; United States / NICHD NIH HHS / HD / HD27905; United States / NICHD NIH HHS / HD / HD27915; United States / NICHD NIH HHS / HD / HD27917; United States / NICHD NIH HHS / HD / HD34116; United States / NICHD NIH HHS / HD / HD34122; United States / NICHD NIH HHS / HD / HD34136; United States / NICHD NIH HHS / HD / HD34208; United States / NICHD NIH HHS / HD / HD34210; United States / NICHD NIH HHS / HD / HD36801; United States / NICHD NIH HHS / HD / HD40500; United States / NICHD NIH HHS / HD / HD40512; United States / NICHD NIH HHS / HD / HD40544; United States / NICHD NIH HHS / HD / HD40560; United States / NCRR NIH HHS / RR / M01-RR-000080
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Hydroxyprogesterones; 0 / Progestins; 276F2O42F5 / 17-alpha-hydroxy-progesterone caproate
  •  go-up   go-down


19. Alvarado DM, Aferol H, McCall K, Huang JB, Techy M, Buchan J, Cady J, Gonzales PR, Dobbs MB, Gurnett CA: Familial isolated clubfoot is associated with recurrent chromosome 17q23.1q23.2 microduplications containing TBX4. Am J Hum Genet; 2010 Jul 9;87(1):154-60
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Familial isolated clubfoot is associated with recurrent chromosome 17q23.1q23.2 microduplications containing TBX4.
  • A recurrent chromosome 17q23.1q23.2 microduplication was identified in 3 of 66 probands with familial isolated clubfoot.
  • [MeSH-minor] Abnormalities, Multiple / genetics. Adult. Child. Child, Preschool. Female. Gene Duplication. Humans. Male. Musculoskeletal Abnormalities / genetics. Pedigree. Penetrance

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
  • [Cites] Hum Hered. 1969;19(4):321-42 [5391957.001]
  • [Cites] J Pediatr Orthop. 2004 Jul-Aug;24(4):349-52 [15205613.001]
  • [Cites] N Z Med J. 1978 Aug 23;88(618):144-6 [280791.001]
  • [Cites] J Pediatr Orthop B. 1995;4(2):129-36 [7670979.001]
  • [Cites] J Pediatr Orthop. 1998 May-Jun;18(3):323-7 [9600557.001]
  • [Cites] Am J Med Genet. 1998 Sep 1;79(2):90-6 [9741465.001]
  • [Cites] Am J Hum Genet. 1998 Oct;63(4):1153-9 [9758599.001]
  • [Cites] Science. 1999 Mar 12;283(5408):1736-9 [10073939.001]
  • [Cites] Nature. 1999 Apr 29;398(6730):810-4 [10235263.001]
  • [Cites] Nature. 1999 Apr 29;398(6730):814-8 [10235264.001]
  • [Cites] J Bone Joint Surg Br. 1964 Aug;46:445-63 [14216453.001]
  • [Cites] J Bone Joint Surg Br. 2006 Aug;88(8):1082-4 [16877610.001]
  • [Cites] J Surg Orthop Adv. 2006 Summer;15(2):71-3 [16919196.001]
  • [Cites] Development. 2007 Jan;134(1):93-103 [17164415.001]
  • [Cites] Am J Hum Genet. 2007 Nov;81(5):1057-69 [17924346.001]
  • [Cites] Clin Orthop Relat Res. 2007 Sep;462:32-7 [17534194.001]
  • [Cites] Nat Genet. 2008 Mar;40(3):322-8 [18278044.001]
  • [Cites] Dev Med Child Neurol. 2008 Jul;50(7):498-502 [18611198.001]
  • [Cites] Development. 2008 Aug;135(15):2543-53 [18579682.001]
  • [Cites] Nature. 2008 Sep 11;455(7210):237-41 [18668038.001]
  • [Cites] Am J Hum Genet. 2008 Nov;83(5):616-22 [18950742.001]
  • [Cites] Nat Genet. 2009 Aug;41(8):931-5 [19597493.001]
  • [Cites] J Med Genet. 2009 Aug;46(8):511-23 [19372089.001]
  • [Cites] Nature. 2009 Aug 6;460(7256):744-7 [19571808.001]
  • [Cites] Am J Med Genet A. 2009 Dec;149A(12):2745-52 [19938081.001]
  • [Cites] J Pathol. 2010 Jan;220(2):174-85 [19827001.001]
  • [Cites] Dev Cell. 2010 Jan 19;18(1):148-56 [20152185.001]
  • [Cites] Am J Hum Genet. 2010 Mar 12;86(3):454-61 [20206336.001]
  • [Cites] J Pediatr Orthop. 1999 Nov-Dec;19(6):760-2 [10573346.001]
  • [Cites] J Med Genet. 2001 Mar;38(3):209-14 [11303519.001]
  • [Cites] Am J Hum Genet. 2003 Jul;73(1):107-14 [12772088.001]
  • [Cites] J Pediatr Orthop. 2003 Jul-Aug;23(4):503-7 [12826951.001]
  • [Cites] Biol Psychiatry. 2003 Dec 1;54(11):1265-73 [14643094.001]
  • [Cites] J Bone Joint Surg Am. 2004 Jan;86-A(1):22-7 [14711941.001]
  • [Cites] Am J Hum Genet. 2004 Jun;74(6):1239-48 [15106123.001]
  • [Cites] Clin Orthop Relat Res. 1972 May;84:9-13 [5032855.001]
  • (PMID = 20598276.001).
  • [ISSN] 1537-6605
  • [Journal-full-title] American journal of human genetics
  • [ISO-abbreviation] Am. J. Hum. Genet.
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / K12 HD001459; United States / NIAMS NIH HHS / AR / P30 AR057235
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / T-Box Domain Proteins; 0 / TBX4 protein, human
  • [Other-IDs] NLM/ PMC2896772
  •  go-up   go-down


20. Tozzi F, Prokopenko I, Perry JD, Kennedy JL, McCarthy AD, Holsboer F, Berrettini W, Middleton LT, Chilcoat HD, Muglia P: Family history of depression is associated with younger age of onset in patients with recurrent depression. Psychol Med; 2008 May;38(5):641-9
Genetic Alliance. consumer health - Depression.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Family history of depression is associated with younger age of onset in patients with recurrent depression.
  • METHOD: A sample of 1022 cases with recurrent major depressive disorder (MDD) was recruited at the Max Planck Institute and at two affiliated hospitals.
  • [MeSH-major] Depressive Disorder, Major / genetics. Genetic Predisposition to Disease / genetics
  • [MeSH-minor] Adolescent. Adult. Age of Onset. Aged. Aged, 80 and over. Anxiety Disorders / diagnosis. Anxiety Disorders / genetics. Anxiety Disorders / psychology. Female. Humans. Male. Middle Aged. Neurotic Disorders / diagnosis. Neurotic Disorders / genetics. Neurotic Disorders / psychology. Probability. Proportional Hazards Models. Recurrence. Regression Analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18272011.001).
  • [ISSN] 0033-2917
  • [Journal-full-title] Psychological medicine
  • [ISO-abbreviation] Psychol Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


21. Shinawi M, Schaaf CP, Bhatt SS, Xia Z, Patel A, Cheung SW, Lanpher B, Nagl S, Herding HS, Nevinny-Stickel C, Immken LL, Patel GS, German JR, Beaudet AL, Stankiewicz P: A small recurrent deletion within 15q13.3 is associated with a range of neurodevelopmental phenotypes. Nat Genet; 2009 Dec;41(12):1269-71
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A small recurrent deletion within 15q13.3 is associated with a range of neurodevelopmental phenotypes.
  • We report a recurrent 680-kb deletion within chromosome 15q13.3 in ten individuals, from four unrelated families, with neurodevelopmental phenotypes including developmental delay, mental retardation and seizures.

  • MedlinePlus Health Information. consumer health - Brain Malformations.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mol Pharmacol. 2002 Mar;61(3):695-705 [11854451.001]
  • [Cites] Hum Mol Genet. 2009 Oct 1;18(19):3626-31 [19592580.001]
  • [Cites] Biol Psychiatry. 2006 Jul 15;60(2):115-22 [16843094.001]
  • [Cites] PLoS One. 2007;2(3):e327 [17389918.001]
  • [Cites] Science. 2007 Dec 7;318(5856):1628-32 [17991829.001]
  • [Cites] Genome Biol. 2007;8(6):R114 [17573966.001]
  • [Cites] Nat Genet. 2008 Mar;40(3):322-8 [18278044.001]
  • [Cites] Nature. 2008 Sep 11;455(7210):237-41 [18668038.001]
  • [Cites] Nature. 2008 Sep 11;455(7210):232-6 [18668039.001]
  • [Cites] Nat Genet. 2009 Feb;41(2):160-2 [19136953.001]
  • [Cites] Schizophr Res. 2009 Apr;109(1-3):102-12 [19181484.001]
  • [Cites] J Med Genet. 2009 Apr;46(4):242-8 [18805830.001]
  • [Cites] J Med Genet. 2009 Jun;46(6):382-8 [19289393.001]
  • [Cites] J Med Genet. 2009 Aug;46(8):511-23 [19372089.001]
  • [Cites] Epilepsy Res. 2002 Apr;49(2):157-72 [12049804.001]
  • (PMID = 19898479.001).
  • [ISSN] 1546-1718
  • [Journal-full-title] Nature genetics
  • [ISO-abbreviation] Nat. Genet.
  • [Language] ENG
  • [Grant] United States / NICHD NIH HHS / HD / HD-037283; United States / NICHD NIH HHS / HD / HD037283-10; United States / NICHD NIH HHS / HD / HD037283-09; United States / NICHD NIH HHS / HD / HD037283-12; United States / NCRR NIH HHS / RR / M01-RR00188; United States / NICHD NIH HHS / HD / R01 HD037283-10; United States / NCRR NIH HHS / RR / M01 RR000188; United States / NICHD NIH HHS / HD / R01 HD037283-08; United States / NICHD NIH HHS / HD / HD037283-08; United States / NICHD NIH HHS / HD / R01 HD037283; United States / NICHD NIH HHS / HD / P30 HD024064; United States / NCRR NIH HHS / RR / RR-019478; United States / NICHD NIH HHS / HD / R01 HD037283-12; United States / NCRR NIH HHS / RR / U54 RR019478; United States / NICHD NIH HHS / HD / HD-024064; United States / NICHD NIH HHS / HD / HD037283-11A2; United States / NICHD NIH HHS / HD / R01 HD037283-11A2; United States / NICHD NIH HHS / HD / R01 HD037283-09
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Chrna7 protein, human; 0 / Receptors, Nicotinic; 0 / alpha7 Nicotinic Acetylcholine Receptor
  • [Other-IDs] NLM/ NIHMS292512; NLM/ PMC3158565
  •  go-up   go-down


22. Trcić RL, Sustercić D, Kuspilić M, Jelić-Puskarić B, Fabijanić I, Kardum-Skelin I: Recurrent chromosomal abnormalities in lymphomas in fine needle aspirates of lymph node. Coll Antropol; 2010 Jun;34(2):387-93
MedlinePlus Health Information. consumer health - Lymphoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recurrent chromosomal abnormalities in lymphomas in fine needle aspirates of lymph node.
  • This has been accomplished by using the fluorescent in situ hybridisation method (FISH) performed on fine needle aspiration (FNA) specimens what is attractive in the diagnosis of lymphoma in the comparation with other methods for collecting samples.
  • The cytogenetic analyses were performed in series of 80 patients with lymphoma (43 women and 37 men, median age 48, range 3-90 years).
  • In our series 89.0% (71) of the specimens yield sufficient numbers of analysable metaphases, comprising 63 non-Hodgkin lymphomas (NHL) and 8 examples of Hodgkin disease (HD).
  • Four abnormal clones detected in Hodgkin disease were typically consisted of a small percentage of metaphases.
  • [MeSH-major] Chromosome Aberrations / classification. Lymph Nodes / pathology. Lymphoma / genetics. Lymphoma / pathology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Biopsy, Fine-Needle / methods. Biopsy, Needle / methods. Female. Gene Rearrangement / genetics. Humans. In Situ Hybridization, Fluorescence. Karyotyping. Lymphoma, B-Cell / genetics. Lymphoma, B-Cell / pathology. Lymphoma, T-Cell / genetics. Lymphoma, T-Cell / pathology. Male. Middle Aged. Translocation, Genetic

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20698107.001).
  • [ISSN] 0350-6134
  • [Journal-full-title] Collegium antropologicum
  • [ISO-abbreviation] Coll Antropol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Croatia
  •  go-up   go-down


23. Girirajan S, Rosenfeld JA, Cooper GM, Antonacci F, Siswara P, Itsara A, Vives L, Walsh T, McCarthy SE, Baker C, Mefford HC, Kidd JM, Browning SR, Browning BL, Dickel DE, Levy DL, Ballif BC, Platky K, Farber DM, Gowans GC, Wetherbee JJ, Asamoah A, Weaver DD, Mark PR, Dickerson J, Garg BP, Ellingwood SA, Smith R, Banks VC, Smith W, McDonald MT, Hoo JJ, French BN, Hudson C, Johnson JP, Ozmore JR, Moeschler JB, Surti U, Escobar LF, El-Khechen D, Gorski JL, Kussmann J, Salbert B, Lacassie Y, Biser A, McDonald-McGinn DM, Zackai EH, Deardorff MA, Shaikh TH, Haan E, Friend KL, Fichera M, Romano C, Gécz J, DeLisi LE, Sebat J, King MC, Shaffer LG, Eichler EE: A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay. Nat Genet; 2010 Mar;42(3):203-9
eScholarship, California Digital Library, University of California. Full text from University of California eScholarship .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay.
  • We report the identification of a recurrent, 520-kb 16p12.1 microdeletion associated with childhood developmental delay.
  • Analysis of other microdeletions with variable expressivity indicates that this two-hit model might be more generally applicable to neuropsychiatric disease.
  • [MeSH-minor] Adult. Case-Control Studies. Child. Child, Preschool. Comparative Genomic Hybridization / methods. Family. Gene Frequency. Humans. Infant. Oligonucleotide Array Sequence Analysis. Pedigree. Phenotype. Polymorphism, Single Nucleotide. Recurrence. Severity of Illness Index


24. Kwok L, Stapleton AE, Stamm WE, Hillier SL, Wobbe CL, Gupta K: Adherence of Lactobacillus crispatus to vaginal epithelial cells from women with or without a history of recurrent urinary tract infection. J Urol; 2006 Nov;176(5):2050-4; discussion 2054
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adherence of Lactobacillus crispatus to vaginal epithelial cells from women with or without a history of recurrent urinary tract infection.
  • PURPOSE: Lactobacillus crispatus strain CTV-05 is a vaginal probiotic proposed for use in women with recurrent urinary tract infection to reduce vaginal colonization with Escherichia coli and the risk of urinary tract infection.
  • However, the ability of this probiotic strain to adhere to the target mucosa, vaginal epithelial cells, has not been assessed in women with recurrent urinary tract infection.
  • We measured the adherence of L. crispatus strain CTV-05 to vaginal epithelial cells collected from more than 100 premenopausal women with (cases) and without (controls) a history of recurrent urinary tract infection.
  • RESULTS: L. crispatus CTV-05 adhered in high numbers to vaginal epithelial cells from women with recurrent urinary tract infection (mean adherence of 50.5 lactobacilli per vaginal epithelial cell) and controls (mean adherence of 39.4 lactobacilli per vaginal epithelial cell).
  • CONCLUSIONS: L. crispatus strain CTV-05 is highly adherent to vaginal epithelial cells collected from a large sample of premenopausal women with or without a history of recent recurrent urinary tract infection.
  • These data strongly support further evaluation of this probiotic in clinical trials of women with recurrent urinary tract infection.


25. Shinawi M, Liu P, Kang SH, Shen J, Belmont JW, Scott DA, Probst FJ, Craigen WJ, Graham BH, Pursley A, Clark G, Lee J, Proud M, Stocco A, Rodriguez DL, Kozel BA, Sparagana S, Roeder ER, McGrew SG, Kurczynski TW, Allison LJ, Amato S, Savage S, Patel A, Stankiewicz P, Beaudet AL, Cheung SW, Lupski JR: Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size. J Med Genet; 2010 May;47(5):332-41
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size.
  • CONCLUSIONS: Recurrent reciprocal 16p11.2 deletion and duplication are characterised by a spectrum of primarily neurocognitive phenotypes that are subject to incomplete penetrance and variable expressivity.

  • Genetic Alliance. consumer health - Epilepsy.
  • Genetics Home Reference. consumer health - 16p11.2 duplication.
  • MedlinePlus Health Information. consumer health - Developmental Disabilities.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 2010 Jan 26;107 Suppl 1:1736-41 [19955444.001]
  • [Cites] Hum Genet. 2009 Oct;126(4):589-602 [19557438.001]
  • [Cites] Neuron. 2002 May 30;34(5):807-20 [12062026.001]
  • [Cites] Brain Res Mol Brain Res. 2002 Nov 15;107(2):89-96 [12425938.001]
  • [Cites] J Cell Sci. 2003 May 15;116(Pt 10):1905-13 [12668731.001]
  • [Cites] Am J Med Genet A. 2003 Aug 30;121A(2):146-50 [12910494.001]
  • [Cites] Nature. 2008 Sep 11;455(7210):237-41 [18668038.001]
  • [Cites] Nature. 2008 Sep 11;455(7210):232-6 [18668039.001]
  • [Cites] Drug Discov Today. 2008 Sep;13(17-18):760-70 [18617013.001]
  • [Cites] N Engl J Med. 2008 Oct 16;359(16):1685-99 [18784092.001]
  • [Cites] J Med Genet. 2008 Nov;45(11):710-20 [18628315.001]
  • [Cites] Genet Med. 2003 Nov-Dec;5(6):430-4 [14614393.001]
  • [Cites] J Immunol. 2004 Apr 15;172(8):5006-15 [15067082.001]
  • [Cites] Epilepsia. 1988 Sep-Oct;29(5):523-9 [3409840.001]
  • [Cites] Biochem Biophys Res Commun. 1995 Jan 17;206(2):439-48 [7826360.001]
  • [Cites] Trends Genet. 1998 Oct;14(10):417-22 [9820031.001]
  • [Cites] Genes Dev. 2005 Apr 1;19(7):827-39 [15805470.001]
  • [Cites] Genet Med. 2005 Jul-Aug;7(6):422-32 [16024975.001]
  • [Cites] Genet Med. 2005 Sep;7(7):479-83 [16170239.001]
  • [Cites] PLoS Genet. 2005 Dec;1(6):e49 [16444292.001]
  • [Cites] J Med Genet. 2006 Aug;43(8):625-33 [16490798.001]
  • [Cites] Nat Genet. 2006 Sep;38(9):1038-42 [16906162.001]
  • [Cites] Nat Genet. 2006 Sep;38(9):1032-7 [16906163.001]
  • [Cites] Nat Genet. 2006 Sep;38(9):999-1001 [16906164.001]
  • [Cites] Am J Med Genet A. 2006 Nov 1;140(21):2257-74 [17022081.001]
  • [Cites] J Med Genet. 2006 Nov;43(11):843-9 [16840569.001]
  • [Cites] Hum Mol Genet. 2007 Mar 1;16(5):567-72 [17360722.001]
  • [Cites] Science. 2007 Apr 20;316(5823):445-9 [17363630.001]
  • [Cites] Nat Genet. 2007 Sep;39(9):1071-3 [17704777.001]
  • [Cites] Nat Genet. 2008 Jan;40(1):90-5 [18059269.001]
  • [Cites] Hum Mol Genet. 2008 Feb 15;17(4):628-38 [18156158.001]
  • [Cites] Am J Hum Genet. 2008 Feb;82(2):477-88 [18252227.001]
  • [Cites] N Engl J Med. 2008 Feb 14;358(7):667-75 [18184952.001]
  • [Cites] Nat Genet. 2008 Mar;40(3):322-8 [18278044.001]
  • [Cites] Genet Med. 2008 Apr;10(4):278-89 [18414211.001]
  • [Cites] Behav Brain Sci. 2008 Jun;31(3):241-61; discussion 261-320 [18578904.001]
  • [Cites] Nat Genet. 2008 Dec;40(12):1466-71 [19029900.001]
  • [Cites] Genome Res. 2008 Dec;18(12):2016-23 [18836033.001]
  • [Cites] Nat Genet. 2009 Feb;41(2):168-77 [19136950.001]
  • [Cites] Nat Genet. 2009 Feb;41(2):160-2 [19136953.001]
  • [Cites] PLoS One. 2009;4(2):e4582 [19242545.001]
  • [Cites] Clin Immunol. 2009 Apr;131(1):24-30 [19097825.001]
  • [Cites] Eur J Med Genet. 2009 Mar-Jun;52(2-3):77-87 [19306953.001]
  • [Cites] J Med Genet. 2009 Jun;46(6):382-8 [19289393.001]
  • [Cites] J Med Genet. 2009 Aug;46(8):511-23 [19372089.001]
  • [Cites] Trends Genet. 2002 Feb;18(2):74-82 [11818139.001]
  • (PMID = 19914906.001).
  • [ISSN] 1468-6244
  • [Journal-full-title] Journal of medical genetics
  • [ISO-abbreviation] J. Med. Genet.
  • [Language] ENG
  • [Grant] United States / NICHD NIH HHS / HD / HD037283-10; United States / NICHD NIH HHS / HD / HD037283-09; United States / NICHD NIH HHS / HD / HD037283-12; United States / NICHD NIH HHS / HD / R01 HD037283-10; United States / NICHD NIH HHS / HD / R01 HD037283-08; United States / NICHD NIH HHS / HD / HD037283-08; United States / NICHD NIH HHS / HD / R01 HD037283; United States / NICHD NIH HHS / HD / R01 HD037283-12; United States / NINDS NIH HHS / NS / R01 NS058529; United States / NICHD NIH HHS / HD / HD037283-11A2; United States / NICHD NIH HHS / HD / R01 HD037283-11A2; United States / NICHD NIH HHS / HD / R01 HD037283-09
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Other-IDs] NLM/ NIHMS292520; NLM/ PMC3158566
  •  go-up   go-down


26. Sheridan MB, Kato T, Haldeman-Englert C, Jalali GR, Milunsky JM, Zou Y, Klaes R, Gimelli G, Gimelli S, Gemmill RM, Drabkin HA, Hacker AM, Brown J, Tomkins D, Shaikh TH, Kurahashi H, Zackai EH, Emanuel BS: A palindrome-mediated recurrent translocation with 3:1 meiotic nondisjunction: the t(8;22)(q24.13;q11.21). Am J Hum Genet; 2010 Aug 13;87(2):209-18
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A palindrome-mediated recurrent translocation with 3:1 meiotic nondisjunction: the t(8;22)(q24.13;q11.21).
  • Palindrome-mediated genomic instability has been associated with chromosomal translocations, including the recurrent t(11;22)(q23;q11).
  • We report a syndrome characterized by extremity anomalies, mild dysmorphia, and intellectual impairment caused by 3:1 meiotic segregation of a previously unrecognized recurrent palindrome-mediated rearrangement, the t(8;22)(q24.13;q11.21).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Tohoku J Exp Med. 1984 Oct;144(2):151-63 [6515649.001]
  • [Cites] Am J Hum Genet. 1983 Mar;35(2):301-8 [6837576.001]
  • [Cites] J Med Genet. 1989 Oct;26(10):642-4 [2585460.001]
  • [Cites] Am J Hum Genet. 1991 Nov;49(5):995-1013 [1928105.001]
  • [Cites] Hum Genet. 1997 Feb;99(2):237-47 [9048928.001]
  • [Cites] Clin Genet. 1996 Dec;50(6):515-9 [9147886.001]
  • [Cites] Genet Couns. 1998;9(2):157-8 [9664215.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9572-7 [9689122.001]
  • [Cites] Clin Genet. 2005 Aug;68(2):146-51 [15996211.001]
  • [Cites] Science. 2006 Feb 17;311(5763):971 [16484486.001]
  • [Cites] Hum Genet. 2006 May;119(4):444-50 [16493556.001]
  • [Cites] Am J Hum Genet. 2006 Sep;79(3):524-38 [16909390.001]
  • [Cites] Am J Med Genet A. 2006 Aug 1;140(15):1658-62 [16838305.001]
  • [Cites] DNA Repair (Amst). 2006 Sep 8;5(9-10):1146-60 [16807136.001]
  • [Cites] DNA Repair (Amst). 2006 Sep 8;5(9-10):1136-45 [16829213.001]
  • [Cites] Genome Res. 2007 Apr;17(4):470-81 [17351131.001]
  • [Cites] Genes Chromosomes Cancer. 2007 Sep;46(9):805-12 [17539022.001]
  • [Cites] PLoS Biol. 2007 Sep 4;5(10):e254 [17803354.001]
  • [Cites] Genet Couns. 2007;18(4):357-65 [18286816.001]
  • [Cites] Nature. 2008 Apr 17;452(7189):872-6 [18421352.001]
  • [Cites] Nature. 2008 Nov 6;456(7218):60-5 [18987735.001]
  • [Cites] DNA Repair (Amst). 2009 Mar 1;8(3):383-9 [19124276.001]
  • [Cites] Am J Med Genet A. 2009 Aug;149A(8):1712-21 [19606488.001]
  • [Cites] Mol Cancer. 2009;8:52 [19642973.001]
  • [Cites] Mol Cancer Res. 2010 Jan;8(1):93-106 [20068067.001]
  • [Cites] J Med Genet. 2010 Feb;47(2):112-5 [19638350.001]
  • [Cites] Eur J Hum Genet. 2010 Jul;18(7):783-7 [20179746.001]
  • [Cites] J Med Genet. 2001 Jun;38(6):E21 [11389168.001]
  • [Cites] Hum Genet. 2001 Aug;109(2):167-77 [11511922.001]
  • [Cites] Nat Genet. 2001 Oct;29(2):139-40 [11586296.001]
  • [Cites] Am J Med Genet. 2002 Apr 1;108(4):322-6 [11920839.001]
  • [Cites] Oncogene. 2002 May 16;21(22):3507-16 [12032852.001]
  • [Cites] Am J Hum Genet. 2002 Aug;71(2):276-85 [12058347.001]
  • [Cites] Am J Hum Genet. 2003 Mar;72(3):733-8 [12557125.001]
  • [Cites] Hum Mol Genet. 2003 Aug 1;12(15):1823-37 [12874103.001]
  • [Cites] Hum Mol Genet. 2003 Nov 1;12(21):2817-25 [12952865.001]
  • [Cites] Mol Cell Biol. 2003 Dec;23(23):8740-50 [14612414.001]
  • [Cites] Hum Mol Genet. 2004 Jan 1;13(1):103-15 [14613967.001]
  • [Cites] Cancer Genet Cytogenet. 2004 Jan 1;148(1):87-8 [14697649.001]
  • [Cites] Exp Cell Res. 1972 Sep;74(1):293-5 [5073314.001]
  • [Cites] Humangenetik. 1974;23(4):297-303 [4420964.001]
  • [Cites] J Med Genet. 1975 Mar;12(1):29-43 [123589.001]
  • [Cites] Clin Genet. 1976 Dec;10(6):329-36 [991443.001]
  • [Cites] Ann Genet. 1977 Mar;20(1):5-11 [302674.001]
  • [Cites] Hum Mol Genet. 2000 Jul 1;9(11):1665-70 [10861293.001]
  • [Cites] Prenat Diagn. 2000 Jun;20(6):511-5 [10861719.001]
  • [Cites] Am J Hum Genet. 2000 Sep;67(3):763-8 [10903930.001]
  • [Cites] Am J Hum Genet. 2001 Jan;68(1):1-13 [11095996.001]
  • [Cites] Am J Med Genet. 1982 Feb;11(2):241-7 [7065009.001]
  • [Cites] Ann Genet. 1984;27(4):224-9 [6335368.001]
  • (PMID = 20673865.001).
  • [ISSN] 1537-6605
  • [Journal-full-title] American journal of human genetics
  • [ISO-abbreviation] Am. J. Hum. Genet.
  • [Language] ENG
  • [Grant] United States / NICHD NIH HHS / HD / P30 HD026979; United States / NCI NIH HHS / CA / R01 CA039926; United States / NCI NIH HHS / CA / CA39926; United States / NICHD NIH HHS / HD / HD26979
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2917714
  •  go-up   go-down


27. Kim SW, Shin HC, Kim IY, Baek MJ, Cho HD: Foreign body granulomas simulating recurrent tumors in patients following colorectal surgery for carcinoma: a report of two cases. Korean J Radiol; 2009 May-Jun;10(3):313-8
MedlinePlus Health Information. consumer health - Liver Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Foreign body granulomas simulating recurrent tumors in patients following colorectal surgery for carcinoma: a report of two cases.
  • We report here two cases of foreign body granulomas that arose from the pelvic wall and liver, respectively, and simulated recurrent colorectal carcinomas in patients with a history of surgery.
  • [MeSH-minor] Adult. Aged. Contrast Media. Diagnosis, Differential. Fluorodeoxyglucose F18. Humans. Hydronephrosis / etiology. Image Enhancement / methods. Liver / pathology. Liver / radionuclide imaging. Magnetic Resonance Imaging. Male. Pelvis / pathology. Pelvis / radiography. Positron-Emission Tomography. Radiopharmaceuticals. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Urol Int. 1999;62(4):220-2 [10567887.001]
  • [Cites] Radiographics. 2000 Mar-Apr;20(2):419-30 [10715340.001]
  • [Cites] AJNR Am J Neuroradiol. 2003 Jun-Jul;24(6):1164-6 [12812947.001]
  • [Cites] AJR Am J Roentgenol. 2003 Sep;181(3):809-17 [12933487.001]
  • [Cites] Radiology. 1991 Aug;180(2):327-32 [2068294.001]
  • [Cites] Br J Radiol. 1996 May;69(821):476-8 [8705188.001]
  • [Cites] Abdom Imaging. 2008 Jan-Feb;33(1):94-7 [17334877.001]
  • [Cites] Br J Radiol. 2005 Aug;78(932):752-4 [16046430.001]
  • [Cites] Ann Acad Med Singapore. 2005 Aug;34(7):457-60 [16123823.001]
  • [Cites] J Clin Oncol. 2005 Nov 20;23(33):8512-9 [16260687.001]
  • [Cites] Yonsei Med J. 2006 Oct 31;47(5):748-51 [17066522.001]
  • [Cites] Ann Nucl Med. 2006 Oct;20(8):553-6 [17134023.001]
  • [Cites] AJR Am J Roentgenol. 2007 Nov;189(5):1203-10 [17954662.001]
  • [Cites] J Comput Assist Tomogr. 2004 Nov-Dec;28(6):839-41 [15538161.001]
  • (PMID = 19412522.001).
  • [ISSN] 2005-8330
  • [Journal-full-title] Korean journal of radiology
  • [ISO-abbreviation] Korean J Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Korea (South)
  • [Chemical-registry-number] 0 / Contrast Media; 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  • [Other-IDs] NLM/ PMC2672189
  • [Keywords] NOTNLM ; Colon, surgery / Foreign bodies / Granuloma
  •  go-up   go-down


28. Muscal E, Brey RL: Antiphospholipid syndrome and the brain in pediatric and adult patients. Lupus; 2010 Apr;19(4):406-11
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Antiphospholipid syndrome and the brain in pediatric and adult patients.
  • Treatment regimens for asymptomatic antibody-positive patients and those with refractory or recurrent disease remain controversial.

  • Genetic Alliance. consumer health - Antiphospholipid Syndrome.
  • MedlinePlus Health Information. consumer health - Blood Clots.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arthritis Rheum. 2002 Aug15;47(4):414-20 [12209489.001]
  • [Cites] Lupus. 2010 Apr;19(5):613-9 [19934177.001]
  • [Cites] N Engl J Med. 2003 Sep 18;349(12):1133-8 [13679527.001]
  • [Cites] Medicine (Baltimore). 2003 Sep;82(5):299-308 [14530779.001]
  • [Cites] Arthritis Rheum. 2003 Oct;48(10):2881-7 [14558094.001]
  • [Cites] JAMA. 2004 Feb 4;291(5):576-84 [14762036.001]
  • [Cites] Stroke. 2004 Mar;35(3):736-41 [14764933.001]
  • [Cites] Pediatrics. 1994 Oct;94(4 Pt 1):500-3 [7936859.001]
  • [Cites] Lupus. 1999;8(2):127-33 [10192507.001]
  • [Cites] Arthritis Rheum. 1999 Apr;42(4):728-34 [10211887.001]
  • [Cites] Arthritis Rheum. 1999 Apr;42(4):735-41 [10211888.001]
  • [Cites] Arthritis Rheum. 2004 Dec;50(12):3947-57 [15593203.001]
  • [Cites] J Thromb Haemost. 2005 May;3(5):848-53 [15869575.001]
  • [Cites] Am J Cardiol. 2005 Jun 15;95(12):1441-7 [15950567.001]
  • [Cites] J Rheumatol. 2006 Sep;33(9):1873-7 [16845706.001]
  • [Cites] Arthritis Rheum. 2007 Jul;56(7):2382-91 [17599766.001]
  • [Cites] Arthritis Rheum. 2007 Dec 15;57(8):1461-72 [18050188.001]
  • [Cites] Arthritis Rheum. 2008 Feb 15;59(2):206-13 [18240179.001]
  • [Cites] J Magn Reson Imaging. 2008 Mar;27(3):483-8 [18224670.001]
  • [Cites] Clin Rheumatol. 2008 Jul;27(7):891-7 [18157495.001]
  • [Cites] Semin Thromb Hemost. 2008 Apr;34(3):274-81 [18720307.001]
  • [Cites] Clin Neurol Neurosurg. 2008 Nov;110(9):905-12 [18928881.001]
  • [Cites] Pediatrics. 2008 Nov;122(5):e1100-7 [18955411.001]
  • [Cites] J Neuroinflammation. 2009;6:3 [19154576.001]
  • [Cites] Stroke. 2009 Jul;40(7):2337-42 [19498198.001]
  • [Cites] Lupus. 2009 Sep;18(10):889-93 [19671788.001]
  • [Cites] Lupus. 2009 Sep;18(10):905-12 [19671791.001]
  • [Cites] Lancet Neurol. 2009 Nov;8(11):998-1005 [19783216.001]
  • [Cites] J Neurol. 2010 Jan;257(1):63-71 [19633967.001]
  • [Cites] Rheumatology (Oxford). 2003 Feb;42(2):200-13 [12595612.001]
  • (PMID = 20353978.001).
  • [ISSN] 1477-0962
  • [Journal-full-title] Lupus
  • [ISO-abbreviation] Lupus
  • [Language] ENG
  • [Grant] United States / NICHD NIH HHS / HD / HD041648-07; United States / NINDS NIH HHS / NS / NS063883-02; United States / NICHD NIH HHS / HD / K12 HD041648-07; United States / NINDS NIH HHS / NS / L40 NS063883-02
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antibodies, Antiphospholipid; 0 / Anticoagulants; 0 / Platelet Aggregation Inhibitors
  • [Number-of-references] 30
  • [Other-IDs] NLM/ NIHMS242431; NLM/ PMC2980850
  •  go-up   go-down


29. Cody JD, Sebold C, Malik A, Heard P, Carter E, Crandall A, Soileau B, Semrud-Clikeman M, Cody CM, Hardies LJ, Li J, Lancaster J, Fox PT, Stratton RF, Perry B, Hale DE: Recurrent interstitial deletions of proximal 18q: a new syndrome involving expressive speech delay. Am J Med Genet A; 2007 Jun 1;143A(11):1181-90
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recurrent interstitial deletions of proximal 18q: a new syndrome involving expressive speech delay.
  • [MeSH-minor] Adult. Anthropometry. Behavior. Child. Child, Preschool. Cognition. Female. Humans. Infant. Male. Neuropsychological Tests. Syndrome

  • Genetics Home Reference. consumer health - proximal 18q deletion syndrome.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2007 Wiley-Liss, Inc.
  • (PMID = 17486614.001).
  • [ISSN] 1552-4825
  • [Journal-full-title] American journal of medical genetics. Part A
  • [ISO-abbreviation] Am. J. Med. Genet. A
  • [Language] eng
  • [Grant] United States / NCRR NIH HHS / RR / M01-RR-01346; United States / NICHD NIH HHS / HD / R01-HD-045907
  • [Publication-type] Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


30. Burwinkel B, Scott JW, Bührer C, van Landeghem FK, Cox GF, Wilson CJ, Grahame Hardie D, Kilimann MW: Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency. Am J Hum Genet; 2005 Jun;76(6):1034-49
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency.
  • Other PRKAG2 missense mutations were previously identified in patients with autosomal dominant hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome, characterized by juvenile-to-adult clinical onset, moderate cardiac glycogenosis, disturbed excitation conduction, risk of sudden cardiac death in midlife, and molecular perturbations that are similar to--but less severe than--those observed for the R531Q mutation.
  • Thus, recurrent heterozygous R531Q missense mutations in PRKAG2 give rise to a massive nonlysosomal cardiac glycogenosis of fetal symptomatic onset and rapidly fatal course, constituting a genotypically and clinically distinct variant of hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome.
  • R531Q and other PRKAG2 mutations enhance the basal activity and alpha -subunit phosphorylation of AMP-activated protein kinase, explaining the dominant nature of PRKAG2 disease mutations.

  • Genetics Home Reference. consumer health - PRKAG2 gene.
  • Gene Ontology. gene/protein/disease-specific - Gene Ontology annotations from this paper .
  • SciCrunch. OMIM: Data: Gene Annotation .
  • SciCrunch. Clinical Genomic Database: Data: Gene Annotation .
  • SciCrunch. KEGG: Data: Disease Annotation .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Invest. 2002 Feb;109(3):357-62 [11827995.001]
  • [Cites] J Am Coll Cardiol. 2005 Mar 15;45(6):922-30 [15766830.001]
  • [Cites] Biochem J. 2002 Apr 1;363(Pt 1):167-74 [11903059.001]
  • [Cites] J Cell Sci. 2002 Jun 1;115(Pt 11):2433-42 [12006627.001]
  • [Cites] Curr Opin Cardiol. 2002 May;17(3):229-34 [12015471.001]
  • [Cites] Neurology. 2002 Jun 25;58(12):1773-8 [12084876.001]
  • [Cites] J Biol Chem. 2002 Dec 27;277(52):51017-24 [12397075.001]
  • [Cites] N Engl J Med. 2003 Apr 24;348(17):1703-5 [12711746.001]
  • [Cites] Circulation. 2003 Jun 10;107(22):2850-6 [12782567.001]
  • [Cites] Eur J Hum Genet. 2003 Jul;11(7):516-26 [12825073.001]
  • [Cites] J Mol Cell Cardiol. 2003 Oct;35(10):1251-5 [14519435.001]
  • [Cites] Curr Biol. 2003 Nov 11;13(22):2004-8 [14614828.001]
  • [Cites] Endocrinology. 2003 Dec;144(12):5179-83 [12960015.001]
  • [Cites] Acta Paediatr. 2003 Nov;92(11):1352-3 [14696860.001]
  • [Cites] Am J Physiol Endocrinol Metab. 2004 Feb;286(2):E194-200 [14559719.001]
  • [Cites] J Clin Invest. 2004 Jan;113(2):182-4 [14722609.001]
  • [Cites] J Clin Invest. 2004 Jan;113(2):274-84 [14722619.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3329-35 [14985505.001]
  • [Cites] J Biol. 2003;2(4):28 [14511394.001]
  • [Cites] J Biol Chem. 2004 Sep 10;279(37):38441-7 [15247217.001]
  • [Cites] J Cell Sci. 2004 Nov 1;117(Pt 23):5479-87 [15509864.001]
  • [Cites] Biochem Biophys Res Commun. 1984 Mar 15;119(2):582-7 [6424667.001]
  • [Cites] Hum Pathol. 1985 Feb;16(2):193-7 [3918928.001]
  • [Cites] J Pediatr. 1987 Jul;111(1):51-6 [3474393.001]
  • [Cites] J Pediatr. 1988 Jul;113(1 Pt 1):82-5 [3385534.001]
  • [Cites] J Biol Chem. 1989 Jun 5;264(16):9126-8 [2498326.001]
  • [Cites] Biochim Biophys Acta. 1989 Jun 15;1012(1):81-6 [2567185.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1993;423(4):303-7 [8236826.001]
  • [Cites] Hum Mol Genet. 1995 Aug;4(8):1313-20 [7581368.001]
  • [Cites] Biochem J. 2000 Mar 15;346 Pt 3:659-69 [10698692.001]
  • [Cites] Ann Neurol. 2000 Apr;47(4):536-40 [10762170.001]
  • [Cites] Science. 2000 May 19;288(5469):1248-51 [10818001.001]
  • [Cites] Methods Mol Biol. 2000;99:63-74 [10909077.001]
  • [Cites] Hum Mol Genet. 2001 May 15;10(11):1215-20 [11371514.001]
  • [Cites] N Engl J Med. 2001 Jun 14;344(24):1823-31 [11407343.001]
  • [Cites] FEBS Lett. 2001 Jul 6;500(3):163-8 [11445078.001]
  • [Cites] Neurology. 2001 Sep 11;57(5):903-5 [11552028.001]
  • [Cites] Bioessays. 2001 Dec;23(12):1112-9 [11746230.001]
  • [Cites] Circulation. 2001 Dec 18;104(25):3030-3 [11748095.001]
  • [Cites] Hum Mol Genet. 1996 May;5(5):653-8 [8733134.001]
  • [Cites] J Biol Chem. 1996 Nov 1;271(44):27879-87 [8910387.001]
  • [Cites] Trends Biochem Sci. 1997 Jan;22(1):12-3 [9020585.001]
  • [Cites] Am J Cardiol. 1997 Mar 15;79(6):834-8 [9070576.001]
  • [Cites] Hum Mol Genet. 1998 Jan;7(1):149-54 [9384616.001]
  • [Cites] Diabetes. 1998 Aug;47(8):1369-73 [9703344.001]
  • [Cites] Biochem J. 1999 Mar 15;338 ( Pt 3):717-22 [10051444.001]
  • [Cites] Pediatr Cardiol. 1999 Jul-Aug;20(4):304-7 [10368461.001]
  • [Cites] Diabetes. 1999 Aug;48(8):1667-71 [10426389.001]
  • [Cites] Z Kardiol. 1999 Oct;88(10):850-6 [10552189.001]
  • [Cites] Am J Physiol. 1999 Aug;277(2 Pt 2):H643-9 [10444490.001]
  • [Cites] Proc Soc Exp Biol Med. 1954 Nov;87(2):440-3 [13237268.001]
  • [Cites] Diabetes. 2004 Dec;53(12):3074-81 [15561936.001]
  • [Cites] N Engl J Med. 2005 Jan 27;352(4):362-72 [15673802.001]
  • [Cites] Hum Mol Genet. 2002 Mar 1;11(5):599-604 [11875054.001]
  • (PMID = 15877279.001).
  • [ISSN] 0002-9297
  • [Journal-full-title] American journal of human genetics
  • [ISO-abbreviation] Am. J. Hum. Genet.
  • [Language] ENG
  • [Databank-accession-numbers] OMIM/ 232300/ 232400/ 300257
  • [Grant] United States / NICHD NIH HHS / HD / N01-HD-8-3284; United Kingdom / Wellcome Trust / /
  • [Publication-type] Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Codon; 0 / Multienzyme Complexes; 0 / Recombinant Fusion Proteins; EC 2.5.1.18 / Glutathione Transferase; EC 2.7.1.19 / Phosphorylase Kinase; EC 2.7.11.1 / AMP-Activated Protein Kinases; EC 2.7.11.1 / Protein-Serine-Threonine Kinases
  • [Other-IDs] NLM/ PMC1196441
  •  go-up   go-down


31. Valuck RJ, Libby AM, Orton HD, Morrato EH, Allen R, Baldessarini RJ: Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry; 2007 Aug;164(8):1198-205
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs.
  • Food and Drug Administration (FDA) issued a public health advisory about the risk of suicidality in pediatric patients taking selective serotonin reuptake inhibitors (SSRIs) for depression, and in 2005, the agency mandated a black box warning and medication guide indicating that pediatric and adult patients may be at risk.
  • The authors examine the effects of this pediatric policy on treatment of adult depression in the community.
  • METHOD: An adult cohort with newly diagnosed episodes of depression was created from a large national integrated claims database of managed care plans from October 1998 to September 2005 (N=475,838 unique episodes).
  • The average percentage of adults with new (versus recurrent) depressive episodes was 88.6% in the preadvisory period (declining at an annual rate of 1.69%), and it decreased significantly to 77.5% (declining more rapidly, at an annual rate of 7.70%).
  • [MeSH-minor] Adolescent. Adult. Advisory Committees / statistics & numerical data. Age Factors. Aged. Aged, 80 and over. Child. Drug Prescriptions / statistics & numerical data. Health Policy / legislation & jurisprudence. Humans. Managed Care Programs / statistics & numerical data. Medicine / statistics & numerical data. Middle Aged. Practice Patterns, Physicians'. Risk Assessment / statistics & numerical data. Seasons. Specialization. United States / epidemiology. United States Food and Drug Administration / legislation & jurisprudence

  • Genetic Alliance. consumer health - Depression.
  • MedlinePlus Health Information. consumer health - Suicide.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17671282.001).
  • [ISSN] 0002-953X
  • [Journal-full-title] The American journal of psychiatry
  • [ISO-abbreviation] Am J Psychiatry
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Serotonin Uptake Inhibitors
  •  go-up   go-down


32. Sipötz J, Gwechenberger M, Richter B, Adlbrecht C, Kornfeld G, Gössinger HD: Treatment of a recurrent atrial tachycardia by isolation of the right inferior pulmonary vein using a multi-electrode duty cycled ablation catheter. Europace; 2010 Dec;12(12):1788-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Treatment of a recurrent atrial tachycardia by isolation of the right inferior pulmonary vein using a multi-electrode duty cycled ablation catheter.
  • [MeSH-minor] Adult. Electrocardiography, Ambulatory. Electrodes. Fluoroscopy. Humans. Male. Secondary Prevention. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20650940.001).
  • [ISSN] 1532-2092
  • [Journal-full-title] Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
  • [ISO-abbreviation] Europace
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


33. Saxena A, de Lagarde D, Leonard H, Williamson SL, Vasudevan V, Christodoulou J, Thompson E, MacLeod P, Ravine D: Lost in translation: translational interference from a recurrent mutation in exon 1 of MECP2. J Med Genet; 2006 Jun;43(6):470-7
SciCrunch. OMIM: Data: Gene Annotation .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lost in translation: translational interference from a recurrent mutation in exon 1 of MECP2.

  • MedlinePlus Health Information. consumer health - Rett Syndrome.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Hematol. 2001 Oct;74(3):281-6 [11721964.001]
  • [Cites] Ann Hum Biol. 2005 Mar-Apr;32(2):228-36 [16096221.001]
  • [Cites] Ment Retard Dev Disabil Res Rev. 2002;8(2):61-5 [12112728.001]
  • [Cites] Biochem J. 2002 Oct 1;367(Pt 1):1-11 [12117416.001]
  • [Cites] Arch Dis Child. 2003 Jan;88(1):38-43 [12495959.001]
  • [Cites] Trends Biochem Sci. 2003 Apr;28(4):182-8 [12713901.001]
  • [Cites] J Med Genet. 2003 May;40(5):e52 [12746406.001]
  • [Cites] Nucleic Acids Res. 2003 Jun 1;31(11):2926-43 [12771219.001]
  • [Cites] J Mol Med (Berl). 2003 Jun;81(6):346-54 [12750821.001]
  • [Cites] J Child Neurol. 2003 Oct;18(10):709-13 [14649554.001]
  • [Cites] J Med Genet. 2004 Jan;41(1):25-30 [14729826.001]
  • [Cites] Nucleic Acids Res. 2004;32(5):1818-23 [15034150.001]
  • [Cites] Nat Genet. 2004 Apr;36(4):339-41 [15034579.001]
  • [Cites] Am J Med Genet A. 2004 Apr 15;126A(2):129-40 [15057977.001]
  • [Cites] EMBO Rep. 2004 Jun;5(6):620-5 [15167888.001]
  • [Cites] Hum Mol Genet. 2004 Nov 1;13(21):2679-89 [15351775.001]
  • [Cites] Eur J Biochem. 1975 Sep 1;57(1):221-30 [809282.001]
  • [Cites] Mol Gen Genet. 1987 May;207(2-3):224-32 [3112515.001]
  • [Cites] J Cell Biol. 1991 Nov;115(4):887-903 [1955461.001]
  • [Cites] EMBO J. 1992 Nov;11(11):4153-8 [1396596.001]
  • [Cites] Am J Hum Genet. 1994 Jun;54(6):989-1003 [8198142.001]
  • [Cites] Methods Mol Biol. 1994;25:267-94 [7516239.001]
  • [Cites] Mol Biol Rep. 1994 May;19(3):195-200 [7969107.001]
  • [Cites] Genomics. 1994 Aug;22(3):648-51 [8001979.001]
  • [Cites] Annu Rev Cell Dev Biol. 1998;14:399-458 [9891789.001]
  • [Cites] Int J Biochem Cell Biol. 1999 Jan;31(1):87-106 [10216946.001]
  • [Cites] Nat Genet. 1999 Oct;23(2):185-8 [10508514.001]
  • [Cites] Eur J Hum Genet. 2005 Jan;13(1):124-6 [15367913.001]
  • [Cites] J Med Genet. 2005 Feb;42(2):e15 [15689438.001]
  • [Cites] Clin Genet. 2005 Jun;67(6):532-3 [15857422.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 May 17;102(20):7309-14 [15883367.001]
  • [Cites] Genome Biol. 2002;3(3):REVIEWS0004 [11897027.001]
  • (PMID = 16155192.001).
  • [ISSN] 1468-6244
  • [Journal-full-title] Journal of medical genetics
  • [ISO-abbreviation] J. Med. Genet.
  • [Language] ENG
  • [Grant] United States / NICHD NIH HHS / HD / R01 HD043100; United States / NICHD NIH HHS / HD / 1 R01 HD43100-01A1
  • [Publication-type] Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / MECP2 protein, human; 0 / Methyl-CpG-Binding Protein 2; 0 / Protein Isoforms; 0 / RNA, Messenger
  • [Other-IDs] NLM/ PMC2593027
  •  go-up   go-down


34. Hannes FD, Sharp AJ, Mefford HC, de Ravel T, Ruivenkamp CA, Breuning MH, Fryns JP, Devriendt K, Van Buggenhout G, Vogels A, Stewart H, Hennekam RC, Cooper GM, Regan R, Knight SJ, Eichler EE, Vermeesch JR: Recurrent reciprocal deletions and duplications of 16p13.11: the deletion is a risk factor for MR/MCA while the duplication may be a rare benign variant. J Med Genet; 2009 Apr;46(4):223-32
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recurrent reciprocal deletions and duplications of 16p13.11: the deletion is a risk factor for MR/MCA while the duplication may be a rare benign variant.

  • COS Scholar Universe. author profiles.
  • Coriell Cell Repositories. culture/stock collections - Coriell Cell Repositories .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mol Cell Biol. 2000 Jun;20(11):4135-48 [10805755.001]
  • [Cites] Am J Med Genet A. 2007 Mar 15;143A(6):610-4 [17318845.001]
  • [Cites] Nature. 2001 Oct 4;413(6855):514-9 [11586358.001]
  • [Cites] Science. 2002 Aug 9;297(5583):1003-7 [12169732.001]
  • [Cites] Annu Rev Genomics Hum Genet. 2002;3:199-242 [12142364.001]
  • [Cites] Mol Cell Biol. 2003 Feb;23(4):1239-50 [12556484.001]
  • [Cites] Am J Hum Genet. 2003 Nov;73(5):1027-40 [14526392.001]
  • [Cites] Am J Hum Genet. 2004 Jul;75(1):75-81 [15148657.001]
  • [Cites] Science. 2004 Jul 23;305(5683):525-8 [15273396.001]
  • [Cites] Nat Genet. 2004 Sep;36(9):949-51 [15286789.001]
  • [Cites] Neuron. 2004 Oct 14;44(2):279-93 [15473967.001]
  • [Cites] Clin Genet. 1998 May;53(5):408-10 [9660062.001]
  • [Cites] Am J Hum Genet. 1999 Aug;65(2):370-86 [10417280.001]
  • [Cites] Genomics. 1999 Sep 15;60(3):295-308 [10493829.001]
  • [Cites] Nature. 2004 Dec 23;432(7020):988-94 [15616553.001]
  • [Cites] J Histochem Cytochem. 2005 Mar;53(3):413-22 [15750031.001]
  • [Cites] Hum Mol Genet. 2007 Mar 1;16(5):567-72 [17360722.001]
  • [Cites] Am J Hum Genet. 2007 May;80(5):938-47 [17436248.001]
  • [Cites] Hum Mutat. 2007 Jul;28(7):674-82 [17480035.001]
  • [Cites] Nat Genet. 2007 Sep;39(9):1071-3 [17704777.001]
  • [Cites] Am J Hum Genet. 2007 Nov;81(5):1057-69 [17924346.001]
  • [Cites] Am J Hum Genet. 2005 May;76(5):865-76 [15800846.001]
  • [Cites] Am J Hum Genet. 2005 Jul;77(1):78-88 [15918152.001]
  • [Cites] Genes Chromosomes Cancer. 2005 Nov;44(3):305-19 [16075461.001]
  • [Cites] Am J Med Genet A. 2005 Dec 15;139(3):231-3 [16278905.001]
  • [Cites] J Med Genet. 2006 Feb;43(2):180-6 [15980116.001]
  • [Cites] Am J Med Genet A. 2006 Jul 15;140(14):1608-13 [16761289.001]
  • [Cites] J Med Genet. 2006 Aug;43(8):625-33 [16490798.001]
  • [Cites] Am J Hum Genet. 2006 Sep;79(3):562-6 [16909395.001]
  • [Cites] Nat Genet. 2006 Sep;38(9):1038-42 [16906162.001]
  • [Cites] Genome Res. 2006 Sep;16(9):1136-48 [16899659.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17626-31 [17101969.001]
  • [Cites] Nature. 2006 Nov 23;444(7118):444-54 [17122850.001]
  • [Cites] Cytogenet Genome Res. 2006;115(3-4):254-61 [17124408.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):31-6 [11134512.001]
  • (PMID = 18550696.001).
  • [ISSN] 1468-6244
  • [Journal-full-title] Journal of medical genetics
  • [ISO-abbreviation] J. Med. Genet.
  • [Language] ENG
  • [Grant] United States / NICHD NIH HHS / HD / R01 HD043569; United States / NICHD NIH HHS / HD / HD043569; United States / Howard Hughes Medical Institute / /
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2658752
  •  go-up   go-down


35. Nassar AH, Abu-Musa AA, Awwad J, Khalil A, Tabbara J, Usta IM: Two dose regimens of nifedipine for management of preterm labor: a randomized controlled trial. Am J Perinatol; 2009 Sep;26(8):575-81
Hazardous Substances Data Bank. Nifedipine .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Women with singleton pregnancies admitted in preterm labor (24 to 34 weeks) were randomized to high-dose (HD) nifedipine ( N = 49; 20 mg loading dose, repeated in 30 minutes, daily 120 to 160 mg slow-release nifedipine for 48 hours followed by 80 to 120 mg daily until 36 weeks) or low-dose (LD) nifedipine ( N = 53; 10 mg, up to four doses every 15 minutes, daily 60 to 80 mg slow-release nifedipine for 48 hours followed by 60 mg daily until 36 weeks).
  • Uterine quiescence at 48 hours (primary outcome); delivery at 48 hours, 34 and 37 weeks; and recurrent preterm labor were similar.
  • Gestational age at delivery was higher in HD (36.0 +/- 2.8 versus 34.7 +/- 3.7 weeks, P = 0.049).
  • However, neonatal mechanical ventilation was needed less and nursery stay was shorter in HD.
  • HD nifedipine does not seem to have an advantage over LD in achieving uterine quiescence at 48 hours.
  • [MeSH-minor] Adult. Female. Humans. Pregnancy. Uterine Contraction / drug effects

  • MedlinePlus Health Information. consumer health - Preterm Labor.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Thieme Medical Publishers.
  • (PMID = 19399705.001).
  • [ISSN] 1098-8785
  • [Journal-full-title] American journal of perinatology
  • [ISO-abbreviation] Am J Perinatol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Tocolytic Agents; I9ZF7L6G2L / Nifedipine
  •  go-up   go-down


36. Harting MT, Blakely ML, Jaffe N, Cox CS Jr, Hayes-Jordan A, Benjamin RS, Raymond AK, Andrassy RJ, Lally KP: Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma. J Pediatr Surg; 2006 Jan;41(1):194-9
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We have taken an approach to attempt surgical resection if at all feasible regardless of number of metastases and disease-free interval (DFI).
  • No statistically significant difference in overall survival or disease-free survival was found based on the number of pulmonary metastases resected.
  • We would advocate considering repeat pulmonary resection for patients with recurrent metastases from osteosarcoma.
  • [MeSH-minor] Adolescent. Adult. Child. Child, Preschool. Disease-Free Survival. Female. Follow-Up Studies. Humans. Infant. Infant, Newborn. Male. Retrospective Studies. Treatment Outcome

  • Genetic Alliance. consumer health - Osteosarcoma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16410132.001).
  • [ISSN] 1531-5037
  • [Journal-full-title] Journal of pediatric surgery
  • [ISO-abbreviation] J. Pediatr. Surg.
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / K23HD001473; United States / NCRR NIH HHS / RR / K24RR17050
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  •  go-up   go-down


37. Emens J, Lewy AJ, Laurie AL, Songer JB: Rest-activity cycle and melatonin rhythm in blind free-runners have similar periods. J Biol Rhythms; 2010 Oct;25(5):381-4
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Such blind free-runners (BFRs) often attempt to maintain a 24-h sleep-wake schedule and consequently suffer from recurrent sleep disruption and daytime somnolence.
  • [MeSH-minor] Actigraphy. Adolescent. Adult. Aged. Biological Clocks / physiology. Child. Female. Humans. Male. Middle Aged. Photoperiod. Young Adult

  • Hazardous Substances Data Bank. MELATONIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20876818.001).
  • [ISSN] 1552-4531
  • [Journal-full-title] Journal of biological rhythms
  • [ISO-abbreviation] J. Biol. Rhythms
  • [Language] eng
  • [Grant] United States / NCRR NIH HHS / RR / K23RR017636; United States / NCRR NIH HHS / RR / M01 RR000334; United States / NIA NIH HHS / AG / R01 AG21826; United States / NEI NIH HHS / EY / R01 EY018312-09A1; United States / NICHD NIH HHS / HD / R01 HD42125; United States / NCRR NIH HHS / RR / UL1 RR024120
  • [Publication-type] Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] JL5DK93RCL / Melatonin
  •  go-up   go-down


38. Okada H, Lieberman FS, Walter KA, Lunsford LD, Kondziolka DS, Bejjani GK, Hamilton RL, Torres-Trejo A, Kalinski P, Cai Q, Mabold JL, Edington HD, Butterfield LH, Whiteside TL, Potter DM, Schold SC Jr, Pollack IF: Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas. J Transl Med; 2007;5:67
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: In University of Pittsburgh Cancer Institute (UPCI) protocol 95-033, adult participants with recurrent glioblastoma multiforme (GBM) or anaplastic astrocytoma (AA) received gross total resection (GTR) of the recurrent tumors, followed by two vaccinations with autologous fibroblasts retrovirally transfected with TFG-IL4-Neo-TK vector admixed with irradiated autologous glioma cells.
  • In UPCI 99-111, adult participants with newly diagnosed GBM or AA, following GTR and radiation therapy, received two intradermal vaccinations with the TFG-IL4-Neo-TK-transfected fibroblasts admixed with type-1 dendritic cells (DC) loaded with autologous tumor lysate.
  • [MeSH-minor] Adult. Aged. Combined Modality Therapy. Feasibility Studies. Female. Humans. Male. Middle Aged

  • Genetic Alliance. consumer health - Glioma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Immunol. 2005 Jun 1;174(11):7194-201 [15905564.001]
  • [Cites] Gene Ther. 2005 May;12(9):733-41 [15772692.001]
  • [Cites] Neoplasia. 2005 Aug;7(8):717-22 [16207473.001]
  • [Cites] Cancer Res. 2006 Jun 1;66(11):5883-91 [16740728.001]
  • [Cites] Cancer Res. 2006 Apr 15;66(8):4478-87 [16618775.001]
  • [Cites] N Engl J Med. 2006 Feb 16;354(7):709-18 [16481638.001]
  • [Cites] J Transl Med. 2007;5:10 [17295916.001]
  • [Cites] Cancer Res. 2007 Jul 1;67(13):6451-8 [17616706.001]
  • [Cites] Hum Gene Ther. 2000 Mar 1;11(4):637-53 [10724042.001]
  • [Cites] Cancer Gene Ther. 2000 Mar;7(3):486-94 [10766355.001]
  • [Cites] J Immunol. 2000 Aug 15;165(4):1877-81 [10925267.001]
  • [Cites] J Exp Med. 2000 Sep 18;192(6):823-33 [10993913.001]
  • [Cites] Cancer Res. 2001 Feb 1;61(3):842-7 [11221866.001]
  • [Cites] J Clin Oncol. 2001 Mar 15;19(6):1848-54 [11251017.001]
  • [Cites] Hum Gene Ther. 2001 Mar 20;12(5):575-95 [11268289.001]
  • [Cites] Gene Ther. 2001 Aug;8(15):1157-66 [11509946.001]
  • [Cites] Nat Immunol. 2001 Nov;2(11):1054-60 [11600887.001]
  • [Cites] Brain Res Brain Res Rev. 2003 May;42(2):97-122 [12738053.001]
  • [Cites] Oncogene. 2003 May 19;22(20):3188-92 [12789295.001]
  • [Cites] Blood. 2003 Jul 1;102(1):36-42 [12560234.001]
  • [Cites] J Neurooncol. 2003 Aug-Sep;64(1-2):13-20 [12952282.001]
  • [Cites] J Clin Oncol. 2003 Oct 15;21(20):3826-35 [14551301.001]
  • [Cites] Curr Neurol Neurosci Rep. 2004 May;4(3):218-27 [15102348.001]
  • [Cites] Cancer Res. 2004 Jul 15;64(14):4973-9 [15256471.001]
  • [Cites] Cancer Res. 2004 Sep 1;64(17):5934-7 [15342370.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3539-43 [8097319.001]
  • [Cites] Hum Gene Ther. 1994 Jan;5(1):41-55 [8155771.001]
  • [Cites] J Immunother Emphasis Tumor Immunol. 1995 May;17(4):238-48 [7582260.001]
  • [Cites] Hum Gene Ther. 1996 Mar 1;7(4):479-87 [8800742.001]
  • [Cites] Neurosurgery. 1996 Jun;38(6):1096-103; discussion 1103-4 [8727138.001]
  • [Cites] J Invest Dermatol. 1998 May;110(5):762-6 [9579542.001]
  • [Cites] Forum (Genova). 1998 Oct-Dec;8(4):357-64 [9863030.001]
  • [Cites] Science. 1999 Feb 19;283(5405):1183-6 [10024247.001]
  • [Cites] Gene Ther. 1999 Feb;6(2):219-26 [10435106.001]
  • [Cites] N Engl J Med. 2005 Mar 10;352(10):987-96 [15758009.001]
  • [Cites] Clin Cancer Res. 2005 Aug 1;11(15):5515-25 [16061868.001]
  • (PMID = 18093335.001).
  • [ISSN] 1479-5876
  • [Journal-full-title] Journal of translational medicine
  • [ISO-abbreviation] J Transl Med
  • [Language] eng
  • [Grant] United States / NCATS NIH HHS / TR / UL1 TR000005
  • [Publication-type] Clinical Trial, Phase I; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Cancer Vaccines; 207137-56-2 / Interleukin-4
  • [Other-IDs] NLM/ PMC2254376
  •  go-up   go-down


39. Schimke LF, Sawalle-Belohradsky J, Roesler J, Wollenberg A, Rack A, Borte M, Rieber N, Cremer R, Maass E, Dopfer R, Reichenbach J, Wahn V, Hoenig M, Jansson AF, Roesen-Wolff A, Schaub B, Seger R, Hill HR, Ochs HD, Torgerson TR, Belohradsky BH, Renner ED: Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis. J Allergy Clin Immunol; 2010 Sep;126(3):611-7.e1
antibodies-online. View related products from antibodies-online.com (subscription/membership/fee required).

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Hyper-IgE syndromes (HIES) are primary immunodeficiency disorders characterized by Staphylococcus aureus abscesses, recurrent pneumonia, increased serum IgE levels, and eczema.
  • [MeSH-minor] Adolescent. Adult. Child. Child, Preschool. Female. Gene Deletion. Humans. Infant. Interleukin-17 / metabolism. Male. Middle Aged. STAT3 Transcription Factor / genetics. T-Lymphocytes, Helper-Inducer / cytology. T-Lymphocytes, Helper-Inducer / immunology

  • Genetic Alliance. consumer health - Eczema.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
  • [ErratumIn] J Allergy Clin Immunol. 2010 Nov;126(5):1015
  • (PMID = 20816194.001).
  • [ISSN] 1097-6825
  • [Journal-full-title] The Journal of allergy and clinical immunology
  • [ISO-abbreviation] J. Allergy Clin. Immunol.
  • [Language] eng
  • [Grant] United States / NIAID NIH HHS / AI / AI063267-01; United States / NICHD NIH HHS / HD / HD017427-41; United States / PHS HHS / / N01A130070
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Interleukin-17; 0 / STAT3 Transcription Factor
  •  go-up   go-down


40. Kushner BH, Kramer K, Modak S, Qin LX, Cheung NK: Differential impact of high-dose cyclophosphamide, topotecan, and vincristine in clinical subsets of patients with chemoresistant neuroblastoma. Cancer; 2010 Jun 15;116(12):3054-60
Hazardous Substances Data Bank. VINCRISTINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Treatment was comprised of high-dose cyclophosphamide (at a dose of 140 mg/kg), topotecan (at a dose of 8 mg/m(2)), and vincristine (at a dose of 0.067 mg/kg or 2 mg/m(2), whichever was lower; maximum dose, 2 mg) (HD-CTV).
  • The Fisher exact test was used for comparisons of response rates among standard subsets of patients (n = 126) with refractory or recurrent neuroblastoma (NB).
  • RESULTS: Among children, major (ie, complete/partial) responses occurred in 11 of 58 (19%) with primary refractory NB, 4 of 14 (29%) with secondary refractory NB, 13 of 25 (52%) with a new (first) disease recurrence, and none of 13 patients with progressive disease (PD) while receiving therapy.
  • Other children had mixed responses (MRs); when combining major responses and MRs, anti-NB activity was noted in 26 of 58 (45%) children with primary refractory NB, 10 of 14 (71%) children with secondary refractory NB, 20 of 25 (80%) children with a new (first) disease recurrence, and 1 of 13 (8%) children with PD while receiving therapy.
  • CONCLUSIONS: Response to HD-CTV as salvage therapy is significantly less likely in adolescents/adults and in children with NB that is persistent or progressing on treatment rather than newly recurrent off treatment.
  • [MeSH-minor] Adolescent. Adult. Child. Child, Preschool. Drug Administration Schedule. Drug Resistance, Neoplasm. Female. Humans. Infant. Male. Neuroblastoma / drug therapy. Salvage Therapy

  • Genetic Alliance. consumer health - Neuroblastoma.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. Topotecan .
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20564411.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA61017; United States / NCI NIH HHS / CA / CA72868
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 5J49Q6B70F / Vincristine; 7M7YKX2N15 / Topotecan; 8N3DW7272P / Cyclophosphamide
  •  go-up   go-down


41. Stryjewski ME, Szczech LA, Benjamin DK Jr, Inrig JK, Kanafani ZA, Engemann JJ, Chu VH, Joyce MJ, Reller LB, Corey GR, Fowler VG Jr: Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis; 2007 Jan 15;44(2):190-6
Hazardous Substances Data Bank. CEFAZOLIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Treatment failure (defined as death or recurrent infection) was determined at 12 weeks after the initial positive blood culture results.
  • [MeSH-minor] Adult. Aged. Female. Humans. Male. Microbial Sensitivity Tests. Middle Aged. Odds Ratio. Renal Dialysis. Risk Factors. Staphylococcus aureus / drug effects. Treatment Failure

  • MedlinePlus Health Information. consumer health - Staphylococcal Infections.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. Vancomycin .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Clin Infect Dis. 2015 Apr 15;60(8):1290-1 [25609683.001]
  • [CommentIn] Clin Infect Dis. 2015 Apr 15;60(8):1291-2 [25609681.001]
  • (PMID = 17173215.001).
  • [ISSN] 1537-6591
  • [Journal-full-title] Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • [ISO-abbreviation] Clin. Infect. Dis.
  • [Language] eng
  • [Grant] United States / NIAID NIH HHS / AI / AI 059111; United States / NICHD NIH HHS / HD / HD-044799-01
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 6Q205EH1VU / Vancomycin; IHS69L0Y4T / Cefazolin
  •  go-up   go-down


42. Shih ML, Lee JA, Hsieh CB, Yu JC, Liu HD, Kebebew E, Clark OH, Duh QY: Thyroidectomy for Hashimoto's thyroiditis: complications and associated cancers. Thyroid; 2008 Jul;18(7):729-34
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • One hundred and fifty-two patients (32.1%) had transient postoperative hypocalcemia, 2 (0.4%) had transient recurrent nerve palsy, and 4 (0.8%) had a postoperative neck hematoma.
  • [MeSH-major] Hashimoto Disease / surgery. Postoperative Complications. Thyroidectomy
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Child. Female. Humans. Hypocalcemia / etiology. Male. Middle Aged. Retrospective Studies. Thyroid Neoplasms / etiology. Treatment Outcome. Vocal Cord Paralysis / etiology

  • MedlinePlus Health Information. consumer health - After Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18631001.001).
  • [ISSN] 1050-7256
  • [Journal-full-title] Thyroid : official journal of the American Thyroid Association
  • [ISO-abbreviation] Thyroid
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


43. Muñoz-Laboy M, Leau CJ, Sriram V, Weinstein HJ, del Aquila EV, Parker R: Bisexual desire and familism: Latino/a bisexual young men and women in New York City. Cult Health Sex; 2009 Apr;11(3):331-44
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We carried out a recurrent theme analysis together with the selection of case studies to illustrate key themes regarding familism and Latino teenage bisexuality.

  • MedlinePlus Health Information. consumer health - Family Issues.
  • MedlinePlus Health Information. consumer health - Gay, Lesbian, Bisexual, and Transgender Health.
  • MedlinePlus Health Information. consumer health - Hispanic American Health.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Ment Retard. 1999 Sep;104(5):466-82 [10541416.001]
  • [Cites] Am J Public Health. 2001 Jun;91(6):940-6 [11392938.001]
  • [Cites] Am J Community Psychol. 2001 Feb;29(1):133-60 [11439825.001]
  • [Cites] Am J Public Health. 2002 May;92(5):773-7 [11988446.001]
  • [Cites] AIDS Educ Prev. 2002 Dec;14(6):457-71 [12512847.001]
  • [Cites] Psychol Addict Behav. 2004 Mar;18(1):3-11 [15008680.001]
  • [Cites] Am J Community Psychol. 2004 Mar;33(1-2):37-49 [15055753.001]
  • [Cites] AIDS Behav. 2004 Jun;8(2):185-97 [15187480.001]
  • [Cites] Cultur Divers Ethnic Minor Psychol. 2004 Aug;10(3):215-28 [15311975.001]
  • [Cites] Cultur Divers Ethnic Minor Psychol. 2004 Aug;10(3):255-67 [15311978.001]
  • [Cites] West J Nurs Res. 1996 Jun;18(3):267-83 [8693722.001]
  • [Cites] J Pers Soc Psychol. 1997 Jun;72(6):1460-76 [9177025.001]
  • [Cites] Psychol Aging. 1999 Sep;14(3):355-64 [10509692.001]
  • [Cites] Adv Data. 2005 Sep 15;(362):1-55 [16250464.001]
  • [Cites] Child Maltreat. 2001 May;6(2):130-42 [16705788.001]
  • [Cites] Soc Work. 2007 Jan;52(1):17-30 [17388080.001]
  • [Cites] Am J Public Health. 2008 Jun;98(6):1081-5 [18445799.001]
  • [Cites] Cult Health Sex. 2008 Jun;10(5):463-77 [18568870.001]
  • [Cites] Arch Sex Behav. 2008 Oct;37(5):773-82 [18521735.001]
  • [Cites] Am J Mens Health. 2008 Mar;2(1):40-56 [19477769.001]
  • (PMID = 19296310.001).
  • [ISSN] 1464-5351
  • [Journal-full-title] Culture, health & sexuality
  • [ISO-abbreviation] Cult Health Sex
  • [Language] ENG
  • [Grant] United States / NIMH NIH HHS / MH / P30 MH043520; United States / NICHD NIH HHS / HD / HD056948-01A2; United States / NICHD NIH HHS / HD / R01 HD056948-01A2; United States / NIMH NIH HHS / MH / P30 MH043520-199011; United States / NIMH NIH HHS / MH / MH043520-199011; United States / NICHD NIH HHS / HD / R01 HD056948
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ NIHMS158537; NLM/ PMC2807363
  •  go-up   go-down


44. Lalani SR, Thakuria JV, Cox GF, Wang X, Bi W, Bray MS, Shaw C, Cheung SW, Chinault AC, Boggs BA, Ou Z, Brundage EK, Lupski JR, Gentile J, Waisbren S, Pursley A, Ma L, Khajavi M, Zapata G, Friedman R, Kim JJ, Towbin JA, Stankiewicz P, Schnittger S, Hansmann I, Ai T, Sood S, Wehrens XH, Martin JF, Belmont JW, Potocki L: 20p12.3 microdeletion predisposes to Wolff-Parkinson-White syndrome with variable neurocognitive deficits. J Med Genet; 2009 Mar;46(3):168-75
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS AND RESULTS: Using the array comparative genomic hybridisation (CGH), we identified five individuals with non-recurrent deletions of 20p12.3.

  • Genetic Alliance. consumer health - Wolff Parkinson White syndrome.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Eur J Haematol. 2003 Jun;70(6):363-72 [12756018.001]
  • [Cites] N Engl J Med. 2001 Jun 14;344(24):1823-31 [11407343.001]
  • [Cites] Circ Res. 2004 Jun 11;94(11):1458-65 [15117823.001]
  • [Cites] Circulation. 1975 Jan;51(1):75-81 [1109322.001]
  • [Cites] Anat Rec. 1981 Sep;201(1):169-77 [7305018.001]
  • [Cites] J Electrocardiol. 1982 Apr;15(2):195-8 [7069337.001]
  • [Cites] J Am Coll Cardiol. 1985 Jan;5(1):130-5 [3964800.001]
  • [Cites] N Engl J Med. 1987 Jul 9;317(2):65-9 [3587328.001]
  • [Cites] J Med Genet. 1990 Dec;27(12):729-37 [2074558.001]
  • [Cites] Trends Genet. 1991 May;7(5):149-54 [2068787.001]
  • [Cites] Am J Med Genet. 1991 Apr 1;39(1):56-63 [1867266.001]
  • [Cites] Mol Cell Biol. 1994 Sep;14(9):5961-74 [8065329.001]
  • [Cites] Eur Heart J. 1994 Jul;15(7):981-7 [7925521.001]
  • [Cites] Clin Invest Med. 1996 Oct;19(5):325-30 [8889270.001]
  • [Cites] Development. 1996 Oct;122(10):2977-86 [8898212.001]
  • [Cites] Clin Genet. 1996 Dec;50(6):535-7 [9147893.001]
  • [Cites] Nat Genet. 1997 Jul;16(3):235-42 [9207787.001]
  • [Cites] Trends Genet. 1998 Oct;14(10):417-22 [9820031.001]
  • [Cites] Development. 1999 Jan;126(2):251-60 [9847239.001]
  • [Cites] Circulation. 1954 Sep;10(3):384-400 [13190611.001]
  • [Cites] Am J Med. 1960 Jun;28:913-20 [13804038.001]
  • [Cites] Genet Med. 2005 Jul-Aug;7(6):422-32 [16024975.001]
  • [Cites] Circ Res. 2005 Aug 5;97(3):219-26 [16037571.001]
  • [Cites] Development. 2005 Dec;132(24):5601-11 [16314491.001]
  • [Cites] Biotechnol J. 2007 Jan;2(1):41-9 [17225249.001]
  • [Cites] PLoS One. 2007;2(3):e327 [17389918.001]
  • [Cites] Nat Genet. 2007 Jul;39(7 Suppl):S43-7 [17597781.001]
  • [Cites] Heart Rhythm. 2008 Jul;5(7):1047-54 [18598963.001]
  • [Cites] Hum Mol Genet. 2001 May 15;10(11):1215-20 [11371514.001]
  • [Cites] Circulation. 2003 Jun 10;107(22):2850-6 [12782567.001]
  • (PMID = 18812404.001).
  • [ISSN] 1468-6244
  • [Journal-full-title] Journal of medical genetics
  • [ISO-abbreviation] J. Med. Genet.
  • [Language] ENG
  • [Grant] United States / NHLBI NIH HHS / HL / R01 HL091771-02; None / None / / R01 HL091771-01; United States / NHLBI NIH HHS / HL / R01 HL091771-01; United States / NIDCR NIH HHS / DE / R01 DE/HD 12324-12; None / None / / R01 HL091771-02; United States / NIDCR NIH HHS / DE / R01 DE012324; United States / NHLBI NIH HHS / HL / R01 HL091771
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / BMP2 protein, human; 0 / Bmp2 protein, mouse; 0 / Bone Morphogenetic Protein 2; 0 / Calcium-Binding Proteins; 0 / Intercellular Signaling Peptides and Proteins; 0 / Membrane Proteins; 134324-36-0 / Serrate proteins
  • [Other-IDs] NLM/ NIHMS94820; NLM/ PMC2680125
  •  go-up   go-down


45. Gombatto SP, Klaesner JW, Norton BJ, Minor SD, Van Dillen LR: Validity and reliability of a system to measure passive tissue characteristics of the lumbar region during trunk lateral bending in people with and people without low back pain. J Rehabil Res Dev; 2008;45(9):1415-29
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Reliability of the measurements between trials within a session was examined in a sample of 50 people (25 men, 25 women; mean +/- standard deviation age = 30.7 +/- 8.9 yr); 31 people reported a history of chronic or recurrent low back pain (LBP) and 19 reported no prior history of LBP.
  • [MeSH-minor] Adult. Biomechanical Phenomena. Chi-Square Distribution. Elasticity. Electromyography. Equipment Design. Female. Humans. Isometric Contraction / physiology. Male. Range of Motion, Articular. Reproducibility of Results. Torque. Transducers

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19319764.001).
  • [ISSN] 1938-1352
  • [Journal-full-title] Journal of rehabilitation research and development
  • [ISO-abbreviation] J Rehabil Res Dev
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / 1 K01HD-01226-05; United States / NICHD NIH HHS / HD / 5 T32 HD07434-10
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Validation Studies
  • [Publication-country] United States
  •  go-up   go-down


46. Raol YH, Lund IV, Bandyopadhyay S, Zhang G, Roberts DS, Wolfe JH, Russek SJ, Brooks-Kayal AR: Enhancing GABA(A) receptor alpha 1 subunit levels in hippocampal dentate gyrus inhibits epilepsy development in an animal model of temporal lobe epilepsy. J Neurosci; 2006 Nov 1;26(44):11342-6
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Previous studies in the adult rat pilocarpine model of TLE found reduced expression of GABR alpha1 subunits and increased expression of alpha4 subunits in dentate gyrus (DG) of epileptic rats compared with controls.
  • Enhanced alpha1 expression in DG resulted in a threefold increase in mean seizure-free time after SE and a 60% decrease in the number of rats developing epilepsy (recurrent spontaneous seizures) in the first 4 weeks after SE.
  • [MeSH-major] Disease Models, Animal. Epilepsy, Temporal Lobe / metabolism. Epilepsy, Temporal Lobe / prevention & control. Parahippocampal Gyrus / metabolism. Protein Subunits / metabolism. Receptors, GABA-A / metabolism

  • Genetic Alliance. consumer health - Epilepsy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Epilepsy Curr. 2007 May-Jun;7(3):88-90 [17520085.001]
  • (PMID = 17079662.001).
  • [ISSN] 1529-2401
  • [Journal-full-title] The Journal of neuroscience : the official journal of the Society for Neuroscience
  • [ISO-abbreviation] J. Neurosci.
  • [Language] eng
  • [Grant] United States / NIDDK NIH HHS / DK / DK47757; United States / NIDDK NIH HHS / DK / DK63973; United States / NINDS NIH HHS / NS / NS050393; United States / NINDS NIH HHS / NS / NS051710; United States / NINDS NIH HHS / NS / NS38595; United States / NINDS NIH HHS / NS / NS38690; United States / NINDS NIH HHS / NS / NS51943; United States / NICHD NIH HHS / HD / P30 HD23979
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / GABRA1 protein, human; 0 / Gabra1 protein, rat; 0 / Protein Subunits; 0 / Receptors, GABA-A
  •  go-up   go-down


47. Wang JH, Lu SN, Tung HD, Changchien CS, Hung CH, Chen CH, Lee CM: Flash-echo contrast sonography in the evaluation of response of small hepatocellular carcinoma to percutaneous ablation. J Clin Ultrasound; 2006 May;34(4):161-8
Hazardous Substances Data Bank. ETHANOL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Recurrent disease was detected in 11 (52.4%) patients; local tumor recurrence occurred in 4 (17.4%) patients.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Contrast Media. Ethanol / administration & dosage. Female. Follow-Up Studies. Humans. Male. Middle Aged. Predictive Value of Tests. Prospective Studies. Sensitivity and Specificity. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2006 Wiley Periodicals, Inc.
  • (PMID = 16615047.001).
  • [ISSN] 0091-2751
  • [Journal-full-title] Journal of clinical ultrasound : JCU
  • [ISO-abbreviation] J Clin Ultrasound
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media; 3K9958V90M / Ethanol
  •  go-up   go-down


48. Hoeflich C, Unterwalder N, Schuett S, Schmolke K, Boenisch O, Hammer M, Scheufele R, Michael D, Volk HD, Scheibenbogen C, von Baehr V, Meisel C: Clinical manifestation of mannose-binding lectin deficiency in adults independent of concomitant immunodeficiency. Hum Immunol; 2009 Oct;70(10):809-12
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We analyzed the distribution of MBL deficiency and its association with concomitant immunodeficiency in 228 adult Caucasian patients with a history of recurrent and/or severe infections.
  • Two hundred forty-one unrelated Caucasians without recurrent or severe infections served as control subjects.
  • The frequency of severe MBL deficiency (plasma levels <or= 50 ng/ml) was significantly higher in patients with a history of recurrent and/or severe infections (p < 0.05, odds ratio 2.1, 95% confidence interval 1.1-4.1), and this association was independent of concomitant antibody or cellular immunodeficiency.
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Female. Humans. Infection / blood. Infection / immunology. Male. Middle Aged. Prevalence. Recurrence. Retrospective Studies. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19580835.001).
  • [ISSN] 1879-1166
  • [Journal-full-title] Human immunology
  • [ISO-abbreviation] Hum. Immunol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Mannose-Binding Lectin
  •  go-up   go-down


49. Owen J, Hankins G, Iams JD, Berghella V, Sheffield JS, Perez-Delboy A, Egerman RS, Wing DA, Tomlinson M, Silver R, Ramin SM, Guzman ER, Gordon M, How HY, Knudtson EJ, Szychowski JM, Cliver S, Hauth JC: Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length. Am J Obstet Gynecol; 2009 Oct;201(4):375.e1-8
Faculty of 1000. commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine. (subscription/membership/fee required).

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: The objective of the study was to assess cerclage to prevent recurrent preterm birth in women with short cervix.

  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • International Agency for Research on Cancer - Screening Group. diagnostics - Histopathology and cytopathology of the uterine cervix - digital atlas .
  • International Agency for Research on Cancer - Screening Group. diagnostics - A practical manual on visual screening for cervical neoplasia .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Obstet Gynecol. 2001 Jun;184(7):1325-9; discussion 1329-31 [11408848.001]
  • [Cites] Ultrasound Obstet Gynecol. 2009 Jan;33(1):70-5 [19072745.001]
  • [Cites] Am J Obstet Gynecol. 2001 Nov;185(5):1098-105 [11717641.001]
  • [Cites] Am J Obstet Gynecol. 2001 Nov;185(5):1106-12 [11717642.001]
  • [Cites] Am J Obstet Gynecol. 2003 Feb;188(2):586-96 [12592276.001]
  • [Cites] N Engl J Med. 2003 Jun 12;348(24):2379-85 [12802023.001]
  • [Cites] Lancet. 2004 Jun 5;363(9424):1849-53 [15183621.001]
  • [Cites] Am J Obstet Gynecol. 2004 Jul;191(1):298-303 [15295382.001]
  • [Cites] Am J Obstet Gynecol. 2004 Oct;191(4):1311-7 [15507959.001]
  • [Cites] Am J Obstet Gynecol. 1983 May 15;146(2):168-74 [6846434.001]
  • [Cites] Am J Obstet Gynecol. 1995 Apr;172(4 Pt 1):1097-103; discussion 1104-6 [7726247.001]
  • [Cites] N Engl J Med. 1996 Feb 29;334(9):567-72 [8569824.001]
  • [Cites] Ultrasound Obstet Gynecol. 1998 Nov;12(5):312-7 [9819868.001]
  • [Cites] Ultrasound Obstet Gynecol. 1998 Nov;12(5):318-22 [9819869.001]
  • [Cites] Br J Obstet Gynaecol. 1998 Nov;105(11):1214-5 [9853774.001]
  • [Cites] Am J Obstet Gynecol. 1999 Oct;181(4):809-15 [10521734.001]
  • [Cites] Obstet Gynecol. 2005 Jul;106(1):181-9 [15994635.001]
  • [Cites] Am J Obstet Gynecol. 2006 Jan;194(1):1-9 [16389003.001]
  • [Cites] Obstet Gynecol. 2006 Feb;107(2 Pt 1):219-20 [16449103.001]
  • [Cites] Obstet Gynecol. 2007 Aug;110(2 Pt 1):405-15 [17666618.001]
  • [Cites] JAMA. 2001 Sep 19;286(11):1340-8 [11560539.001]
  • (PMID = 19788970.001).
  • [ISSN] 1097-6868
  • [Journal-full-title] American journal of obstetrics and gynecology
  • [ISO-abbreviation] Am. J. Obstet. Gynecol.
  • [Language] ENG
  • [Grant] United States / NICHD NIH HHS / HD / HD039939-05; United States / NICHD NIH HHS / HD / U01 HD039939-05; United States / NICHD NIH HHS / HD / K24 HD043314-05; United States / NICHD NIH HHS / HD / U01 HD039939; United States / NICHD NIH HHS / HD / HD043314-05; United States / NICHD NIH HHS / HD / K24 HD043314; United States / NICHD NIH HHS / HD / 5K24 HD43314-5
  • [Publication-type] Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS151965; NLM/ PMC2768604
  •  go-up   go-down


50. Fujimura Y, Yasuno F, Farris A, Liow JS, Geraci M, Drevets W, Pine DS, Ghose S, Lerner A, Hargreaves R, Burns HD, Morse C, Pike VW, Innis RB: Decreased neurokinin-1 (substance P) receptor binding in patients with panic disorder: positron emission tomographic study with [18F]SPA-RQ. Biol Psychiatry; 2009 Jul 1;66(1):94-7
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We sought to determine if patients with panic disorder have altered density of NK(1) receptors in brain because of their history of recurrent panic attacks.

  • Genetic Alliance. consumer health - Panic disorder 1.
  • MedlinePlus Health Information. consumer health - Panic Disorder.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Brain Res. 1999 Nov 27;848(1-2):90-5 [10612700.001]
  • [Cites] J Psychiatr Res. 2001 Sep-Oct;35(5):293-6 [11591432.001]
  • [Cites] Neuroimage. 2002 Jul;16(3 Pt 1):577-86 [12169244.001]
  • [Cites] Eur J Pharmacol. 2003 Feb 28;463(1-3):235-72 [12600714.001]
  • [Cites] J Cereb Blood Flow Metab. 2003 Sep;23(9):1096-112 [12973026.001]
  • [Cites] J Consult Clin Psychol. 1988 Dec;56(6):893-7 [3204199.001]
  • [Cites] Eur Neuropsychopharmacol. 1991 May;1(2):137-41 [1821703.001]
  • [Cites] Psychosom Med. 1996 Jul-Aug;58(4):302-13 [8827792.001]
  • [Cites] Science. 1998 Sep 11;281(5383):1640-5 [9733503.001]
  • [Cites] Mol Imaging Biol. 2004 Nov-Dec;6(6):373-84 [15564148.001]
  • [Cites] Biol Psychiatry. 2005 Jul 15;58(2):132-42 [16038684.001]
  • [Cites] Biol Psychiatry. 2006 Feb 1;59(3):216-23 [16248986.001]
  • [Cites] Mol Imaging Biol. 2005 Jul-Aug;7(4):262-72 [16155744.001]
  • [Cites] Am J Psychiatry. 2006 Apr;163(4):637-43 [16585438.001]
  • [Cites] Synapse. 2007 Apr;61(4):242-51 [17230546.001]
  • [Cites] Biol Psychiatry. 2007 Apr 15;61(8):1002-6 [16950220.001]
  • [Cites] J Cereb Blood Flow Metab. 2007 Sep;27(9):1533-9 [17519979.001]
  • [Cites] Neuropsychopharmacology. 2008 Jul;33(8):1929-41 [17957216.001]
  • [CommentIn] Biol Psychiatry. 2010 Feb 15;67(4):e25-6 [19854434.001]
  • (PMID = 19200949.001).
  • [ISSN] 1873-2402
  • [Journal-full-title] Biological psychiatry
  • [ISO-abbreviation] Biol. Psychiatry
  • [Language] ENG
  • [Grant] United States / NIMH NIH HHS / MH / Z01 MH002852; United States / Intramural NIH HHS / / Z01 MH002852-04
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / (2-fluoromethoxy-5-(5-trifluoromethyltetrazol-1-yl)benzyl)(2-phenylpiperidin-3-yl)amine; 0 / Piperidines; 0 / Receptors, Neurokinin-1; 0 / Tetrazoles
  • [Other-IDs] NLM/ NIHMS160526; NLM/ PMC2789441
  •  go-up   go-down


51. Bromer JG, Aldad TS, Taylor HS: Defining the proliferative phase endometrial defect. Fertil Steril; 2009 Mar;91(3):698-704
Hazardous Substances Data Bank. CLOMIPHENE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Subjects who carried a primary diagnosis of polycystic ovary syndrome, endometriosis, or recurrent pregnancy loss all achieved a significantly lower peak endometrial thickness than control subjects.

  • MedlinePlus Health Information. consumer health - Female Infertility.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. MENOTROPINS .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Gynecol Endocrinol. 2006 Sep;22(9):506-10 [17071535.001]
  • [Cites] Bull Exp Biol Med. 2006 Feb;141(2):204-7 [16984097.001]
  • [Cites] Reprod Biomed Online. 2007 Feb;14(2):224-34 [17298727.001]
  • [Cites] Reprod Biol Endocrinol. 2007;5:18 [17506907.001]
  • [Cites] J Soc Gynecol Investig. 2006 Oct;13(7):467-76 [16990031.001]
  • [Cites] Fertil Steril. 2000 Jan;73(1):85-9 [10632418.001]
  • [Cites] Fertil Steril. 2000 Feb;73(2):287-91 [10685531.001]
  • [Cites] Gynecol Obstet Invest. 2001;51(2):120-3 [11223706.001]
  • [Cites] Hum Reprod. 2002 Jan;17(1):190-4 [11756386.001]
  • [Cites] Biol Reprod. 2002 Feb;66(2):297-304 [11804942.001]
  • [Cites] Int J Gynaecol Obstet. 2003 Jan;80(1):49-53 [12527460.001]
  • [Cites] Zentralbl Gynakol. 2003 Mar-Apr;125(3-4):136-41 [12961106.001]
  • [Cites] Ultrasound Med Biol. 1986 Apr;12(4):271-7 [3521022.001]
  • [Cites] Fertil Steril. 1986 Sep;46(3):442-7 [3091409.001]
  • [Cites] Br J Obstet Gynaecol. 1987 Sep;94(9):889-94 [3663551.001]
  • [Cites] Hum Reprod. 1987 Oct;2(7):545-7 [3119658.001]
  • [Cites] J Ultrasound Med. 1989 Oct;8(10):549-53 [2681824.001]
  • [Cites] Fertil Steril. 1990 Jun;53(6):989-93 [2351238.001]
  • [Cites] Fertil Steril. 1992 Jan;57(1):33-6 [1730327.001]
  • [Cites] Int J Gynecol Pathol. 1992 Oct;11(4):273-82 [1399233.001]
  • [Cites] Fertil Steril. 1993 Apr;59(4):756-60 [8458492.001]
  • [Cites] Fertil Steril. 1993 Jun;59(6):1179-86 [8495762.001]
  • [Cites] Hum Reprod. 1996 Apr;11(4):844-9 [8671338.001]
  • [Cites] Fertil Steril. 1997 Feb;67(2):256-60 [9022599.001]
  • [Cites] Gynecol Obstet Invest. 1999;47(4):251-4 [10352387.001]
  • [Cites] Hum Reprod. 2005 Oct;20(10):2958-63 [15979992.001]
  • [Cites] Mol Cell Endocrinol. 2006 Mar 27;248(1-2):94-103 [16406281.001]
  • [Cites] Fertil Steril. 2006 Jun;85(6):1784-90 [16643909.001]
  • [Cites] Mol Hum Reprod. 2006 Jul;12(7):435-42 [16735457.001]
  • [Cites] Gynecol Oncol. 2006 Oct;103(1):307-14 [16677694.001]
  • [Cites] Fertil Steril. 2007 Jan;87(1):53-9 [17081537.001]
  • (PMID = 18314107.001).
  • [ISSN] 1556-5653
  • [Journal-full-title] Fertility and sterility
  • [ISO-abbreviation] Fertil. Steril.
  • [Language] ENG
  • [Grant] United States / NICHD NIH HHS / HD / R01 HD036887-06; United States / NICHD NIH HHS / HD / U54 HD052668; United States / NICHD NIH HHS / HD / HD052668-01A10001; United States / NICHD NIH HHS / HD / U54 HD052668-01A10001; United States / NICHD NIH HHS / HD / R01 HD036887; United States / NICHD NIH HHS / HD / HD036887-06
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Fertility Agents, Female; 1HRS458QU2 / Clomiphene; 9002-68-0 / Follicle Stimulating Hormone
  • [Other-IDs] NLM/ NIHMS101598; NLM/ PMC2699408
  •  go-up   go-down


52. Bulik CM, Von Holle A, Hamer R, Knoph Berg C, Torgersen L, Magnus P, Stoltenberg C, Siega-Riz AM, Sullivan P, Reichborn-Kjennerud T: Patterns of remission, continuation and incidence of broadly defined eating disorders during early pregnancy in the Norwegian Mother and Child Cohort Study (MoBa). Psychol Med; 2007 Aug;37(8):1109-18
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • EDNOS subtypes included binge eating disorder (BED) and recurrent self-induced purging in the absence of binge eating (EDNOS-P).

  • Genetic Alliance. consumer health - Pregnancy.
  • MedlinePlus Health Information. consumer health - Health Problems in Pregnancy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] JAMA. 2001 Feb 14;285(6):755-60 [11176913.001]
  • [Cites] Acta Obstet Gynecol Scand. 2000 Jun;79(6):435-9 [10857866.001]
  • [Cites] Am J Psychiatry. 2001 Sep;158(9):1461-6 [11532732.001]
  • [Cites] Prog Brain Res. 2001;133:1-38 [11589124.001]
  • [Cites] Int J Obes Relat Metab Disord. 2001 Oct;25(10):1517-24 [11673775.001]
  • [Cites] N Engl J Med. 2002 Jan 3;346(1):33-8 [11778000.001]
  • [Cites] Am J Psychiatry. 2002 Jun;159(6):1048-50 [12042197.001]
  • [Cites] Am J Prev Med. 2002 Oct;23(3):150-9 [12350446.001]
  • [Cites] Twin Res. 2002 Oct;5(5):415-23 [12613498.001]
  • [Cites] Acta Psychiatr Scand. 2003 Sep;108(3):196-202 [12890274.001]
  • [Cites] Int J Eat Disord. 2004 Mar;35(2):123-32; discussion 133-5 [14994348.001]
  • [Cites] Am J Epidemiol. 2004 Apr 1;159(7):702-6 [15033648.001]
  • [Cites] Nicotine Tob Res. 2004 Apr;6 Suppl 2:S203-16 [15203822.001]
  • [Cites] Int J Eat Disord. 2004 Sep;36(2):220-3 [15282692.001]
  • [Cites] Int J Eat Disord. 2004 Nov;36(3):307-14 [15478129.001]
  • [Cites] Am J Obstet Gynecol. 1977 Nov 15;129(6):698-9 [920770.001]
  • [Cites] Am J Dis Child. 1984 Jan;138(1):68-9 [6691316.001]
  • [Cites] Am J Obstet Gynecol. 1986 Mar;154(3):503-9 [3953698.001]
  • [Cites] Obstet Gynecol. 1986 May;67(5):627-32 [3960435.001]
  • [Cites] Eur J Obstet Gynecol Reprod Biol. 1986 Sep;22(5-6):293-6 [3770278.001]
  • [Cites] Br J Psychiatry. 1987 Jun;150:777-81 [3651730.001]
  • [Cites] Am J Obstet Gynecol. 1987 Nov;157(5):1194-8 [3688074.001]
  • [Cites] Obstet Gynecol. 1988 May;71(5):708-10 [3357659.001]
  • [Cites] Br Med J (Clin Res Ed). 1988 Apr 2;296(6627):962-5 [3129109.001]
  • [Cites] Br Med J (Clin Res Ed). 1988 Apr 9;296(6628):1038 [3130128.001]
  • [Cites] Acta Psychiatr Scand. 1988 May;77(5):611-7 [3269214.001]
  • [Cites] Am J Obstet Gynecol. 1990 Oct;163(4 Pt 1):1196-9 [2220927.001]
  • [Cites] Am J Obstet Gynecol. 1991 Mar;164(3):785-90 [2003542.001]
  • [Cites] Am J Prev Med. 1993 Sep-Oct;9(5):267-73 [8257615.001]
  • [Cites] Br J Psychiatry. 1993 Dec;163:721-32 [8306113.001]
  • [Cites] Int J Eat Disord. 1995 Sep;18(2):119-26 [7581413.001]
  • [Cites] J Nutr. 1996 Jan;126(1):146-53 [8558295.001]
  • [Cites] J Psychosom Res. 1998 Mar-Apr;44(3-4):465-77 [9587889.001]
  • [Cites] Psychol Med. 1998 May;28(3):599-610 [9626716.001]
  • [Cites] J Clin Psychiatry. 1999 Feb;60(2):130-5; quiz 135-7 [10084645.001]
  • [Cites] Br J Psychiatry. 1999 Feb;174:135-40 [10211167.001]
  • [Cites] Biostatistics. 2005 Jan;6(1):39-44 [15618526.001]
  • [Cites] Obstet Gynecol. 2005 Feb;105(2):255-60 [15684148.001]
  • [Cites] BMJ. 2005 Oct 15;331(7521):877 [16169871.001]
  • [Cites] Int J Eat Disord. 2005 Nov;38(3):191-9 [16211629.001]
  • [Cites] Epidemiology. 2006 May;17(3):252-4 [16617271.001]
  • [Cites] Curr Opin Psychiatry. 2006 Jul;19(4):389-94 [16721169.001]
  • [Cites] Int J Epidemiol. 2006 Oct;35(5):1146-50 [16926217.001]
  • [Cites] Int J Eat Disord. 2007 Jan;40(1):1-6 [16958118.001]
  • [ErratumIn] Psychol Med. 2012 Apr;42(4):893
  • (PMID = 17493296.001).
  • [ISSN] 0033-2917
  • [Journal-full-title] Psychological medicine
  • [ISO-abbreviation] Psychol Med
  • [Language] ENG
  • [Grant] United States / NICHD NIH HHS / HD / R01 HD047186-01A1; United States / NINDS NIH HHS / NS / 1 U01 NS 047537-01; United States / NICHD NIH HHS / HD / R01 HD047186; United States / NINDS NIH HHS / NS / U01 NS047537; United States / NIEHS NIH HHS / ES / N01 ES-85433; United States / NICHD NIH HHS / HD / HD047186-01A1; United States / NICHD NIH HHS / HD / HD047186
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Other-IDs] NLM/ NIHMS95308; NLM/ PMC2657803
  •  go-up   go-down


53. Quinzii CM, Hirano M, DiMauro S: CoQ10 deficiency diseases in adults. Mitochondrion; 2007 Jun;7 Suppl:S122-6
Pharmacogenomics Knowledge Base. meta-databases - Pharmacogenomic Annotation 827853629 for PMID:17485248 [PharmGKB] .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Deficiency of Coenzyme Q10 (CoQ10) in muscle has been associated with a spectrum of diseases including infantile-onset multi-systemic diseases, encephalomyopathies with recurrent myobinuria, cerebellar ataxia, and pure myopathy.
  • CoQ10 deficiency predominantly affects children, but patients have presented with adult-onset cerebellar ataxia or myopathy.
  • Mutations in the CoQ10 biosynthetic genes, COQ2 and PDSS2, have been identified in children with the infantile form of CoQ10 deficiency; however, the molecular genetic bases of adult-onset CoQ10 deficiency remains undefined.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Lancet. 2000 Jul 29;356(9227):391-5 [10972372.001]
  • [Cites] Neurology. 2006 Jan 24;66(2):253-5 [16434667.001]
  • [Cites] Neurology. 2001 Apr 10;56(7):849-55 [11294920.001]
  • [Cites] Neurology. 2001 Aug 14;57(3):515-8 [11502923.001]
  • [Cites] J Pediatr. 2001 Sep;139(3):456-8 [11562630.001]
  • [Cites] Nat Genet. 2001 Oct;29(2):184-8 [11586299.001]
  • [Cites] Nat Genet. 2001 Oct;29(2):189-93 [11586300.001]
  • [Cites] J Biol Chem. 2002 Mar 29;277(13):10973-81 [11788608.001]
  • [Cites] Free Radic Biol Med. 2002 Sep 1;33(5):627-38 [12208349.001]
  • [Cites] Ann Neurol. 2002 Dec;52(6):750-4 [12447928.001]
  • [Cites] Neurology. 2003 Apr 8;60(7):1206-8 [12682339.001]
  • [Cites] Biochim Biophys Acta. 2004 Jan 28;1660(1-2):171-99 [14757233.001]
  • [Cites] Neurology. 2004 Mar 9;62(5):818-20 [15007142.001]
  • [Cites] J Neurol Sci. 2006 Jul 15;246(1-2):153-8 [16677673.001]
  • [Cites] Lancet. 2006 Jul 1;368(9529):70-82 [16815381.001]
  • [Cites] Biofactors. 2005;25(1-4):117-26 [16873936.001]
  • [Cites] Am J Hum Genet. 2006 Dec;79(6):1125-9 [17186472.001]
  • [Cites] Arch Neurol. 2004 Jun;61(6):889-92 [15210526.001]
  • [Cites] Neurology. 2004 Aug 24;63(4):727-9 [15326254.001]
  • [Cites] J Bioenerg Biomembr. 2004 Aug;36(4):381-6 [15377876.001]
  • [Cites] Proc Natl Acad Sci U S A. 1985 Feb;82(3):901-4 [3856239.001]
  • [Cites] Proc Natl Acad Sci U S A. 1989 Apr;86(7):2379-82 [2928337.001]
  • [Cites] Drug Metab Dispos. 1992 May-Jun;20(3):423-7 [1355718.001]
  • [Cites] J Nutr. 1996 Sep;126(9):2089-97 [8814196.001]
  • [Cites] Neurology. 1997 May;48(5):1238-43 [9153450.001]
  • [Cites] J Neurol Sci. 1998;156(1):41-6 [9559985.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8892-7 [9671775.001]
  • [Cites] Neurology. 2005 Feb 8;64(3):539-41 [15699391.001]
  • [Cites] Arch Neurol. 2005 Feb;62(2):317-20 [15710863.001]
  • [Cites] Neurology. 2005 Aug 23;65(4):606-8 [16116126.001]
  • [Cites] Arch Neurol. 2005 Nov;62(11):1709-12 [16286544.001]
  • [Cites] Am J Hum Genet. 2006 Feb;78(2):345-9 [16400613.001]
  • [Cites] Antioxid Redox Signal. 2000 Summer;2(2):213-30 [11229527.001]
  • (PMID = 17485248.001).
  • [ISSN] 1567-7249
  • [Journal-full-title] Mitochondrion
  • [ISO-abbreviation] Mitochondrion
  • [Language] ENG
  • [Grant] United States / NINDS NIH HHS / NS / NS011766-27A2; United States / NINDS NIH HHS / NS / P01 NS011766; United States / NICHD NIH HHS / HD / R01 HD057543; United States / NINDS NIH HHS / NS / P01 NS011766-27A2
  • [Publication-type] Journal Article; Review
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 1339-63-5 / Ubiquinone
  • [Number-of-references] 45
  • [Other-IDs] NLM/ NIHMS25299; NLM/ PMC2001314
  •  go-up   go-down


54. Nessim SJ, Bargman JM, Austin PC, Nisenbaum R, Jassal SV: Predictors of peritonitis in patients on peritoneal dialysis: results of a large, prospective Canadian database. Clin J Am Soc Nephrol; 2009 Jul;4(7):1195-200
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Study variables included age, gender, race, cause of renal disease, diabetes status, transfer from hemodialysis (HD), previous renal transplant, and continuous ambulatory PD (CAPD) versus automated PD (APD).
  • Using the negative binomial regression model, factors that were independently associated with a higher peritonitis rate included age, Black race, and having transferred from HD.
  • The Andersen-Gill model for recurrent events yielded similar results.
  • CONCLUSIONS: Predictors of PD peritonitis included Black race, transferring from HD to PD, and diabetes among women.
  • [MeSH-minor] Adult. African Continental Ancestry Group / statistics & numerical data. Aged. Canada / epidemiology. Databases, Factual. Diabetes Complications / epidemiology. Female. Humans. Incidence. Male. Middle Aged. Multivariate Analysis. Predictive Value of Tests. Regression Analysis. Renal Dialysis / statistics & numerical data. Risk Factors. Sex Distribution

  • MedlinePlus Health Information. consumer health - Kidney Failure.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nephrol Dial Transplant. 2001 Mar;16(3):604-7 [11239039.001]
  • [Cites] Am J Kidney Dis. 2005 Feb;45(2):372-80 [15685516.001]
  • [Cites] Nephrology (Carlton). 2005 Apr;10(2):192-7 [15877681.001]
  • [Cites] Perit Dial Int. 2005 Jul-Aug;25(4):374-9 [16022095.001]
  • [Cites] Kidney Int Suppl. 2006 Nov;(103):S55-62 [17080112.001]
  • [Cites] Nephrol Dial Transplant. 2007 Sep;22(9):2653-8 [17517797.001]
  • [Cites] Kidney Int Suppl. 2008 Apr;(108):S76-80 [18379553.001]
  • [Cites] Clin J Am Soc Nephrol. 2009 Jan;4(1):135-41 [18987296.001]
  • [Cites] Am J Kidney Dis. 1999 Dec;34(6):1065-74 [10585316.001]
  • [Cites] Adv Perit Dial. 2001;17:117-21 [11510257.001]
  • [Cites] Nephrol Dial Transplant. 2001 Sep;16(9):1957-8 [11522896.001]
  • [Cites] Perit Dial Int. 2002 Mar-Apr;22(2):234-8 [11990409.001]
  • [Cites] Am J Kidney Dis. 2003 Mar;41(3):664-9 [12612991.001]
  • [Cites] Perit Dial Int. 2004 Jul-Aug;24(4):340-6 [15335147.001]
  • [Cites] Nephrol Dial Transplant. 2004 Oct;19(10):2584-91 [15304559.001]
  • [Cites] Perit Dial Int. 1989;9(3):159-63 [2488361.001]
  • [Cites] Ann Intern Med. 1994 Feb 15;120(4):264-71 [8291819.001]
  • [Cites] J Am Soc Nephrol. 1995 Apr;5(10):1835-8 [7787152.001]
  • [Cites] J Am Soc Nephrol. 1995 Aug;6(2):184-91 [7579083.001]
  • [Cites] Am J Kidney Dis. 1996 Sep;28(3):428-36 [8804243.001]
  • [Cites] J Am Soc Nephrol. 1996 Nov;7(11):2392-8 [8959630.001]
  • [Cites] Kidney Int. 1998 Dec;54(6):2123-8 [9853278.001]
  • [Cites] J Am Soc Nephrol. 1999 Feb;10(2):354-65 [10215336.001]
  • [Cites] Am J Kidney Dis. 1999 Mar;33(3):535-40 [10070918.001]
  • [Cites] Perit Dial Int. 1999 May-Jun;19(3):253-8 [10433162.001]
  • [Cites] Perit Dial Int. 2005 Mar-Apr;25(2):107-31 [15796137.001]
  • (PMID = 19406969.001).
  • [ISSN] 1555-905X
  • [Journal-full-title] Clinical journal of the American Society of Nephrology : CJASN
  • [ISO-abbreviation] Clin J Am Soc Nephrol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2709510
  •  go-up   go-down


55. Kim KC, Rhee KJ, Shin HD, Kim YM: Estimating the dimensions of the rotator interval with use of magnetic resonance arthrography. J Bone Joint Surg Am; 2007 Nov;89(11):2450-5
MedlinePlus Health Information. consumer health - MRI Scans.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CONCLUSIONS: There are significant differences in the dimensions of the rotator interval between patients with and without recurrent anterior shoulder instability.
  • [MeSH-minor] Adolescent. Adult. Female. Humans. Male. Middle Aged. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17974888.001).
  • [ISSN] 1535-1386
  • [Journal-full-title] The Journal of bone and joint surgery. American volume
  • [ISO-abbreviation] J Bone Joint Surg Am
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


56. Chen TW, Liu HD, Shyu RY, Yu JC, Shih ML, Chang TM, Hsieh CB: Giant malignant gastrointestinal stromal tumors: recurrence and effects of treatment with STI-571. World J Gastroenterol; 2005 Jan 14;11(2):260-3
Hazardous Substances Data Bank. IMATINIB MESYLATE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We hypothesized that treatment with imatinib mesylate (Gleevec; STI-571), a c-kit tyrosine kinase inhibitor, as palliative therapy would prolong the survival of patients with recurrent giant malignant GISTs after resection.
  • We compared the survival rate to determine the prognostic factors and the effects of STI-571 on patients with recurrent malignant gastrointestinal stromal tumor.
  • [MeSH-minor] Adult. Benzamides. Female. Follow-Up Studies. Humans. Imatinib Mesylate. Male. Middle Aged. Recurrence. Retrospective Studies. Stromal Cells / pathology. Survival Analysis. Time Factors

  • Genetic Alliance. consumer health - Gastrointestinal Stromal Tumors.
  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15633227.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Benzamides; 0 / Piperazines; 0 / Pyrimidines; 8A1O1M485B / Imatinib Mesylate
  • [Other-IDs] NLM/ PMC4205413
  •  go-up   go-down


57. Rizzo S, Genovesi-Ebert F, Belting C, Vento A, Cresti F: A pilot study on the use of silicone oil-RMN3 as heavier-than-water endotamponade agent. Graefes Arch Clin Exp Ophthalmol; 2005 Nov;243(11):1153-7
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • AIMS: This work was conducted to report an interventional non-comparative pilot study using Oxane HD, a mixture of ultra-purified silicone oil and RMN3, a partially fluorinated olefin, as heavier-than-water internal tamponade.
  • Indications included recurrent retinal detachment (RD) with proliferative vitreoretinopathy (PVR) (stage > or =C2) arising from inferior or posterior tears, recurrences after vitreoretinal surgery, penetrating trauma and combined rhegmatogenous and choroidal detachment.
  • The patients underwent a pars plana vitrectomy, membrane peeling, and Oxane HD was used as long-term internal tamponade.
  • The overall anatomical success rate obtained using Oxane HD was 53.5%.
  • In 15 patients with previous marked scleral buckling, the success rate was 26%: in nine patients recurrent RD occurred in the inferior sector, in five patients new tears were detected in the lower sectors; membrane formation was observed in 15 eyes.
  • CONCLUSION: Oxane HD may be a useful tool in complicated RD with large inferior breaks, inferior PVR or combined rhegmatogenous, and choroidal detachment without marked scleral buckling, which put the eye profile out of shape, led to a higher failure rate and reduced the tamponading effectiveness of Oxane HD.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Anesthesia, Local. Drug Therapy, Combination. Epiretinal Membrane / surgery. Female. Humans. Laser Coagulation. Male. Middle Aged. Pilot Projects. Prospective Studies. Viscosity

  • MedlinePlus Health Information. consumer health - Retinal Detachment.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Retina. 1992;12(3 Suppl):S40-5 [1455082.001]
  • [Cites] Ophthalmology. 1983 Feb;90(2):121-5 [6856248.001]
  • [Cites] Ophthalmologica. 1992;204(2):77-81 [1594185.001]
  • [Cites] Ophthalmic Surg. 1993 Oct;24(10 ):681-5 [8259246.001]
  • [Cites] Am J Ophthalmol. 2002 Jan;133(1):95-101 [11755844.001]
  • [Cites] Surv Ophthalmol. 1995 Mar-Apr;39(5):375-95 [7604361.001]
  • [Cites] Eur J Ophthalmol. 2002 Nov-Dec;12(6):518-22 [12510721.001]
  • [Cites] Retina. 2003 Jun;23(3):335-42 [12824833.001]
  • [Cites] Graefes Arch Clin Exp Ophthalmol. 1994 Jul;232(7):438-44 [7926877.001]
  • [Cites] Br J Ophthalmol. 2004 May;88(5):692-6 [15090425.001]
  • [Cites] Semin Ophthalmol. 2000 Mar;15(1):25-35 [10749312.001]
  • (PMID = 15983817.001).
  • [ISSN] 0721-832X
  • [Journal-full-title] Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
  • [ISO-abbreviation] Graefes Arch. Clin. Exp. Ophthalmol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Alkenes; 0 / Silicone Oils
  •  go-up   go-down


58. Gamblin TC, Krasinskas AM, Slivka AS, Tublin ME, Demetris J, Shue E, Caro S, Marsh JW, James Moser A: Fibroinflammatory biliary stricture: a rare bile duct lesion masquerading as cholangiocarcinoma. J Gastrointest Surg; 2009 Apr;13(4):713-21
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • All patients presented with jaundice; six patients had coexisting autoimmune disease.
  • At 41 month median follow-up (range 15-58 months), there was no evidence of recurrent FIBS in ten patients, while one was lost to follow-up.
  • [MeSH-minor] Actins / metabolism. Adult. Aged. Cholangiopancreatography, Endoscopic Retrograde. Constriction, Pathologic. Female. Humans. Immunohistochemistry. Inflammation / pathology. Male. Middle Aged. Muscle, Smooth / metabolism. Portal Vein / radiography. Retrospective Studies. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Bile Duct Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19057967.001).
  • [ISSN] 1873-4626
  • [Journal-full-title] Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
  • [ISO-abbreviation] J. Gastrointest. Surg.
  • [Language] eng
  • [Grant] United States / NIDDK NIH HHS / DK / DK-51485; United States / NICHD NIH HHS / HD / K12 HD 049109
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins
  •  go-up   go-down


59. Taveras EM, Camargo CA Jr, Rifas-Shiman SL, Oken E, Gold DR, Weiss ST, Gillman MW: Association of birth weight with asthma-related outcomes at age 2 years. Pediatr Pulmonol; 2006 Jul;41(7):643-8
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The main outcome measures were parent report of (1) any wheezing (or whistling in the chest) from birth to age 2 years, (2) recurrent wheezing during the first 2 years of life, and (3) doctor's diagnosis of asthma, wheeze or reactive airway disease ("asthma") by age 2.
  • By age 2 years, 34% of children had any wheezing, 14% had recurrent wheezing, and 16% had doctor-diagnosed asthma.
  • Boys had a higher incidence of asthma-related outcomes than girls, and exposure to passive smoking, parental history of asthma, and exposure to older siblings were all associated with greater risk of recurrent wheeze or asthma-related outcomes at age 2 years.

  • Genetic Alliance. consumer health - Asthma.
  • MedlinePlus Health Information. consumer health - Asthma.
  • MedlinePlus Health Information. consumer health - Asthma in Children.
  • MedlinePlus Health Information. consumer health - Birth Weight.
  • MedlinePlus Health Information. consumer health - Fetal Health and Development.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Thorax. 2001 Nov;56(11):835-8 [11641506.001]
  • [Cites] Acta Paediatr Suppl. 2004 Dec;93(446):26-33 [15702667.001]
  • [Cites] Int J Epidemiol. 2002 Dec;31(6):1240-5 [12540729.001]
  • [Cites] Obes Res. 2003 Apr;11(4):496-506 [12690076.001]
  • [Cites] Clin Exp Allergy. 2003 Jun;33(6):737-45 [12801306.001]
  • [Cites] Am J Epidemiol. 2003 Sep 1;158(5):406-15 [12936895.001]
  • [Cites] BMC Pediatr. 2003 Jul 8;3:6 [12848901.001]
  • [Cites] Arch Pediatr Adolesc Med. 2004 Jan;158(1):60-4 [14706960.001]
  • [Cites] J Pediatr. 2004 Feb;144(2):240-5 [14760269.001]
  • [Cites] Clin Exp Allergy. 2004 Mar;34(3):381-8 [15005731.001]
  • [Cites] Chest. 2004 Oct;126(4):1147-53 [15486376.001]
  • [Cites] Clin Rev Allergy. 1987 Nov;5(4):339-47 [3319125.001]
  • [Cites] Am J Epidemiol. 1990 Jul;132(1):83-95 [2356817.001]
  • [Cites] Am Rev Respir Dis. 1990 Sep;142(3):555-62 [2389907.001]
  • [Cites] Arch Dis Child. 1991 May;66(5):584-7 [2039246.001]
  • [Cites] N Engl J Med. 1992 Mar 26;326(13):862-6 [1542323.001]
  • [Cites] Am Rev Respir Dis. 1992 Oct;146(4):888-94 [1416415.001]
  • [Cites] BMJ. 1993 Mar 27;306(6881):817-20 [8490372.001]
  • [Cites] J Pediatr. 1993 Aug;123(2):223-9 [8345417.001]
  • [Cites] Arch Dis Child. 1995 Sep;73(3):231-4 [7492161.001]
  • [Cites] Pediatrics. 1997 Apr;99(4):E1 [9099776.001]
  • [Cites] Arch Pediatr Adolesc Med. 1998 Dec;152(12):1197-200 [9856429.001]
  • [Cites] Clin Exp Allergy. 1999 Mar;29(3):330-3 [10202339.001]
  • [Cites] Am J Respir Crit Care Med. 1999 Jul;160(1):227-36 [10390405.001]
  • [Cites] Int J Epidemiol. 2002 Apr;31(2):294-9 [11980782.001]
  • (PMID = 16703577.001).
  • [ISSN] 8755-6863
  • [Journal-full-title] Pediatric pulmonology
  • [ISO-abbreviation] Pediatr. Pulmonol.
  • [Language] ENG
  • [Grant] United States / NIDDK NIH HHS / DK / P30 DK040561; United States / NHLBI NIH HHS / HL / HL 68041; None / None / / P30 DK040561-11; United States / NICHD NIH HHS / HD / R37 HD034568; United States / NHLBI NIH HHS / HL / R01 HL064925; United States / NIDDK NIH HHS / DK / P30 DK040561-11; United States / NHLBI NIH HHS / HL / HL 64925; United States / NICHD NIH HHS / HD / HD 34568; United States / NHLBI NIH HHS / HL / K24 HL068041; United States / NICHD NIH HHS / HD / R01 HD034568
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS10702; NLM/ PMC1488724
  •  go-up   go-down


60. Lai CH, Chang TC, Hsueh S, Wu TI, Chao A, Chou HH, Wang PN: Outcome and prognostic factors in ovarian germ cell malignancies. Gynecol Oncol; 2005 Mar;96(3):784-91
MedlinePlus Health Information. consumer health - Ovarian Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Histology (DSG/IMT versus non-DSG/IMT) (P < 0.0001) and International Federation of Gynecology and Obstetrics stage (P = 0.001) were significantly associated with treatment failure, while histology (P = 0.0004), salvage high-dose chemotherapy (HD-CT) after primary chemotherapy failed (P = 0.0405), and residual tumor after salvage surgery (P = 0.0014) were significant prognostic factors for overall survival.
  • Aggressive HD-CT with salvage surgery needs to be applied for recurrent/persistent disease after primary chemotherapy.
  • [MeSH-minor] Adolescent. Adult. Chemotherapy, Adjuvant. Child. Female. Humans. Middle Aged. Neoplasm Recurrence, Local / therapy. Neoplasm Staging. Prognosis. Retrospective Studies. Salvage Therapy. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15721426.001).
  • [ISSN] 0090-8258
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


61. Maldonado F, Tazelaar HD, Wang CW, Ryu JH: Yellow nail syndrome: analysis of 41 consecutive patients. Chest; 2008 Aug;134(2):375-381
Faculty of 1000. commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine. (subscription/membership/fee required).

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • All but one patient had chronic respiratory manifestations that included pleural effusions (46%), bronchiectasis (44%), chronic sinusitis (41%), and recurrent pneumonias (22%); 26 patients (63%) had lymphedema.
  • Eight patients underwent surgical management of recurrent pleural effusions including pleurodesis and decortication; two additional patients underwent pleurodesis via tube thoracostomy.
  • Among those still alive (20 patients), the disease appeared stable.
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Cohort Studies. Female. Humans. Lymphedema / complications. Male. Middle Aged. Prognosis. Respiratory Tract Diseases / complications. Retrospective Studies. Syndrome

  • Genetic Alliance. consumer health - Yellow nail syndrome.
  • MedlinePlus Health Information. consumer health - Nail Diseases.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Chest. 2008 Dec;134(6):1353; author reply 1353-4 [19059976.001]
  • (PMID = 18403655.001).
  • [ISSN] 0012-3692
  • [Journal-full-title] Chest
  • [ISO-abbreviation] Chest
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


62. Cole SR, Chu H, Allison PD, Gange SJ: Combined analysis of retrospective and prospective occurrences in cohort studies: HIV-1 serostatus and incident pneumonia. Int J Epidemiol; 2006 Dec;35(6):1442-6
HIV InSite. treatment guidelines - Women and HIV .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: The authors show how information collected on retrospective occurrence times may be combined with prospective occurrence times in the analysis of recurrent events from cohort studies.
  • We illustrate our methods using data from the Women's Interagency HIV Study, which recorded 384 retrospective and 352 prospective occurrences of pneumonia in 9478 retrospective and 7857 prospective person-years among 2610 adult women.
  • The proposed method for the analysis of bidirectional occurrence times will improve precision when the estimated associations are homogeneous across occurrence types, or may provide added insight into either the data collection or disease process when the estimated associations are heterogeneous.
  • [MeSH-minor] AIDS-Related Opportunistic Infections / epidemiology. Adult. Age Distribution. Female. Humans. Incidence. Models, Statistical. Prospective Studies. Recurrence. Retrospective Studies. Risk Factors. United States / epidemiology

  • Genetic Alliance. consumer health - HIV.
  • MedlinePlus Health Information. consumer health - Pneumonia.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16936292.001).
  • [ISSN] 0300-5771
  • [Journal-full-title] International journal of epidemiology
  • [ISO-abbreviation] Int J Epidemiol
  • [Language] eng
  • [Grant] United States / NCRR NIH HHS / RR / M01-RR-00071; United States / NCRR NIH HHS / RR / M01-RR-00079; United States / NCRR NIH HHS / RR / M01-RR-00083; United States / NIAID NIH HHS / AI / U01-AI-31834; United States / NIAID NIH HHS / AI / U01-AI-34989; United States / NIAID NIH HHS / AI / U01-AI-34993; United States / NIAID NIH HHS / AI / U01-AI-34994; United States / NIAID NIH HHS / AI / U01-AI-35004; United States / NIAID NIH HHS / AI / U01-AI-42590; United States / NICHD NIH HHS / HD / U01-HD-32632
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] England
  •  go-up   go-down


63. Feely T, Copley A, Bleyer AJ: Catheter lock solutions to prevent bloodstream infections in high-risk hemodialysis patients. Am J Nephrol; 2007;27(1):24-9
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Antimicrobial catheter lock solutions (CLS) have been shown to prevent bacteremia in chronic hemodialysis (HD) patients with new HD catheters.
  • However, there is little information regarding the usage of these solutions in patients who have a history of recurrent bacteremia and are at very high risk of infection.
  • METHODS: A retrospective chart review was performed to identify patients who had a history of recurrent bacteremia and had received prophylaxis with antimicrobial CLS.
  • RESULTS: Nine patients with recurrent bacteremia were identified.
  • [MeSH-minor] Adult. Drug Combinations. Equipment Failure. Female. Follow-Up Studies. Humans. Incidence. Male. Middle Aged. Retrospective Studies. Risk Factors

  • MedlinePlus Health Information. consumer health - Antibiotics.
  • MedlinePlus Health Information. consumer health - Dialysis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2007 S. Karger AG, Basel
  • (PMID = 17215571.001).
  • [ISSN] 1421-9670
  • [Journal-full-title] American journal of nephrology
  • [ISO-abbreviation] Am. J. Nephrol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents; 0 / Dialysis Solutions; 0 / Drug Combinations
  •  go-up   go-down


64. Kwon CM, Lee SH, Kim JH, Lee KH, Kim HD, Hong YH, Lee CK: A case of Behçet's disease with pericarditis, thrombotic thrombocytopenic purpura, deep vein thrombosis and coronary artery pseudo aneurysm. Korean J Intern Med; 2006 Mar;21(1):50-6
MedlinePlus Health Information. consumer health - Pericardial Disorders.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A case of Behçet's disease with pericarditis, thrombotic thrombocytopenic purpura, deep vein thrombosis and coronary artery pseudo aneurysm.
  • Behçet's disease with concomitant thrombotic thrombocytopenic purpura (TTP), coronary artery stenosis and coronary artery pseudo aneurysm is rare.
  • Here we report a case of Behçet's disease with several cardiovascular complications, namely: pericarditis, deep vein thrombosis (DVT), TTP, coronary artery stenosis, and a coronary artery pseudo aneurysm.
  • After confirmation of Behçet's disease on the basis of a history of recurrent oral and genital ulcers and erythema nodosum, remission was achieved after treatment with methylprednisolone pulse therapy, colchicine, catheter directed thrombolysis and thrombectomy.
  • [MeSH-minor] Adult. Echocardiography. Female. Humans


65. Jinnah HA, Visser JE, Harris JC, Verdu A, Larovere L, Ceballos-Picot I, Gonzalez-Alegre P, Neychev V, Torres RJ, Dulac O, Desguerre I, Schretlen DJ, Robey KL, Barabas G, Bloem BR, Nyhan W, De Kremer R, Eddey GE, Puig JG, Reich SG, Lesch-Nyhan Disease International Study Group: Delineation of the motor disorder of Lesch-Nyhan disease. Brain; 2006 May;129(Pt 5):1201-17
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Delineation of the motor disorder of Lesch-Nyhan disease.
  • Lesch-Nyhan disease (LND) is caused by deficiency of the purine salvage enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT).
  • Affected individuals exhibit over-production of uric acid, along with a characteristic neurobehavioural syndrome that includes mental retardation, recurrent self-injurious behaviour and motor disability.

  • Genetics Home Reference. consumer health - Lesch-Nyhan syndrome.
  • MedlinePlus Health Information. consumer health - Dystonia.
  • COS Scholar Universe. author profiles.
  • Coriell Cell Repositories. culture/stock collections - Coriell Cell Repositories .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Q J Med. 1982;51(201):43-78 [7111674.001]
  • [Cites] Tohoku J Exp Med. 1982 Jul;137(3):275-82 [7112549.001]
  • [Cites] Can Med Assoc J. 1984 May 15;130(10):1323-4 [6722697.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 1984 Aug;47(8):775-80 [6470718.001]
  • [Cites] Lancet. 1985 Feb 9;1(8424):338-9 [2857386.001]
  • [Cites] Adv Exp Med Biol. 1986;195 Pt A:197-203 [3728152.001]
  • [Cites] Neuropediatrics. 1986 Aug;17(3):158-61 [3762872.001]
  • [Cites] J Oral Med. 1987 Jan-Mar;42(1):10-3, 66 [3469343.001]
  • [Cites] J Inherit Metab Dis. 1987;10(3):210-23 [2828760.001]
  • [Cites] Adv Neurol. 1988;49:365-81 [3278547.001]
  • [Cites] Ann Neurol. 1988 May;23(5):466-9 [2455472.001]
  • [Cites] Adv Neurol. 1988;50:1-8 [3041755.001]
  • [Cites] Neurosurgery. 1989 Jun;24(6):902-5 [2747865.001]
  • [Cites] J Inherit Metab Dis. 1989;12(2):184-96 [2502677.001]
  • [Cites] Q J Med. 1989 Apr;71(264):291-306 [2687930.001]
  • [Cites] Mov Disord. 1999 Jan;14(1):194-5 [9918379.001]
  • [Cites] Neuropediatrics. 1999 Apr;30(2):66-71 [10401687.001]
  • [Cites] Am J Med. 1964 Apr;36:561-70 [14142409.001]
  • [Cites] Neurology. 1962 Jun;12:410-2 [13861319.001]
  • [Cites] N Engl J Med. 1965 Jul 15;273:130-5 [14303658.001]
  • [Cites] Nucleosides Nucleotides Nucleic Acids. 2004 Oct;23(8-9):1153-60 [15571220.001]
  • [Cites] Spine (Phila Pa 1976). 1989 Nov;14(11):1154-9 [2603049.001]
  • [Cites] Acta Neurol Scand. 1990 Feb;81(2):184-7 [2327243.001]
  • [Cites] Pediatr Neurol. 1991 Sep-Oct;7(5):389-91 [1764145.001]
  • [Cites] J Autism Dev Disord. 1992 Jun;22(2):189-203 [1624404.001]
  • [Cites] J Inherit Metab Dis. 1992;15(5):790-1 [1434518.001]
  • [Cites] Laryngoscope. 1994 Jan;104(1 Pt 1):30-2 [8295454.001]
  • [Cites] J Autism Dev Disord. 1994 Feb;24(1):67-81 [8188575.001]
  • [Cites] Dev Med Child Neurol. 1995 Aug;37(8):715-22 [7672468.001]
  • [Cites] N Engl J Med. 1996 Jun 13;334(24):1568-72 [8628337.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 May 28;93(11):5539-43 [8643611.001]
  • [Cites] J Bone Joint Surg Br. 1996 Jul;78(4):613-9 [8682830.001]
  • [Cites] Mov Disord. 1996 Jan;11(1):79-81 [8771071.001]
  • [Cites] Somat Cell Mol Genet. 1996 Mar;22(2):145-50 [8782493.001]
  • [Cites] Mov Disord. 1996 Sep;11(5):563-6 [8866498.001]
  • [Cites] Prog Neuropsychopharmacol Biol Psychiatry. 1996 Jul;20(5):793-800 [8870064.001]
  • [Cites] Spine (Phila Pa 1976). 1996 Mar 15;21(6):757-62 [8882700.001]
  • [Cites] Neurosci Biobehav Rev. 1997 Jul;21(4):425-35 [9195600.001]
  • [Cites] Dev Med Child Neurol. 1997 Jul;39(7):492-3 [9285444.001]
  • [Cites] Arch Neurol. 1998 Apr;55(4):547-53 [9561984.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 2000 Feb;68(2):186-90 [10644785.001]
  • [Cites] Hum Mutat. 2000 Apr;15(4):383 [10737990.001]
  • [Cites] Brain Res Brain Res Rev. 2000 Apr;32(2-3):449-75 [10760551.001]
  • [Cites] Brain Dev. 2000 Sep;22 Suppl 1:S122-31 [10984673.001]
  • [Cites] Mutat Res. 2000 Oct;463(3):309-26 [11018746.001]
  • [Cites] Neurology. 2001 Jan 23;56(2):260-3 [11160968.001]
  • [Cites] Pediatr Neurol. 2001 Mar;24(3):200-4 [11301220.001]
  • [Cites] Medicine (Baltimore). 2001 Mar;80(2):102-12 [11307586.001]
  • [Cites] Spine (Phila Pa 1976). 2001 Oct 15;26(20):2283-8 [11598522.001]
  • [Cites] J Int Neuropsychol Soc. 2001 Nov;7(7):805-12 [11771623.001]
  • [Cites] Neurology. 2002 Feb 26;58(4):649-52 [11865150.001]
  • [Cites] Pediatrics. 2003 Jan;111(1):e89-97 [12509602.001]
  • [Cites] J Neurosurg. 2003 Feb;98(2):414-6 [12593632.001]
  • [Cites] Dev Med Child Neurol. 2003 Mar;45(3):167-71 [12613772.001]
  • [Cites] J Neural Transm Suppl. 2003;(65):89-100 [12946051.001]
  • [Cites] J Child Neurol. 2003 Sep;18 Suppl 1:S1-8 [13677567.001]
  • [Cites] Adv Neurol. 2004;94:163-70 [14509670.001]
  • [Cites] Pediatr Neurol. 2004 Oct;31(4):298-303 [15464646.001]
  • [Cites] Arch Neurol. 1965 Dec;13(6):639-55 [5850672.001]
  • [Cites] Am J Dis Child. 1967 Feb;113(2):195-206 [6019435.001]
  • [Cites] Dev Med Child Neurol. 1967 Oct;9(5):563-72 [6066021.001]
  • [Cites] Fed Proc. 1968 Jul-Aug;27(4):1042-6 [4298062.001]
  • [Cites] Tohoku J Exp Med. 1968 Jul;95(3):253-60 [5707898.001]
  • [Cites] Am J Dis Child. 1969 Sep;118(3):501-6 [5807658.001]
  • [Cites] Med J Aust. 1969 Oct 4;2(14):696-9 [5348655.001]
  • [Cites] Neurology. 1970 Dec;20(12):1194-9 [5529908.001]
  • [Cites] Lancet. 1970 Dec 26;2(7687):1367 [4098945.001]
  • [Cites] Lancet. 1974 Apr 20;1(7860):761 [4132504.001]
  • [Cites] Arch Dis Child. 1974 Sep;49(9):693-702 [4472817.001]
  • [Cites] Ann Rheum Dis. 1975 Jun;34(3):249-55 [1155984.001]
  • [Cites] Arch Dis Child. 1975 Aug;50(8):666 [1200693.001]
  • [Cites] Neuropadiatrie. 1976 Aug;7(3):351-5 [989165.001]
  • [Cites] J Autism Child Schizophr. 1976 Sep;6(3):235-52 [1086851.001]
  • [Cites] Eur J Pediatr. 1979 Oct;132(2):93-8 [499264.001]
  • [Cites] Arch Neurol. 1980 Mar;37(3):132-6 [7356417.001]
  • [Cites] J Neurol Sci. 1981 Aug;51(2):311-27 [7276982.001]
  • [Cites] N Engl J Med. 1981 Nov 5;305(19):1106-11 [6117011.001]
  • [Cites] Zentralbl Allg Pathol. 1982;126(1-2):95-104 [7090606.001]
  • [Cites] Dev Med Child Neurol. 1982 Jun;24(3):293-306 [7095300.001]
  • [Cites] Nucleosides Nucleotides Nucleic Acids. 2004 Oct;23(8-9):1161-4 [15571221.001]
  • [Cites] Mol Genet Metab. 2005 May;85(1):70-7 [15862283.001]
  • [Cites] Lancet Neurol. 2005 Jul;4(7):423-31 [15963445.001]
  • [Cites] Dev Med Child Neurol. 2005 Oct;47(10):673-7 [16174310.001]
  • [Cites] Neurology. 2005 Dec 13;65(11):E25 [16344506.001]
  • (PMID = 16549399.001).
  • [ISSN] 1460-2156
  • [Journal-full-title] Brain : a journal of neurology
  • [ISO-abbreviation] Brain
  • [Language] ENG
  • [Grant] United States / NICHD NIH HHS / HD / R01 HD053312; United States / NICHD NIH HHS / HD / HD33095; United States / NINDS NIH HHS / NS / NS01985
  • [Publication-type] Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Review
  • [Publication-country] England
  • [Number-of-references] 95
  • [Other-IDs] NLM/ NIHMS416988; NLM/ PMC3508431
  •  go-up   go-down


66. Tartaglia M, Martinelli S, Stella L, Bocchinfuso G, Flex E, Cordeddu V, Zampino G, Burgt Iv, Palleschi A, Petrucci TC, Sorcini M, Schoch C, Foa R, Emanuel PD, Gelb BD: Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease. Am J Hum Genet; 2006 Feb;78(2):279-90
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease.
  • To test this model, we investigated further the diversity of germline and somatic PTPN11 mutations, delineated the association of those mutations with disease, characterized biochemically a panel of mutant SHP-2 proteins recurring in NS, LS, and leukemia, and performed molecular dynamics simulations to determine the structural effects of selected mutations.
  • Our results document a strict correlation between the identity of the lesion and disease and demonstrate that NS-causative mutations have less potency for promoting SHP-2 gain of function than do leukemia-associated ones.
  • Furthermore, we show that the recurrent LS-causing Y279C and T468M amino acid substitutions engender loss of SHP-2 catalytic activity, identifying a previously unrecognized behavior for this class of missense PTPN11 mutations.
  • [MeSH-minor] Adult. Amino Acid Sequence. Cohort Studies. Female. Germ-Line Mutation. Humans. Male. Mutation. Protein Conformation. Protein Tyrosine Phosphatase, Non-Receptor Type 11

  • MedlinePlus Health Information. consumer health - Leukemia.
  • COS Scholar Universe. author profiles.
  • Pharmacogenomics Knowledge Base. meta-databases - Pharmacogenomic Annotation 827852603 for PMID:16358218 [PharmGKB] .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • SciCrunch. OMIM: Data: Gene Annotation .
  • SciCrunch. Clinical Genomic Database: Data: Gene Annotation .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Pediatr. 1997 Jun;130(6):885-9 [9202609.001]
  • [Cites] Mol Cell Biol. 1997 Sep;17(9):5499-507 [9271425.001]
  • [Cites] Cell. 1998 Feb 20;92(4):441-50 [9491886.001]
  • [Cites] Electrophoresis. 1997 Dec;18(15):2714-23 [9504803.001]
  • [Cites] Mol Cell Biol. 1998 Oct;18(10):6075-82 [9742124.001]
  • [Cites] Proteins. 1999 Oct 1;37(1):1-9 [10451545.001]
  • [Cites] J Med Genet. 2004 Nov;41(11):e117 [15520399.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Nov 9;101(45):16064-9 [15520383.001]
  • [Cites] Eur J Hum Genet. 2004 Dec;12(12):1069-72 [15470362.001]
  • [Cites] Proteins. 2005 Jan 1;58(1):7-13 [15521065.001]
  • [Cites] Cancer Res. 2004 Dec 15;64(24):8816-20 [15604238.001]
  • [Cites] Br J Haematol. 2005 Feb;128(3):318-23 [15667533.001]
  • [Cites] J Hum Genet. 2005;50(1):21-5 [15690106.001]
  • [Cites] J Med Genet. 2005 Feb;42(2):e11 [15689434.001]
  • [Cites] Cancer Cell. 2005 Feb;7(2):179-91 [15710330.001]
  • [Cites] Leuk Res. 2005 Apr;29(4):459-62 [15725481.001]
  • [Cites] Haematologica. 2005 Mar;90(3):412-3 [15749679.001]
  • [Cites] Br J Haematol. 2005 Mar;128(6):805-12 [15755284.001]
  • [Cites] Am J Med Genet A. 2005 Apr 15;134A(2):165-70 [15723289.001]
  • [Cites] Am J Hum Genet. 2002 Aug;71(2):389-94 [12058348.001]
  • [Cites] J Clin Endocrinol Metab. 2002 Aug;87(8):3529-33 [12161469.001]
  • [Cites] J Med Genet. 2002 Aug;39(8):571-4 [12161596.001]
  • [Cites] Hum Mutat. 2002 Oct;20(4):298-304 [12325025.001]
  • [Cites] Adv Protein Chem. 2002;61:161-210 [12461824.001]
  • [Cites] Eur J Hum Genet. 2003 Jan;11(1):85-8 [12529711.001]
  • [Cites] Eur J Hum Genet. 2003 Feb;11(2):201-6 [12634870.001]
  • [Cites] Nat Genet. 2003 Jun;34(2):148-50 [12717436.001]
  • [Cites] Trends Biochem Sci. 2003 Jun;28(6):284-93 [12826400.001]
  • [Cites] Genet Couns. 2003;14(2):259 [12872825.001]
  • [Cites] J Med Genet. 2003 Sep;40(9):704-8 [12960218.001]
  • [Cites] Curr Opin Hematol. 2004 Jan;11(1):44-50 [14676626.001]
  • [Cites] Hum Mutat. 2003 Jun;21(6):654 [14961557.001]
  • [Cites] Hum Mutat. 2004 Mar;23(3):267-77 [14974085.001]
  • [Cites] Birth Defects Res A Clin Mol Teratol. 2004 Feb;70(2):95-8 [14991917.001]
  • [Cites] Blood. 2004 Mar 15;103(6):2325-31 [14644997.001]
  • [Cites] J Pediatr. 2004 Mar;144(3):368-74 [15001945.001]
  • [Cites] Br J Haematol. 2004 Mar;124(6):843-4 [15009076.001]
  • [Cites] Curr Hematol Rep. 2004 May;3(3):203-9 [15087069.001]
  • [Cites] J Med Genet. 2004 May;41(5):e68 [15121796.001]
  • [Cites] Leukemia. 2004 Jun;18(6):1142-4 [15085150.001]
  • [Cites] Am J Med Genet A. 2004 Jul 1;128A(1):63-6 [15211660.001]
  • [Cites] Blood. 2004 Jul 15;104(2):307-13 [14982869.001]
  • [Cites] J Clin Endocrinol Metab. 2004 Jul;89(7):3359-64 [15240615.001]
  • [Cites] Leukemia. 2004 Nov;18(11):1831-4 [15385933.001]
  • [Cites] Am J Med Genet A. 2004 Nov 1;130A(4):378-83 [15384080.001]
  • [Cites] Am J Med Genet A. 2004 Nov 1;130A(4):432-4 [15389709.001]
  • [Cites] Am J Dis Child. 1968 Oct;116(4):373-80 [4386970.001]
  • [Cites] Am J Med. 1976 Mar;60(3):447-56 [1258892.001]
  • [Cites] J Med Genet. 1987 Jan;24(1):9-13 [3543368.001]
  • [Cites] Am J Med Genet. 1994 Nov 1;53(2):187-91 [7856646.001]
  • [Cites] Cell. 1995 Feb 10;80(3):473-83 [7859288.001]
  • [Cites] Leukemia. 1995 Oct;9(10):1783-6 [7564526.001]
  • [Cites] J Mol Graph. 1996 Feb;14(1):51-5, 29-32 [8744573.001]
  • [Cites] J Biol Chem. 1996 Aug 30;271(35):21353-8 [8702915.001]
  • [Cites] Blood. 2005 May 1;105(9):3737-42 [15644411.001]
  • [Cites] Br J Haematol. 2005 May;129(3):333-9 [15842656.001]
  • [Cites] J Hum Genet. 2005;50(4):192-202 [15834506.001]
  • [Cites] Am J Hematol. 2005 Jun;79(2):171-2 [15929108.001]
  • [Cites] Haematologica. 2005 Jun;90(6):853-4 [15951301.001]
  • [Cites] Blood. 2005 Jul 1;106(1):311-7 [15761018.001]
  • [Cites] Am J Med Genet A. 2005 Jul 15;136(2):146-51 [15940693.001]
  • [Cites] Am J Med Genet A. 2005 Jul 30;136(3):242-5 [15948193.001]
  • [Cites] Clin Genet. 2005 Aug;68(2):190-1 [15996221.001]
  • [Cites] Eur J Pediatr. 2005 Aug;164(8):497-500 [15889278.001]
  • [Cites] Prenat Diagn. 2005 Jul;25(7):574-6 [16032767.001]
  • [Cites] Eur J Med Genet. 2005 Apr-Jun;48(2):81-96 [16053901.001]
  • [Cites] Br J Haematol. 2005 Sep;130(5):801-3 [16115145.001]
  • [Cites] Annu Rev Genomics Hum Genet. 2005;6:45-68 [16124853.001]
  • [Cites] J Biol Chem. 2005 Sep 2;280(35):30984-93 [15987685.001]
  • [Cites] Blood. 2005 Sep 15;106(6):2183-5 [15928039.001]
  • [Cites] J Clin Endocrinol Metab. 2005 Sep;90(9):5377-81 [15985475.001]
  • [Cites] Eur J Pediatr. 2003 Jul;162(7-8):548-9 [12739139.001]
  • [Cites] J Clin Endocrinol Metab. 2005 Sep;90(9):5156-60 [15956085.001]
  • [Cites] Mol Cell Biol. 2000 Jan;20(1):299-311 [10594032.001]
  • [Cites] J Pediatr Hematol Oncol. 1999 Nov-Dec;21(6):523-7 [10598665.001]
  • [Cites] Nat Genet. 2000 Mar;24(3):296-9 [10700187.001]
  • [Cites] Nat Genet. 2000 Apr;24(4):420-3 [10742110.001]
  • [Cites] Blood. 2001 Feb 15;97(4):911-4 [11159516.001]
  • [Cites] Mol Cell Biol. 2001 Nov;21(21):7117-36 [11585896.001]
  • [Cites] Nat Genet. 2001 Dec;29(4):465-8 [11704759.001]
  • [Cites] Am J Hum Genet. 2002 Jun;70(6):1555-63 [11992261.001]
  • [Cites] J Pediatr Hematol Oncol. 1997 Mar-Apr;19(2):177-9 [9149755.001]
  • [Cites] EMBO J. 1997 May 1;16(9):2352-64 [9171349.001]
  • (PMID = 16358218.001).
  • [ISSN] 0002-9297
  • [Journal-full-title] American journal of human genetics
  • [ISO-abbreviation] Am. J. Hum. Genet.
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / K24 HD001294; United States / NCI NIH HHS / CA / R01 CA095621; United States / NICHD NIH HHS / HD / HD01294; United States / NHLBI NIH HHS / HL / R01 HL071207; United States / NHLBI NIH HHS / HL / P50 HL074728; United States / NHLBI NIH HHS / HL / HL074728; United States / NCI NIH HHS / CA / CA095621; Italy / Telethon / / GGP04172; United States / NHLBI NIH HHS / HL / HL71207
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Intracellular Signaling Peptides and Proteins; EC 3.1.3.48 / PTPN11 protein, human; EC 3.1.3.48 / Protein Tyrosine Phosphatase, Non-Receptor Type 11; EC 3.1.3.48 / Protein Tyrosine Phosphatases
  • [Other-IDs] NLM/ PMC1380235
  •  go-up   go-down


67. Graham JM Jr, Visootsak J, Dykens E, Huddleston L, Clark RD, Jones KL, Moeschler JB, Opitz JM, Morford J, Simensen R, Rogers RC, Schwartz CE, Friez MJ, Stevenson RE: Behavior of 10 patients with FG syndrome (Opitz-Kaveggia syndrome) and the p.R961W mutation in the MED12 gene. Am J Med Genet A; 2008 Dec 1;146A(23):3011-7
SciCrunch. Clinical Genomic Database: Data: Gene Annotation .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We also characterize the behavior of eight additional individuals with FG syndrome and this recurrent mutation in MED12 using the Vineland Adaptive Behavior Scales 2nd edition, the Reiss Profile of Fundamental Goals and Motivation Sensitivities, and the Achenbach Child Behavior Checklist.
  • Based on the behavior phenotype in 10 males with this recurrent MED12 mutation, we offer specific recommendations and interventional strategies.

  • Genetic Alliance. consumer health - FG Syndrome.
  • Genetic Alliance. consumer health - Opitz syndrome.
  • Genetics Home Reference. consumer health - FG syndrome.
  • MedlinePlus Health Information. consumer health - Child Behavior Disorders.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. (L)-Tryptophan .
  • Hazardous Substances Data Bank. (L)-ARGININE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2008 Wiley-Liss, Inc.
  • [Cites] J Pediatr. 1976 Apr;88(4 Pt 1):589-91 [1255317.001]
  • [Cites] Am J Med Genet. 1977;1(1):47-58 [565138.001]
  • [Cites] Ment Retard Dev Disabil Res Rev. 2000;6(2):84-95 [10899801.001]
  • [Cites] Am J Med Genet. 1997 Nov 28;73(1):87-90 [9375929.001]
  • [Cites] Am J Med Genet. 1998 Nov 2;80(2):145-56 [9805132.001]
  • [Cites] Am J Med Genet. 1999 Aug 27;85(5):470-5 [10405444.001]
  • [Cites] Am J Med Genet. 1999 Sep 10;86(2):112-4 [10449643.001]
  • [Cites] Am J Med Genet A. 2005 Mar 15;133A(3):240-7 [15637708.001]
  • [Cites] Nat Genet. 2007 Apr;39(4):451-3 [17334363.001]
  • [Cites] Am J Med Genet A. 2007 Jun 1;143A(11):1198-203 [17497714.001]
  • [Cites] Am J Med Genet. 2000 Summer;97(2):112-8 [11180218.001]
  • [Cites] Am J Med Genet. 2000 Nov 13;95(2):178-81 [11078572.001]
  • [Cites] Nat Genet. 2007 Sep;39(9):1127-33 [17704778.001]
  • [Cites] Z Kinderheilkd. 1974 Apr 8;117(1):1-18 [4365204.001]
  • [Cites] J Med Genet. 2009 Jan;46(1):9-13 [18805826.001]
  • [Cites] Ment Retard Dev Disabil Res Rev. 2004;10(1):42-8 [14994287.001]
  • [Cites] Am J Med Genet. 2002 Sep 15;112(1):6-11 [12239712.001]
  • [Cites] Am J Med Genet. 1982 Jun;12(2):147-54 [7201743.001]
  • (PMID = 18973276.001).
  • [ISSN] 1552-4833
  • [Journal-full-title] American journal of medical genetics. Part A
  • [ISO-abbreviation] Am. J. Med. Genet. A
  • [Language] ENG
  • [Grant] United States / NCRR NIH HHS / RR / M01-RR00425; United States / NICHD NIH HHS / HD / P01 HD022657; United States / NICHD NIH HHS / HD / P01 HD022657-12; United States / NCRR NIH HHS / RR / K12 RR025009,; United States / NICHD NIH HHS / HD / HD22657; United States / NCRR NIH HHS / RR / KL2 RR025009; United States / NIGMS NIH HHS / GM / T32 GM008243; United States / NCATS NIH HHS / TR / UL1 TR000454; United States / NICHD NIH HHS / HD / R01 HD026202; United States / NIGMS NIH HHS / GM / 5-T32-GM08243; United States / NCRR NIH HHS / RR / M01 RR000425; United States / NIMHD NIH HHS / MD / L32 MD000625; United States / NICHD NIH HHS / HD / HD262020
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / MED12 protein, human; 0 / Mediator Complex; 0 / Receptors, Thyroid Hormone; 8DUH1N11BX / Tryptophan; 94ZLA3W45F / Arginine
  • [Other-IDs] NLM/ NIHMS76047; NLM/ PMC3092600
  •  go-up   go-down


68. Meira FS, Poli de Figueiredo CE, Figueiredo AE: Influence of sodium profile in preventing complications during hemodialysis. Hemodial Int; 2007 Oct;11 Suppl 3:S29-32
Hazardous Substances Data Bank. SODIUM .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Although a safe procedure, hemodialysis (HD) can cause numerous complications.
  • The objective of this study was to evaluate the incidence of complications during dialysis, interdialytic weight gain, and the predialysis and postdialysis blood pressure in HD patients with and without variable sodium.
  • Patients were observed during 12 HD sessions and those presenting with recurrent hypotension were selected for a step-wise model of variable sodium profiling.
  • [MeSH-minor] Adult. Aged. Dialysis Solutions / chemistry. Dialysis Solutions / pharmacology. Female. Humans. Hypotension / drug therapy. Hypotension / prevention & control. Male. Middle Aged. Muscle Cramp / etiology

  • MedlinePlus Health Information. consumer health - Dialysis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17897108.001).
  • [ISSN] 1492-7535
  • [Journal-full-title] Hemodialysis international. International Symposium on Home Hemodialysis
  • [ISO-abbreviation] Hemodial Int
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] Canada
  • [Chemical-registry-number] 0 / Dialysis Solutions; 9NEZ333N27 / Sodium
  •  go-up   go-down


69. Henry SM, Hitt JR, Jones SL, Bunn JY: Decreased limits of stability in response to postural perturbations in subjects with low back pain. Clin Biomech (Bristol, Avon); 2006 Nov;21(9):881-92
ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Twenty-four healthy subjects [mean 33 (SD 11) years] who had no low back pain and 26 subjects [mean 39 (SD 13) years] with chronic, recurrent low back pain were instructed to stand with feet placed on separate force plates, which were mounted on a moveable platform.

  • MedlinePlus Health Information. consumer health - Foot Health.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16806618.001).
  • [ISSN] 0268-0033
  • [Journal-full-title] Clinical biomechanics (Bristol, Avon)
  • [ISO-abbreviation] Clin Biomech (Bristol, Avon)
  • [Language] ENG
  • [Grant] United States / NICHD NIH HHS / HD / R01 HD040909; United States / NICHD NIH HHS / HD / K01 HD01194-05; United States / NICHD NIH HHS / HD / R01 HD04099
  • [Publication-type] Controlled Clinical Trial; Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] England
  •  go-up   go-down


70. Bucerius J, Herkel C, Joe AY, Altehoefer C, Finke J, Moser E, Reinhardt MJ: (18)F-FDG PET and conventional imaging for assessment of Hodgkin's disease and non Hodgkin's lymphoma. An analysis of 193 patient studies. Nuklearmedizin; 2006;45(3):105-10; quiz N25-6
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] (18)F-FDG PET and conventional imaging for assessment of Hodgkin's disease and non Hodgkin's lymphoma. An analysis of 193 patient studies.
  • The AIM of this study was to assess the diagnostic value of FDG-PET and conventional imaging (CI) in a large series of patient with Hodgkin's disease (HD) or non-Hodgkin's lymphoma (NHL) at three time points during their course of disease.
  • PATIENTS, METHODS: 169 consecutive lymphoma patients (69 HD; 100 NHL) were included.
  • Differences in staging and diagnosis of residual or recurrent lymphoma were compared.
  • CONCLUSION: FDG-PET should be considered as the diagnostic modality of choice for post-therapeutic assessment of lymphoma patients and may be a reliable alternative to CI for staging at baseline and diagnosis of recurrence.
  • [MeSH-major] Fluorodeoxyglucose F18. Hodgkin Disease / radionuclide imaging. Lymphoma, Non-Hodgkin / radionuclide imaging
  • [MeSH-minor] Adult. Female. Humans. Male. Middle Aged. Radiopharmaceuticals. Recurrence. Retrospective Studies. Tomography, X-Ray Computed. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Hodgkin Disease.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16710505.001).
  • [ISSN] 0029-5566
  • [Journal-full-title] Nuklearmedizin. Nuclear medicine
  • [ISO-abbreviation] Nuklearmedizin
  • [Language] eng; ger
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


71. Miodrag N, Hodapp RM: Chronic stress and health among parents of children with intellectual and developmental disabilities. Curr Opin Psychiatry; 2010 Sep;23(5):407-11
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • So far, increased rates of caregiver health problems have been linked to caring for an elderly parent or for a child with recurrent cancer.
  • [MeSH-minor] Adult. Caregivers / psychology. Child. Health Status. Humans

  • Genetic Alliance. consumer health - Developmental Disabilities.
  • MedlinePlus Health Information. consumer health - Developmental Disabilities.
  • MedlinePlus Health Information. consumer health - Stress.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20592593.001).
  • [ISSN] 1473-6578
  • [Journal-full-title] Current opinion in psychiatry
  • [ISO-abbreviation] Curr Opin Psychiatry
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / P30HD 15052
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Review
  • [Publication-country] United States
  •  go-up   go-down


72. Hojaili B, Keiser HD: Relapsing polychondritis presenting with complete heart block. J Clin Rheumatol; 2008 Feb;14(1):24-6
Hazardous Substances Data Bank. PREDNISONE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Relapsing polychondritis (RP) is a rare autoimmune disease characterized by recurrent inflammation of cartilagenous structures, including the ears, nose, trachea, and joints.
  • Cardiovascular involvement is relatively common, but involvement of the conduction system leading to various degrees of heart block is a rare and late manifestation of the disease usually requiring a pacemaker.
  • [MeSH-minor] Adult. Blood Sedimentation / drug effects. Bradycardia / etiology. Female. Humans

  • Genetic Alliance. consumer health - Relapsing polychondritis.
  • MedlinePlus Health Information. consumer health - Steroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18431094.001).
  • [ISSN] 1536-7355
  • [Journal-full-title] Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
  • [ISO-abbreviation] J Clin Rheumatol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-Inflammatory Agents; VB0R961HZT / Prednisone
  •  go-up   go-down


73. Jaffee SR, Belsky J, Harrington H, Caspi A, Moffitt TE: When parents have a history of conduct disorder: how is the caregiving environment affected? J Abnorm Psychol; 2006 May;115(2):309-19
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Recurrent disorder, comorbidity, and adversity in the family of origin did not fully account for these findings.
  • The cumulative consequences of early-onset conduct disorder and assortative mating for antisocial behavior may explain the long-term effects of conduct disorder on young adult functioning.
  • [MeSH-minor] Adolescent. Adult. Child. Child, Preschool. Female. Humans. Male. Surveys and Questionnaires

  • MedlinePlus Health Information. consumer health - Caregivers.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16737395.001).
  • [ISSN] 0021-843X
  • [Journal-full-title] Journal of abnormal psychology
  • [ISO-abbreviation] J Abnorm Psychol
  • [Language] eng
  • [Grant] United Kingdom / Medical Research Council / / G0100527; United States / NICHD NIH HHS / HD / 5R01HD32948; United States / NICHD NIH HHS / HD / HD050961; United States / NIMH NIH HHS / MH / MH45070
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


74. Kennedy CM, Nygaard IE, Bradley CS, Galask RP: Bladder and bowel symptoms among women with vulvar disease: are they universal? J Reprod Med; 2007 Dec;52(12):1073-8
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bladder and bowel symptoms among women with vulvar disease: are they universal?
  • OBJECTIVE: To compare the prevalence of painful bladder syndrome, recurrent urinary tract infections, urinary leakage and irritable bowel syndrome between women with specific vulvar disorders and controls.
  • RESULTS: As compared to controls, painful bladder syndrome was more prevalent among subjects with dysplasia, vestibulitis and contact vulvitis; a history of recurrent urinary tract infection was more prevalent among subjects with contact vulvitis; and urinary incontinence was less prevalent in subjects with lichen sclerosus.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Comorbidity. Cross-Sectional Studies. Female. Humans. Middle Aged. Pain / epidemiology. Prevalence. Recurrence. Surveys and Questionnaires. Urinary Incontinence / epidemiology. Urinary Tract Infections / epidemiology

  • MedlinePlus Health Information. consumer health - Bladder Diseases.
  • MedlinePlus Health Information. consumer health - Vulvar Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18210896.001).
  • [ISSN] 0024-7758
  • [Journal-full-title] The Journal of reproductive medicine
  • [ISO-abbreviation] J Reprod Med
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / 1K23 HD045769-01
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  •  go-up   go-down


75. Neijt A, Schreuder R: Rhythm versus analogy: prosodic form variation in Dutch compounds. Lang Speech; 2007;50(Pt 4):533-66
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • However, the results observed in this experiment can only be explained satisfactorily in terms of rhythm: the preference for a recurrent pattern of stressed and unstressed syllables.
  • [MeSH-minor] Adult. Humans. Netherlands. Phonetics. Psycholinguistics. Speech Acoustics

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18330216.001).
  • [ISSN] 0023-8309
  • [Journal-full-title] Language and speech
  • [ISO-abbreviation] Lang Speech
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


76. Lee WI, Torgerson TR, Schumacher MJ, Yel L, Zhu Q, Ochs HD: Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood; 2005 Mar 1;105(5):1881-90
SciCrunch. Clinical Genomic Database: Data: Gene Annotation .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The hyper immunoglobulin M (IgM) syndrome (HIGM), characterized by recurrent infections, low serum IgG and IgA, normal or elevated IgM, and defective class switch recombination and somatic hypermutation, is a heterogenous disorder with at least 5 distinct molecular defects, including mutations of the genes coding for the CD40 ligand (CD40L) and IKK-gamma (NEMO) genes, both X-linked; and mutations of CD40, activation-induced cytidine deaminase (AICDA), and uracil-DNA glycosylase (UNG), associated with autosomal recessive HIGM syndromes.
  • We found mutations of CD40L in 98 males; AICDA in 4 patients (3 males, 1 female); UNG in one adult male; and Btk in 3 boys.
  • [MeSH-minor] Adult. Antigens, CD40 / genetics. CD40 Ligand / genetics. Cohort Studies. Cytidine Deaminase. Cytosine Deaminase / genetics. DNA Glycosylases / genetics. Family Health. Female. Humans. I-kappa B Kinase. Male. Molecular Epidemiology. Mutation. Prevalence. Protein-Serine-Threonine Kinases / genetics. Protein-Tyrosine Kinases / genetics. Uracil-DNA Glycosidase

  • COS Scholar Universe. author profiles.
  • Coriell Cell Repositories. culture/stock collections - Coriell Cell Repositories .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15358621.001).
  • [ISSN] 0006-4971
  • [Journal-full-title] Blood
  • [ISO-abbreviation] Blood
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / HD 17427-33
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD40; 0 / Immunoglobulin M; 147205-72-9 / CD40 Ligand; EC 2.7.1.- / IKBKE protein, human; EC 2.7.10.1 / Agammaglobulinaemia tyrosine kinase; EC 2.7.10.1 / Protein-Tyrosine Kinases; EC 2.7.11.1 / Protein-Serine-Threonine Kinases; EC 2.7.11.10 / CHUK protein, human; EC 2.7.11.10 / I-kappa B Kinase; EC 2.7.11.10 / IKBKB protein, human; EC 3.2.2.- / DNA Glycosylases; EC 3.2.2.- / Uracil-DNA Glycosidase; EC 3.5.4.- / AICDA (activation-induced cytidine deaminase); EC 3.5.4.1 / Cytosine Deaminase; EC 3.5.4.5 / Cytidine Deaminase
  •  go-up   go-down


77. Teng Y, Xie X, Walker S, Rempala G, Kozlowski DJ, Mumm JS, Cowell JK: Knockdown of zebrafish Lgi1a results in abnormal development, brain defects and a seizure-like behavioral phenotype. Hum Mol Genet; 2010 Nov 15;19(22):4409-20
ZFIN. ZFIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Epilepsy is a common disorder, typified by recurrent seizures with underlying neurological disorders or disease.
  • High-dose Lgi1a morphants have morphological defects which persist into adult stages that are typified by smaller brains and eyes and abnormalities in tail shape, and display hyperactive swimming behaviors.

  • MedlinePlus Health Information. consumer health - Seizures.
  • Gene Ontology. gene/protein/disease-specific - Gene Ontology annotations from this paper .
  • SciCrunch. ZFIN: Data: Gene Expression .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Neurology. 2007 Sep 18;69(12):1298-300 [17875918.001]
  • [Cites] Epilepsia. 2007 Jun;48(6):1151-7 [17521353.001]
  • [Cites] Exp Neurol. 2008 Jun;211(2):480-8 [18402939.001]
  • [Cites] J Pharmacol Toxicol Methods. 2008 May-Jun;57(3):176-87 [18337127.001]
  • [Cites] MMWR Surveill Summ. 2008 Aug 8;57(6):1-20 [18685554.001]
  • [Cites] Hum Mol Genet. 2009 Apr 15;18(R1):R107-12 [19297397.001]
  • [Cites] Hum Mutat. 2009 Apr;30(4):530-6 [19191227.001]
  • [Cites] Epilepsy Res. 2007 Jun;75(1):18-28 [17485198.001]
  • [Cites] Mamm Genome. 2007 May;18(5):328-37 [17565425.001]
  • [Cites] Nat Med. 2009 Oct;15(10):1208-14 [19701204.001]
  • [Cites] Genomics. 2010 Feb;95(2):93-100 [19835947.001]
  • [Cites] Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3799-804 [20133599.001]
  • [Cites] Hum Mol Genet. 2010 May 1;19(9):1702-11 [20130004.001]
  • [Cites] Am J Med Genet. 2001 Summer;106(2):146-59 [11579435.001]
  • [Cites] Nat Genet. 2002 Mar;30(3):335-41 [11810107.001]
  • [Cites] Epilepsia. 2003 Oct;44(10):1289-97 [14510822.001]
  • [Cites] Annu Rev Neurosci. 2003;26:599-625 [14527270.001]
  • [Cites] Arch Neurol. 2003 Nov;60(11):1546-51 [14623726.001]
  • [Cites] Curr Opin Neurol. 2004 Apr;17(2):147-53 [15021241.001]
  • [Cites] Nat Genet. 1995 May;10(1):56-60 [7647791.001]
  • [Cites] Dev Dyn. 1995 Jul;203(3):253-310 [8589427.001]
  • [Cites] Oncogene. 1998 Dec 3;17(22):2873-81 [9879993.001]
  • [Cites] Ann Neurol. 1999 Feb;45(2):182-8 [9989620.001]
  • [Cites] Neuroscience. 2005;131(3):759-68 [15730879.001]
  • [Cites] Hum Mol Genet. 2005 Jun 15;14(12):1613-20 [15857855.001]
  • [Cites] Mol Biol Evol. 2005 Nov;22(11):2209-16 [16014869.001]
  • [Cites] Epilepsia. 2005;46 Suppl 10:59-60 [16359474.001]
  • [Cites] Neuron. 2006 Mar 2;49(5):697-706 [16504945.001]
  • [Cites] Science. 2006 Sep 22;313(5794):1792-5 [16990550.001]
  • [Cites] Hum Mol Genet. 2006 Dec 1;15(23):3436-45 [17067999.001]
  • [Cites] Nat Rev Genet. 2007 May;8(5):353-67 [17440532.001]
  • [Cites] Biochem Biophys Res Commun. 2007 Jun 29;358(2):521-7 [17493584.001]
  • [Cites] Development. 2008 May;135(10):1735-43 [18403413.001]
  • (PMID = 20819949.001).
  • [ISSN] 1460-2083
  • [Journal-full-title] Human molecular genetics
  • [ISO-abbreviation] Hum. Mol. Genet.
  • [Language] ENG
  • [Grant] United States / NICHD NIH HHS / HD / HD053767; United States / NIMH NIH HHS / MH / MH083614; United States / NINDS NIH HHS / NS / NS046706
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Lgi1a protein, zebrafish; 0 / Nerve Tissue Proteins; 0 / Oligonucleotides, Antisense; 0 / Zebrafish Proteins
  • [Other-IDs] NLM/ PMC2957326
  •  go-up   go-down


78. Yatsenko SA, Brundage EK, Roney EK, Cheung SW, Chinault AC, Lupski JR: Molecular mechanisms for subtelomeric rearrangements associated with the 9q34.3 microdeletion syndrome. Hum Mol Genet; 2009 Jun 1;18(11):1924-36
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In contrast to genomic disorders that are often associated with recurrent rearrangements, breakpoints involving the 9q34.3 subtelomere region are highly variable.

  • Genetics Home Reference. consumer health - chromosome 9.
  • Genetics Home Reference. consumer health - EHMT1 gene.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Med Genet. 2006 Oct;43(10):822-8 [16284256.001]
  • [Cites] PLoS Genet. 2006 Apr;2(4):e48 [16604155.001]
  • [Cites] Am J Med Genet C Semin Med Genet. 2007 Nov 15;145C(4):327-34 [17910073.001]
  • [Cites] Prenat Diagn. 2007 Dec;27(12):1112-7 [17849500.001]
  • [Cites] Genome Res. 2007 Dec;17(12):1783-6 [17989245.001]
  • [Cites] Cell. 2007 Dec 28;131(7):1235-47 [18160035.001]
  • [Cites] Am J Med Genet A. 2008 Sep 1;146A(17):2242-51 [18663743.001]
  • [Cites] Eur J Med Genet. 2008 Sep-Oct;51(5):479-87 [18547887.001]
  • [Cites] PLoS Genet. 2009 Jan;5(1):e1000327 [19180184.001]
  • [Cites] Am J Hum Genet. 2006 Aug;79(2):370-7 [16826528.001]
  • [Cites] Am J Hum Genet. 2000 Sep;67(3):610-22 [10924407.001]
  • [Cites] Eur J Hum Genet. 2000 Oct;8(10):764-70 [11039576.001]
  • [Cites] Trends Genet. 2002 Feb;18(2):74-82 [11818139.001]
  • [Cites] Nat Genet. 2002 Jul;31(3):241-7 [12053178.001]
  • [Cites] Am J Hum Genet. 2003 May;72(5):1200-12 [12687501.001]
  • [Cites] Nucleic Acids Res. 2003 Jul 1;31(13):3406-15 [12824337.001]
  • [Cites] Chromosome Res. 2004;12(2):133-41 [15053483.001]
  • [Cites] Am J Med Genet A. 2004 Apr 30;126A(3):278-83 [15054842.001]
  • [Cites] J Hum Genet. 2004;49(8):440-4 [15258833.001]
  • [Cites] Proc Natl Acad Sci U S A. 1988 Sep;85(18):6622-6 [3413114.001]
  • [Cites] Cell. 1990 Oct 5;63(1):119-32 [2208276.001]
  • [Cites] Am J Hum Genet. 1994 Sep;55(3):505-12 [7521575.001]
  • [Cites] Nat Genet. 1995 Feb;9(2):132-40 [7719339.001]
  • [Cites] Hum Mol Genet. 1996 Aug;5(8):1163-9 [8842736.001]
  • [Cites] Am J Hum Genet. 1997 Jan;60(1):113-20 [8981954.001]
  • [Cites] Hum Mol Genet. 1997 Aug;6(8):1305-13 [9259277.001]
  • [Cites] Trends Genet. 1998 Oct;14(10):417-22 [9820031.001]
  • [Cites] Am J Hum Genet. 1999 Nov;65(5):1387-95 [10521304.001]
  • [Cites] J Biol Chem. 2004 Nov 12;279(46):47411-4 [15326170.001]
  • [Cites] J Med Genet. 2005 Apr;42(4):328-35 [15805160.001]
  • [Cites] Crit Rev Biochem Mol Biol. 2007 Jul-Aug;42(4):271-83 [17687669.001]
  • (PMID = 19293338.001).
  • [ISSN] 1460-2083
  • [Journal-full-title] Human molecular genetics
  • [ISO-abbreviation] Hum. Mol. Genet.
  • [Language] ENG
  • [Grant] United States / NICHD NIH HHS / HD / HD24064; United States / NICHD NIH HHS / HD / P01 HD39420
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2678925
  •  go-up   go-down


79. Ishikawa H, Reierstad S, Demura M, Rademaker AW, Kasai T, Inoue M, Usui H, Shozu M, Bulun SE: High aromatase expression in uterine leiomyoma tissues of African-American women. J Clin Endocrinol Metab; 2009 May;94(5):1752-6
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CONTEXT: Symptomatic uterine leiomyoma is associated with irregular uterine bleeding, anemia, and recurrent pregnancy loss.

  • Genetic Alliance. consumer health - Uterine Fibroid.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • MedlinePlus Health Information. consumer health - Uterine Fibroids.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Endocrinology. 2000 Oct;141(10):3852-61 [11014242.001]
  • [Cites] Fertil Steril. 2007 Apr;87(4):725-36 [17430732.001]
  • [Cites] Obstet Gynecol. 2002 Feb;99(2):229-34 [11814502.001]
  • [Cites] J Clin Endocrinol Metab. 2002 Jun;87(6):2540-8 [12050211.001]
  • [Cites] Fertil Steril. 2004 Jan;81(1):132-6 [14711556.001]
  • [Cites] J Clin Endocrinol Metab. 1994 Mar;78(3):736-43 [8126151.001]
  • [Cites] Obstet Gynecol. 1997 Dec;90(6):967-73 [9397113.001]
  • [Cites] J Clin Endocrinol Metab. 2007 May;92(5):1979-82 [17341559.001]
  • [Cites] Fertil Steril. 2007 Jun;87(6):1399-412 [17307170.001]
  • [Cites] Obstet Gynecol. 2007 Sep;110(3):643-9 [17766612.001]
  • [Cites] J Clin Endocrinol Metab. 2008 Mar;93(3):981-91 [18182446.001]
  • [Cites] Best Pract Res Clin Obstet Gynaecol. 2008 Aug;22(4):589-601 [18373954.001]
  • [Cites] Fertil Steril. 2009 Jan;91(1):240-3 [18249392.001]
  • [Cites] Reprod Sci. 2008 Dec;15(10):1044-53 [18955734.001]
  • [Cites] Pharmacol Rev. 2005 Sep;57(3):359-83 [16109840.001]
  • [Cites] Am J Obstet Gynecol. 2006 Oct;195(4):955-64 [16723104.001]
  • [Cites] Obstet Gynecol. 2006 Dec;108(6):1381-7 [17138770.001]
  • [Cites] Lancet. 2001 Jan 27;357(9252):293-8 [11214143.001]
  • (PMID = 19240151.001).
  • [ISSN] 1945-7197
  • [Journal-full-title] The Journal of clinical endocrinology and metabolism
  • [ISO-abbreviation] J. Clin. Endocrinol. Metab.
  • [Language] ENG
  • [Grant] United States / NICHD NIH HHS / HD / R01 HD046260; United States / NICHD NIH HHS / HD / HD46260
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Aromatase Inhibitors; 0 / Estrogen Receptor alpha; 0 / Estrogen Receptor beta; 0 / Progestins; 0 / RNA, Messenger; 0 / Receptors, Progesterone; EC 1.14.14.1 / Aromatase
  • [Other-IDs] NLM/ PMC2684481
  •  go-up   go-down


80. Van Dillen LR, Gombatto SP, Collins DR, Engsberg JR, Sahrmann SA: Symmetry of timing of hip and lumbopelvic rotation motion in 2 different subgroups of people with low back pain. Arch Phys Med Rehabil; 2007 Mar;88(3):351-60
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PARTICIPANTS: Subjects were 39 people (23 men, 16 women; mean age, 28.1+/-8.0 y) with chronic or recurrent LBP who regularly participated in a rotation-related sport and associated their LBP symptoms with participation.
  • [MeSH-minor] Adult. Biomechanical Phenomena. Cross-Sectional Studies. Female. Humans. Imaging, Three-Dimensional. Lower Extremity / physiology. Male. Models, Biological

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17321829.001).
  • [ISSN] 0003-9993
  • [Journal-full-title] Archives of physical medicine and rehabilitation
  • [ISO-abbreviation] Arch Phys Med Rehabil
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / 1-K01HD-01226-05
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


81. Wang RY, Jones JR, Chen S, Rogers RC, Friez MJ, Schwartz CE, Graham JM Jr: A previously unreported mutation in a Currarino syndrome kindred. Am J Med Genet A; 2006 Sep 15;140(18):1923-30
SciCrunch. Clinical Genomic Database: Data: Gene Annotation .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Sacral malformation, presacral mass, and anorectal malformations comprise the classic triad, but other common symptoms and malformations include neonatal-onset bowel obstruction, chronic constipation, recurrent perianal sepsis, renal/urinary tract anomalies, female internal genital anomalies, tethered spinal cord, and anterior meningocele.
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Humans. Infant. Middle Aged. Pedigree. Syndrome

  • SciCrunch. OMIM: Data: Gene Annotation .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16906559.001).
  • [ISSN] 1552-4825
  • [Journal-full-title] American journal of medical genetics. Part A
  • [ISO-abbreviation] Am. J. Med. Genet. A
  • [Language] eng
  • [Grant] United States / NIGMS NIH HHS / GM / GM08243; United States / NICHD NIH HHS / HD / HD22657-11
  • [Publication-type] Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Homeodomain Proteins; 0 / MNX1 protein, human; 0 / Transcription Factors
  •  go-up   go-down


82. Busse ME, Wiles CM, Rosser AE: Mobility and falls in people with Huntington's disease. J Neurol Neurosurg Psychiatry; 2009 Jan;80(1):88-90
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mobility and falls in people with Huntington's disease.
  • OBJECTIVE: The aim of this study was to estimate the frequency of falls in people with Huntington's disease (HD) and make a preliminary assessment of tools appropriate for assessing the risk of falling.
  • SUBJECTS: 24 people with HD.
  • Unified Huntington Disease Rating Scale (UHDRS) motor, Functional Assessment Scale (FAS), Independence Scale (IS) and Total Functional Capacity (TFC) scores were obtained as well as data about falls and stumbles.
  • Differences between "recurrent fallers" (>or=2 falls/year) and "non-fallers" (<or=1 fall/year) for the range of outcome measures were investigated and probabilities calculated.
  • RESULTS: Mean (SD) age (years) of people with HD (n = 24) tested was 56.6 (11.7) and BMI (kg/m(2)) 24.7 (5.5).
  • Recurrent fallers walked less (p<0.01) and slower than non-fallers.
  • People with HD had increased risk of falls if TUG scores were >or=14 s or BBS scores <or=40.
  • CONCLUSION: A high proportion of HD patients have recurrent falls, and the BBS and TUG appear to be useful in falls risk assessment.
  • [MeSH-major] Accidental Falls / statistics & numerical data. Huntington Disease / epidemiology. Huntington Disease / physiopathology. Motor Activity
  • [MeSH-minor] Adult. Aged. Disability Evaluation. Female. Humans. Logistic Models. Male. Middle Aged. Postural Balance. Risk Factors

  • MedlinePlus Health Information. consumer health - Falls.
  • MedlinePlus Health Information. consumer health - Huntington's Disease.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19091714.001).
  • [ISSN] 1468-330X
  • [Journal-full-title] Journal of neurology, neurosurgery, and psychiatry
  • [ISO-abbreviation] J. Neurol. Neurosurg. Psychiatr.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


83. Lovely LP, Fazleabas AT, Fritz MA, McAdams DG, Lessey BA: Prevention of endometrial apoptosis: randomized prospective comparison of human chorionic gonadotropin versus progesterone treatment in the luteal phase. J Clin Endocrinol Metab; 2005 Apr;90(4):2351-6
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The clinical utility of these findings includes a rational use of luteal-phase support for treatment of women with infertility and/or recurrent pregnancy loss.
  • [MeSH-minor] Adult. DNA Fragmentation. Female. Humans. In Situ Nick-End Labeling. Luteal Phase. Prospective Studies. Proto-Oncogene Proteins c-bcl-2 / analysis. bcl-2-Associated X Protein. bcl-X Protein

  • Hazardous Substances Data Bank. PROGESTERONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15671112.001).
  • [ISSN] 0021-972X
  • [Journal-full-title] The Journal of clinical endocrinology and metabolism
  • [ISO-abbreviation] J. Clin. Endocrinol. Metab.
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / HD 34824; United States / NICHD NIH HHS / HD / HD 42280; United States / NICHD NIH HHS / HD / U54 HD-30476
  • [Publication-type] Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / BAX protein, human; 0 / BCL2L1 protein, human; 0 / Chorionic Gonadotropin; 0 / Proto-Oncogene Proteins c-bcl-2; 0 / bcl-2-Associated X Protein; 0 / bcl-X Protein; 4G7DS2Q64Y / Progesterone
  •  go-up   go-down


84. Engenhart-Cabillic R, Farhoud A, Sure U, Heinze S, Henzel M, Mennel HD, Bertalanffy H: Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment. Strahlenther Onkol; 2006 Nov;182(11):641-6
Genetic Alliance. consumer health - Meningioma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Patients with atypical meningioma received radiotherapy only for the recurrent disease.
  • By comparing the proliferation rate in four cases with atypical meningioma operated twice, the recurrent tumor had a higher proliferation rate than the first tumor in three cases.
  • CONCLUSION: Considering the higher rate of recurrence in aggressive meningiomas even after radical surgical excision and the possibility that the recurrent tumor is more aggressive than the original one, surgery should be combined with postoperative fractionated radiotherapy to improve local tumor control.
  • [MeSH-minor] Adult. Age Factors. Aged. Biomarkers. Combined Modality Therapy. Dose Fractionation. Female. Follow-Up Studies. Humans. Ki-67 Antigen / metabolism. Male. Meninges / pathology. Microsurgery. Middle Aged. Neoplasm Recurrence, Local. Practice Guidelines as Topic. Prognosis. Radiotherapy Dosage. Sex Factors. Stereotaxic Techniques. Survival Analysis. Time Factors. World Health Organization

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17072521.001).
  • [ISSN] 0179-7158
  • [Journal-full-title] Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]
  • [ISO-abbreviation] Strahlenther Onkol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biomarkers; 0 / Ki-67 Antigen
  •  go-up   go-down


85. Barnes TW, Vassallo R, Tazelaar HD, Hartman TE, Ryu JH: Diffuse bronchiolar disease due to chronic occult aspiration. Mayo Clin Proc; 2006 Feb;81(2):172-6
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diffuse bronchiolar disease due to chronic occult aspiration.
  • OBJECTIVE: To describe clinical, radiological, and histopathologic features of diffuse bronchiolar disease due to chronic occult aspiration.
  • PATIENTS AND METHODS: We identified 4 patients encountered from July 2001 to January 2004 who had persistent respiratory symptoms and lung Infiltrates and who were eventually diagnosed by surgical lung biopsy as having diffuse bronchiolar disease due to chronic occult aspiration.
  • CONCLUSION: Diffuse bronchiolar disease likely represents an underrecognized form of aspiration-related lung disease and may occur in relatively young Individuals without symptoms suggestive of recurrent aspiration.
  • [MeSH-minor] Adult. Female. Gastroesophageal Reflux / complications. Humans. Male. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16471070.001).
  • [ISSN] 0025-6196
  • [Journal-full-title] Mayo Clinic proceedings
  • [ISO-abbreviation] Mayo Clin. Proc.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


86. Clyne OJ, O'Sullivan O, Flood HD: Pubovaginal sling for urodynamic stress incontinence: effect on patient quality of life. Ir Med J; 2005 Mar;98(3):75-7
MedlinePlus Health Information. consumer health - Pelvic Support Problems.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • At 6 months 95% of the subjects remained dry, 3 complained of recurrent USI, 7 complained of urgency and 1 of UI.
  • [MeSH-minor] Adolescent. Adult. Female. Humans. Length of Stay. Middle Aged. Prospective Studies. Quality of Life. Treatment Outcome. Urodynamics

  • Genetic Alliance. consumer health - Incontinence.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15869063.001).
  • [ISSN] 0332-3102
  • [Journal-full-title] Irish medical journal
  • [ISO-abbreviation] Ir Med J
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] Ireland
  •  go-up   go-down


87. Hahn MK, Blackford JU, Haman K, Mazei-Robison M, English BA, Prasad HC, Steele A, Hazelwood L, Fentress HM, Myers R, Blakely RD, Sanders-Bush E, Shelton R: Multivariate permutation analysis associates multiple polymorphisms with subphenotypes of major depression. Genes Brain Behav; 2008 Jun;7(4):487-95
Hazardous Substances Data Bank. Norepinephrine .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Unipolar major depressive disorder (MDD) is a prevalent, disabling condition with multiple genetic and environmental factors impacting disease risk.
  • This within-disease design requires both a well-phenotyped cohort and a robust statistical approach that retains power with multiple tests of genetic association.
  • MPT analyses show significant associations of the norepinephrine transporter (NET, SLC6A2) -182 T/C (rs2242446) with recurrent depression [odds ratio, OR = 4.15 (1.91-9.02)], NET -3081 A/T (rs28386840) with increase in appetite [OR = 3.58 (1.53-8.39)] and the presynaptic choline transporter (CHT, SLC5A7) Ile89Val (rs1013940) with HAM-D-17 total score {i.e. overall depression severity [OR = 2.74 (1.05-7.18)]}.

  • Genetic Alliance. consumer health - Depression.
  • Genetic Alliance. consumer health - Major depressive disorder.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Affect Disord. 1999 Oct;55(2-3):149-57 [10628884.001]
  • [Cites] Genes Brain Behav. 2007 Jul;6(5):411-24 [17010154.001]
  • [Cites] J Abnorm Psychol. 2000 Feb;109(1):145-9 [10740946.001]
  • [Cites] Am J Psychiatry. 2000 Oct;157(10):1552-62 [11007705.001]
  • [Cites] Curr Psychiatry Rep. 2000 Apr;2(2):165-9 [11122950.001]
  • [Cites] Mol Psychiatry. 2001 Mar;6(2):239-42 [11317230.001]
  • [Cites] Neuropsychopharmacology. 2002 Apr;26(4):489-93 [11927173.001]
  • [Cites] Am J Med Genet. 2002 May 8;114(4):413-22 [11992563.001]
  • [Cites] Neuropsychobiology. 2002;45(4):182-5 [12097806.001]
  • [Cites] Biol Psychiatry. 2002 Sep 15;52(6):457-77 [12361664.001]
  • [Cites] Neuropsychopharmacology. 2002 Nov;27(5):869-73 [12431861.001]
  • [Cites] J Biol Chem. 2002 Nov 22;277(47):45315-22 [12237312.001]
  • [Cites] Am J Med Genet B Neuropsychiatr Genet. 2003 May 15;119B(1):118-30 [12707949.001]
  • [Cites] Ann Med. 2003;35(2):122-34 [12795340.001]
  • [Cites] J Psychiatr Res. 2003 Sep-Oct;37(5):375-86 [12849930.001]
  • [Cites] Science. 2003 Jul 18;301(5631):386-9 [12869766.001]
  • [Cites] Mol Psychiatry. 2003 Nov;8(11):942-6 [14593433.001]
  • [Cites] J Affect Disord. 2003 Dec;77(3):273-5 [14612228.001]
  • [Cites] Pharmacopsychiatry. 2003 Nov;36 Suppl 3:S195-202 [14677079.001]
  • [Cites] Neuropsychobiology. 2004;49(4):174-7 [15118352.001]
  • [Cites] Biol Psychiatry. 2004 May 15;55(10):1023-30 [15121487.001]
  • [Cites] Arch Gen Psychiatry. 2004 May;61(5):468-74 [15123491.001]
  • [Cites] Hum Mol Genet. 2004 Sep 1;13(17):1903-11 [15229186.001]
  • [Cites] Am J Psychiatry. 2004 Sep;161(9):1575-80 [15337646.001]
  • [Cites] J Clin Exp Neuropsychol. 2004 May;26(3):320-31 [15512923.001]
  • [Cites] Prog Neuropsychopharmacol Biol Psychiatry. 1983;7(2-3):297-307 [6684317.001]
  • [Cites] Psychiatr Dev. 1983 Winter;1(4):387-418 [6371802.001]
  • [Cites] Arch Gen Psychiatry. 1988 Aug;45(8):742-7 [3395203.001]
  • [Cites] Br J Psychiatry. 1990 Nov;157:645-55 [2279201.001]
  • [Cites] Psychopharmacol Bull. 1991;27(1):17-22 [1862201.001]
  • [Cites] Acta Psychiatr Scand. 1992 Nov;86(5):371-8 [1485527.001]
  • [Cites] Science. 1996 Nov 1;274(5288):740-3 [8966556.001]
  • [Cites] Psychol Med. 1997 Jan;27(1):107-17 [9122291.001]
  • [Cites] Nature. 1997 May 1;387(6628):94-7 [9139828.001]
  • [Cites] Lancet. 1997 May 24;349(9064):1498-504 [9167458.001]
  • [Cites] J Pers Disord. 1997 Fall;11(3):279-84 [9348491.001]
  • [Cites] Mol Psychiatry. 1998 Mar;3(2):162-8 [9577841.001]
  • [Cites] Arch Gen Psychiatry. 1999 Apr;56(4):322-7 [10197826.001]
  • [Cites] Psychiatry Res. 1999 Jul 30;87(1):1-5 [10512149.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62 [14399272.001]
  • [Cites] Neuropsychobiology. 2004;50(4):301-4 [15539861.001]
  • [Cites] J Clin Psychiatry. 2006 Feb;67(2):179-84 [16566611.001]
  • [Cites] Am J Hum Genet. 2006 May;78(5):815-26 [16642437.001]
  • [Cites] Bioinformatics. 2006 Sep 15;22(18):2244-8 [16870938.001]
  • [Cites] Arch Gen Psychiatry. 2006 Oct;63(10):1121-9 [17015814.001]
  • [Cites] Physiol Behav. 2006 Nov 30;89(4):490-500 [16887153.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19164-9 [17146058.001]
  • [Cites] J Neurosci. 2007 Jan 17;27(3):684-91 [17234600.001]
  • [Cites] Trends Pharmacol Sci. 2007 Mar;28(3):122-7 [17275930.001]
  • [Cites] Mol Psychiatry. 2000 Jan;5(1):32-8 [10673766.001]
  • (PMID = 18081710.001).
  • [ISSN] 1601-183X
  • [Journal-full-title] Genes, brain, and behavior
  • [ISO-abbreviation] Genes Brain Behav.
  • [Language] ENG
  • [Grant] United States / NIMH NIH HHS / MH / MH052339-03A1; United States / NIMH NIH HHS / MH / MH034007-20; United States / NIMH NIH HHS / MH / K01 MH076018; United States / NIGMS NIH HHS / GM / GM069313-01; United States / NIMH NIH HHS / MH / R01 MH052339; United States / NIGMS NIH HHS / GM / F31 GM069313-01; United States / NIMH NIH HHS / MH / MH012896-01; United States / NIMH NIH HHS / MH / R01 MH073630; United States / NIMH NIH HHS / MH / MH34007; United States / NIMH NIH HHS / MH / R37 MH034007-20; United States / NIMH NIH HHS / MH / MH073630-01A1; United States / NHLBI NIH HHS / HL / P01 HL056693-03; United States / NIMH NIH HHS / MH / R01 MH052339-03A1; United States / NICHD NIH HHS / HD / P30 HD015052-21; United States / NIGMS NIH HHS / GM / GM069313; United States / NICHD NIH HHS / HD / P30 HD015052; United States / NHLBI NIH HHS / HL / HL56693; United States / NIMH NIH HHS / MH / MH076018; United States / NIMH NIH HHS / MH / MH12896; United States / NIMH NIH HHS / MH / MH01741; United States / NIGMS NIH HHS / GM / GM069313-02; United States / NIMH NIH HHS / MH / K24 MH001741-01; United States / NIMH NIH HHS / MH / MH067472-02; United States / NIMH NIH HHS / MH / MH012896-02; United States / NIMH NIH HHS / MH / K24 MH001741; United States / NIGMS NIH HHS / GM / F31 GM069313; United States / NIMH NIH HHS / MH / F32 MH012896; United States / NIMH NIH HHS / MH / MH073630; United States / NCRR NIH HHS / RR / RR-00095; United States / NHLBI NIH HHS / HL / P01 HL056693; United States / NIMH NIH HHS / MH / F31 MH067472-01; United States / NICHD NIH HHS / HD / HD015052-21; United States / NCRR NIH HHS / RR / M01 RR000095; United States / NIGMS NIH HHS / GM / F31 GM069313-02; United States / NIMH NIH HHS / MH / MH001741-01; United States / NIMH NIH HHS / MH / R37 MH034007; United States / NIMH NIH HHS / MH / F32 MH012896-02; United States / NIMH NIH HHS / MH / R01 MH034007; United States / NIMH NIH HHS / MH / R01 MH073630-01A1; United States / NICHD NIH HHS / HD / HD15052; United States / NIMH NIH HHS / MH / MH52339; United States / NIMH NIH HHS / MH / MH067472; United States / NIMH NIH HHS / MH / F31 MH067472; United States / NIMH NIH HHS / MH / F32 MH012896-01; United States / NIMH NIH HHS / MH / F31 MH067472-02
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Membrane Transport Proteins; 0 / Norepinephrine Plasma Membrane Transport Proteins; 0 / choline transporter; N9YNS0M02X / Acetylcholine; X4W3ENH1CV / Norepinephrine
  • [Other-IDs] NLM/ NIHMS71629; NLM/ PMC2670227
  •  go-up   go-down


88. Graham JM Jr, Clark RD, Moeschler JB, Rogers RC: Behavioral features in young adults with FG syndrome (Opitz-Kaveggia syndrome). Am J Med Genet C Semin Med Genet; 2010 Nov 15;154C(4):477-85
SciCrunch. Clinical Genomic Database: Data: Gene Annotation .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We present case studies of five adult males who were previously published with the clinical diagnosis of FG syndrome and then subsequently proven by Risheg et al.
  • [Risheg et al. (2007); Nature Genetics 39:451-453] to have the recurrent p.R961W mutation.
  • They remain impulsive and can have aggressive outbursts when making the transition to adult life, but these challenges can be managed, as demonstrated by these clinical histories.

  • Genetic Alliance. consumer health - FG Syndrome.
  • Genetic Alliance. consumer health - Opitz syndrome.
  • Genetic Alliance. consumer health - Young syndrome.
  • MedlinePlus Health Information. consumer health - Self-harm.
  • COS Scholar Universe. author profiles.
  • The Weizmann Institute of Science GeneCards and MalaCards databases. gene/protein/disease-specific - MalaCards for fg syndrome .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2010 Wiley-Liss, Inc.
  • [Cites] Z Kinderheilkd. 1974 Apr 8;117(1):1-18 [4365204.001]
  • [Cites] Am J Med Genet A. 2007 Jun 1;143A(11):1198-203 [17497714.001]
  • [Cites] Nat Genet. 2007 Apr;39(4):451-3 [17334363.001]
  • [Cites] Am J Med Genet A. 2008 Dec 1;146A(23):3011-7 [18973276.001]
  • [Cites] J Med Genet. 2009 Jan;46(1):9-13 [18805826.001]
  • [Cites] Genet Med. 2009 Nov;11(11):769-75 [19938245.001]
  • [Cites] Ment Retard Dev Disabil Res Rev. 2004;10(1):42-8 [14994287.001]
  • [Cites] Am J Med Genet. 1999 Aug 27;85(5):470-5 [10405444.001]
  • [Cites] Am J Med Genet. 1998 Nov 2;80(2):145-56 [9805132.001]
  • [Cites] J Commun Disord. 1993 Jun;26(2):83-100 [7688382.001]
  • (PMID = 20981778.001).
  • [ISSN] 1552-4876
  • [Journal-full-title] American journal of medical genetics. Part C, Seminars in medical genetics
  • [ISO-abbreviation] Am J Med Genet C Semin Med Genet
  • [Language] ENG
  • [Grant] United States / NCRR NIH HHS / RR / M01-RR00425; United States / NICHD NIH HHS / HD / P01 HD022657; United States / NICHD NIH HHS / HD / HD22657; United States / NIGMS NIH HHS / GM / T32 GM008243; United States / NICHD NIH HHS / HD / R01 HD026202; United States / NIGMS NIH HHS / GM / 5-T32-GM08243; United States / NICHD NIH HHS / HD / HD26202; United States / NCRR NIH HHS / RR / M01 RR000425; United States / NIGMS NIH HHS / GM / T32 GM008243-16
  • [Publication-type] Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / MED12 protein, human; 0 / Mediator Complex
  • [Other-IDs] NLM/ NIHMS236069; NLM/ PMC2967396
  •  go-up   go-down


89. Scharfman HE, Malthankar-Phatak GH, Friedman D, Pearce P, McCloskey DP, Harden CL, Maclusky NJ: A rat model of epilepsy in women: a tool to study physiological interactions between endocrine systems and seizures. Endocrinology; 2009 Sep;150(9):4437-42
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The muscarinic convulsant pilocarpine was used to elicit status epilepticus (SE) in adult female Sprague Dawley rats.
  • Mortality, morbidity, estrous cyclicity, and the ultimate success of the procedure (i.e. induction of recurrent, spontaneous seizures) were monitored.

  • MedlinePlus Health Information. consumer health - Epilepsy.
  • MedlinePlus Health Information. consumer health - Seizures.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. Pentobarbital .
  • Hazardous Substances Data Bank. RALOXIFENE .
  • Hazardous Substances Data Bank. PILOCARPINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Epilepsia. 1999 Dec;40(12):1688-96 [10612331.001]
  • [Cites] Ann Neurol. 2008 Dec;64(6):687-97 [19107990.001]
  • [Cites] Drugs. 2000 Aug;60(2):379-411 [10983739.001]
  • [Cites] Neuropsychopharmacology. 2001 Aug;25(2):242-57 [11425508.001]
  • [Cites] Neuroscience. 2002;111(1):71-81 [11955713.001]
  • [Cites] Biol Reprod. 2002 Nov;67(5):1379-85 [12390866.001]
  • [Cites] Epilepsy Res. 2002 Dec;52(2):73-7 [12458023.001]
  • [Cites] Ann Neurol. 2003 Mar;53(3):288-91 [12601696.001]
  • [Cites] Endocrine. 2003 Jun;21(1):17-26 [12777699.001]
  • [Cites] Neurology. 2003 Sep 1;61(6 Suppl 2):S2-15 [14504304.001]
  • [Cites] J Neurosci. 2003 Dec 17;23(37):11641-52 [14684866.001]
  • [Cites] Exp Neurol. 2004 Jan;185(1):63-80 [14697319.001]
  • [Cites] J Neurobiol. 2004 Nov;61(2):209-21 [15389604.001]
  • [Cites] Electroencephalogr Clin Neurophysiol. 1972 Mar;32(3):281-94 [4110397.001]
  • [Cites] Neuroendocrinology. 1984 Nov;39(5):476-80 [6542625.001]
  • [Cites] Braz J Med Biol Res. 1987;20(6):829-32 [3455264.001]
  • [Cites] Epilepsy Res. 1993 Feb;14(2):149-59 [7681003.001]
  • [Cites] Epilepsia. 1997 Oct;38(10):1082-8 [9579954.001]
  • [Cites] Epilepsy Res. 1998 Sep;32(1-2):266-74 [9761326.001]
  • [Cites] Horm Metab Res. 1998 Aug;30(8):500-3 [9761379.001]
  • [Cites] Brain Res. 1999 Aug 14;838(1-2):136-50 [10446326.001]
  • [Cites] J Endocrinol. 1956 Jul;13(4):399-404 [13345955.001]
  • [Cites] Epilepsy Res. 2004 Dec;62(2-3):99-118 [15579299.001]
  • [Cites] Drug Saf. 2005;28(8):721-30 [16048357.001]
  • [Cites] Fertil Steril. 2005 Oct;84 Suppl 2:1228-34 [16210015.001]
  • [Cites] Exp Neurol. 2005 Nov;196(1):73-86 [16084511.001]
  • [Cites] Epilepsia. 2006 Sep;47(9):1423-40 [16981857.001]
  • [Cites] J Neurosci. 2006 Nov 1;26(44):11342-6 [17079662.001]
  • [Cites] J Neurosci. 2007 Feb 7;27(6):1239-46 [17287497.001]
  • [Cites] Pharmacol Ther. 2007 Oct;116(1):58-76 [17512983.001]
  • [Cites] J Neurosci. 2007 Dec 19;27(51):14012-22 [18094240.001]
  • [Cites] Recent Pat CNS Drug Discov. 2008 Jun;3(2):128-37 [18537772.001]
  • [Cites] Headache. 2008 Jul;48 Suppl 2:S77-89 [18700946.001]
  • [Cites] J Neurosci Nurs. 1999 Dec;31(6):328-31 [10726240.001]
  • (PMID = 19443573.001).
  • [ISSN] 1945-7170
  • [Journal-full-title] Endocrinology
  • [ISO-abbreviation] Endocrinology
  • [Language] ENG
  • [Grant] United States / NINDS NIH HHS / NS / R56 NS037562; United States / NINDS NIH HHS / NS / R01 NS037562; United States / NICHD NIH HHS / HD / U10 HD047890; United States / NINDS NIH HHS / NS / NS 37562; United States / NICHD NIH HHS / HD / HD 047890
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anticonvulsants; 01MI4Q9DI3 / Pilocarpine; 4F86W47BR6 / Raloxifene Hydrochloride; I4744080IR / Pentobarbital
  • [Other-IDs] NLM/ PMC2736077
  •  go-up   go-down


90. Grobman WA, Lai Y, Landon MB, Spong CY, Leveno KJ, Rouse DJ, Varner MW, Moawad AH, Caritis SN, Harper M, Wapner RJ, Sorokin Y, Miodovnik M, Carpenter M, O'Sullivan MJ, Sibai BM, Langer O, Thorp JM, Ramin SM, Mercer BM, National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units Network (MFMU): Development of a nomogram for prediction of vaginal birth after cesarean delivery. Obstet Gynecol; 2007 Apr;109(4):806-12
Faculty of 1000. commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine. (subscription/membership/fee required).

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The prediction model is based on a multivariable logistic regression, including the variables of maternal age, body mass index, ethnicity, prior vaginal delivery, the occurrence of a VBAC, and a potentially recurrent indication for the cesarean delivery.
  • [MeSH-minor] Adolescent. Adult. Body Mass Index. Continental Population Groups. Female. Forecasting. Humans. Maternal Age. Pregnancy. Pregnancy Complications. ROC Curve. Retrospective Studies

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Obstet Gynecol. 2007 Apr;109(4):796-7 [17400837.001]
  • (PMID = 17400840.001).
  • [ISSN] 0029-7844
  • [Journal-full-title] Obstetrics and gynecology
  • [ISO-abbreviation] Obstet Gynecol
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / HD21410; United States / NICHD NIH HHS / HD / HD21414; United States / NICHD NIH HHS / HD / HD27860; United States / NICHD NIH HHS / HD / HD27861; United States / NICHD NIH HHS / HD / HD27869; United States / NICHD NIH HHS / HD / HD27905; United States / NICHD NIH HHS / HD / HD27915; United States / NICHD NIH HHS / HD / HD27917; United States / NICHD NIH HHS / HD / HD34116; United States / NICHD NIH HHS / HD / HD34122; United States / NICHD NIH HHS / HD / HD34136; United States / NICHD NIH HHS / HD / HD34208; United States / NICHD NIH HHS / HD / HD34210; United States / NICHD NIH HHS / HD / HD36801; United States / NICHD NIH HHS / HD / HD40485; United States / NICHD NIH HHS / HD / HD40500; United States / NICHD NIH HHS / HD / HD40512; United States / NICHD NIH HHS / HD / HD40544; United States / NICHD NIH HHS / HD / HD40545; United States / NICHD NIH HHS / HD / HD40560
  • [Publication-type] Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  •  go-up   go-down


91. Sibai B, Meis PJ, Klebanoff M, Dombrowski MP, Weiner SJ, Moawad AH, Northen A, Iams JD, Varner MW, Caritis SN, O'Sullivan MJ, Miodovnik M, Leveno KJ, Conway D, Wapner RJ, Carpenter M, Mercer B, Ramin SM, Thorp JM Jr, Peaceman AM, Gabbe S, Maternal Fetal Medicine Units Network of the National Institute of Child Health and Human Development: Plasma CRH measurement at 16 to 20 weeks' gestation does not predict preterm delivery in women at high-risk for preterm delivery. Am J Obstet Gynecol; 2005 Sep;193(3 Pt 2):1181-6
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • STUDY DESIGN: This is an analysis of data from a multicenter placebo-controlled trial designed to evaluate the role of 17 alpha hydroxyprogesterone caproate (17P) in the prevention of recurrent preterm birth.
  • CONCLUSION: A single measurement of corticotropin-releasing hormone at 16 to 20 weeks' gestation is not a good biomarker for recurrent preterm delivery in patients at high risk for this complication.
  • [MeSH-minor] Adult. Female. Humans. Predictive Value of Tests. Pregnancy. Pregnancy Trimester, Second

  • MedlinePlus Health Information. consumer health - Health Problems in Pregnancy.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16157134.001).
  • [ISSN] 0002-9378
  • [Journal-full-title] American journal of obstetrics and gynecology
  • [ISO-abbreviation] Am. J. Obstet. Gynecol.
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / HD21410; United States / NICHD NIH HHS / HD / HD21414; United States / NICHD NIH HHS / HD / HD27860; United States / NICHD NIH HHS / HD / HD27861; United States / NICHD NIH HHS / HD / HD27869; United States / NICHD NIH HHS / HD / HD27905; United States / NICHD NIH HHS / HD / HD27915; United States / NICHD NIH HHS / HD / HD27917; United States / NICHD NIH HHS / HD / HD34116; United States / NICHD NIH HHS / HD / HD34122; United States / NICHD NIH HHS / HD / HD34136; United States / NICHD NIH HHS / HD / HD34208; United States / NICHD NIH HHS / HD / HD34210; United States / NICHD NIH HHS / HD / HD36801; United States / NICHD NIH HHS / HD / HD40500; United States / NICHD NIH HHS / HD / HD40512; United States / NICHD NIH HHS / HD / HD40544; United States / NICHD NIH HHS / HD / HD40560
  • [Publication-type] Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 9015-71-8 / Corticotropin-Releasing Hormone
  •  go-up   go-down


92. Huang GS, Arend RC, Sakaris A, Hebert TM, Goldberg GL: Extragenital adenosarcoma: a case report, review of the literature, and management discussion. Gynecol Oncol; 2009 Dec;115(3):472-5
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • She underwent a second surgery for management of a high-grade bowel obstruction, due to pathologically confirmed recurrent intraperitoneal adenosarcoma.
  • A complete clinical response was achieved with liposomal doxorubicin, and the patient remains disease-free eighteen months after completion of chemotherapy.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19712965.001).
  • [ISSN] 1095-6859
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] ENG
  • [Grant] United States / NICHD NIH HHS / HD / K12 HD000849; United States / NICHD NIH HHS / HD / 5K12HD00849; United States / NCI NIH HHS / CA / L30 CA124342; United States / NCI NIH HHS / CA / CA124342-02; United States / NCI NIH HHS / CA / L30 CA124342-02
  • [Publication-type] Case Reports; Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS141852; NLM/ PMC4451226
  •  go-up   go-down


93. Peipert J, Redding CA, Blume J, Allsworth JE, Iannuccillo K, Lozowski F, Mayer K, Morokoff PJ, Rossi JS: Design of a stage-matched intervention trial to increase dual method contraceptive use (Project PROTECT). Contemp Clin Trials; 2007 Sep;28(5):626-37
ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The primary outcomes of this trial were 1) self-reported use of dual methods of contraception and 2) the biological outcomes of an unintended pregnancy or an incident or recurrent sexually transmitted disease.

  • MedlinePlus Health Information. consumer health - Birth Control.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17374567.001).
  • [ISSN] 1551-7144
  • [Journal-full-title] Contemporary clinical trials
  • [ISO-abbreviation] Contemp Clin Trials
  • [Language] ENG
  • [Grant] United States / NICHD NIH HHS / HD / R01 HD036663; United States / NICHD NIH HHS / HD / 1R01-HD36663-01; United States / NICHD NIH HHS / HD / K24 HD01298-03
  • [Publication-type] Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  •  go-up   go-down


94. Kim HJ, Park HY, Kim E, Lee KS, Kim KK, Choi BO, Kim SM, Bae JS, Lee SO, Chun JY, Park TJ, Cheong HS, Jo I, Shin HD: Common CYP7A1 promoter polymorphism associated with risk of neuromyelitis optica. Neurobiol Dis; 2010 Feb;37(2):349-55
Genetic Alliance. consumer health - Devic Disease.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Neuromyelitis optica (NMO) is a severe idiopathic inflammatory disease of the central nervous system primarily affecting the optic nerves and spinal cord.
  • In this study, we generated genome-wide SNP data from NMO patients and normal controls (53 cases and 240 controls), and followed up on the association signals with samples from a larger number of inflammatory demyelinating diseases, including NMO (n=93), multiple sclerosis (MS, n=71), idiopathic recurrent transverse myelitis (IRTM, n=57), and normal controls (n=240).
  • [MeSH-major] Cholesterol 7-alpha-Hydroxylase / genetics. Genetic Predisposition to Disease / genetics. Neuromyelitis Optica / genetics. Neuromyelitis Optica / metabolism. Polymorphism, Genetic / genetics. Promoter Regions, Genetic / genetics
  • [MeSH-minor] Adult. DNA Mutational Analysis. Female. Gene Dosage / genetics. Genetic Markers / genetics. Genome-Wide Association Study. Genotype. Humans. Male. Middle Aged. Multiple Sclerosis / genetics. Multiple Sclerosis / metabolism. Multiple Sclerosis / physiopathology. Myelitis, Transverse / genetics. Myelitis, Transverse / metabolism. Myelitis, Transverse / physiopathology. Optic Nerve / metabolism. Optic Nerve / pathology. Optic Nerve / physiopathology. Polymorphism, Single Nucleotide / genetics. Spinal Cord / metabolism. Spinal Cord / pathology. Spinal Cord / physiopathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19850125.001).
  • [ISSN] 1095-953X
  • [Journal-full-title] Neurobiology of disease
  • [ISO-abbreviation] Neurobiol. Dis.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Genetic Markers; EC 1.14.13.17 / Cholesterol 7-alpha-Hydroxylase
  •  go-up   go-down


95. Karadimas CL, Vu TH, Holve SA, Chronopoulou P, Quinzii C, Johnsen SD, Kurth J, Eggers E, Palenzuela L, Tanji K, Bonilla E, De Vivo DC, DiMauro S, Hirano M: Navajo neurohepatopathy is caused by a mutation in the MPV17 gene. Am J Hum Genet; 2006 Sep;79(3):544-8
SciCrunch. Clinical Genomic Database: Data: Gene Annotation .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Navajo neurohepatopathy (NNH) is an autosomal recessive disease that is prevalent among Navajo children in the southwestern United States.
  • The major clinical features are hepatopathy, peripheral neuropathy, corneal anesthesia and scarring, acral mutilation, cerebral leukoencephalopathy, failure to thrive, and recurrent metabolic acidosis with intercurrent infections.
  • Identification of a single missense mutation in patients with NNH confirms that the disease is probably due to a founder effect and extends the phenotypic spectrum associated with MPV17 mutations.


96. Gombatto SP, Collins DR, Sahrmann SA, Engsberg JR, Van Dillen LR: Patterns of lumbar region movement during trunk lateral bending in 2 subgroups of people with low back pain. Phys Ther; 2007 Apr;87(4):441-54
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • SUBJECTS: Participants were 44 people (28 men and 16 women; age [X+/-SD], 28.5+/-8.4 years) with chronic or recurrent LBP.
  • [MeSH-minor] Adult. Female. Humans. Male. Torsion Abnormality

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17374634.001).
  • [ISSN] 0031-9023
  • [Journal-full-title] Physical therapy
  • [ISO-abbreviation] Phys Ther
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / 1 K01HD01226-05; United States / NICHD NIH HHS / HD / 5 T32 HD07434-10
  • [Publication-type] Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


97. Rhee KJ, Kim KC, Shin HD, Kim YM: Revision using modified transglenoid reconstruction in recurred glenohumeral instability combined with anchor-induced arthropathy. Knee Surg Sports Traumatol Arthrosc; 2007 Dec;15(12):1494-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 25-year-old man presented with a history of pain and crepitus in the right shoulder; he had been previously treated with arthroscopic anterior stabilization using four metallic suture anchors for recurrent traumatic anterior instability 1 year earlier.
  • In this report, we present a patient with recurrent glenohumeral instability combined with anchor-induced arthropathy who was managed with modified arthroscopic transglenoid reconstruction following arthroscopic suture anchor retrieval.
  • [MeSH-minor] Adult. Arthroscopy. Humans. Male. Reoperation. Shoulder Dislocation / surgery. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address: